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Utilizing(Human(Induced(Pluripotent(Stem(Cells(in(the(Study(of(Alcohol(Use(Disorder(
(
Richard(Lieberman,(Ph.D.(
University(of(Connecticut((
2016(
(
Abstract:))Alcohol(use(disorder(is(a(complex,(heterogeneous(disorder(that(affects(≈14%(of(
the(U.S.(population.((Much(of(what(is(known(about(the(molecular(effects(of(alcohol(on(the(
brain(has(been(derived(from(studies(utilizing(rodent(or(human(postNmortem(tissue(model(
systems.( ( The( advent( of( induced( pluripotent( stem( cell( (iPSC)( technologies( allows( for( the(
examination(of(phenotypicallyN(and(geneticallyNcharacterized(human(neural(cells(in#vitro.((
Much(of(the(work(presented(in(this(dissertation(explores(the(utility(of(iPSCs(in(the(study(of(
alcohol(use(disorder.((We(start(by(exploring(whether(human(iPSCNderived(neural(cells(can(
recapitulate( the( findings( in( animal( models( examining( the( molecular( effects( of( acute( and(
chronic( alcohol( exposure( on( ligand( gated( ion( channel( function( and( gene( expression(
(chapter( 2).( ( Next,( we( utilize( iPSCs( in( the( study( of( a( common( single( nucleotide(
polymorphism( in( the( GABRA2# gene( that( has( been( linked( to( the( development( of( AUD(
(chapter( 3).( ( Finally,( we( use( in( a( large( human( sample( to( identify( a( novel( gene( x(
environment( interaction( for( a( polymorphism( in( the( FKBP5( gene( that( moderates( heavy(
alcohol( consumption( in( the( setting( of( early( life( trauma,( and( explore( the( molecular(
implications(of(the(polymorphism(in(human(iPSCNderived(neural(cultures((chapters(4(and(
5).((This(work(suggests(that(iPSC(neural(differentiation(is(a(promising(tool(in(the(study(of(
complex(psychiatric(disorders(such(as(drug(addiction.(
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Chapter)1.)
Introduction)
(
Alcohol)Use)Disorder(
(

It(is(estimated(that(over(60%(of(the(U.S.(population(consumes(alcohol,(most(of(which(

drink( at( moderate,( safe( amounts,( defined( by( the( National( Institute( of( Alcohol( Abuse( and(
Alcoholism((NIAAA)(as(7(drinks(per(week(for(women(with(no(more(than(three(consumed(in(
one( day,( and( 14( drinks( per( week( for( men( with( no( more( than( four( consumed( in( one( day.(((
Moderate(alcohol(consumption(has(been(shown(to(have(health(benefits(including(reducing(
risk(of(stroke,(heart(disease((O'Keefe(et(al.,(2007),(and(dementia((Deng(et(al.,(2006).((But(the(
same( moderate( alcohol( consumption( also( has( adverse( affects( on( health( including( liver(
cirrhosis(and(increased(risks(of(cancers,(particularly(of(the(mouth(and(throat((Corrao(et(al.,(
2004),(highlighting(the(drug’s(complexity(and(heterogeneity.((Furthermore,(the(benefits(of(
alcohol(consumption(create(a(sharp(JNshaped(curve,(with(heavy(daily(alcohol(consumption(
associated(with(greater(overall(mortality(and(increased(risks(of(stroke((O'Keefe(et(al.,(2007)(
and(dementia((Deng(et(al.,(2006).((Heavy(drinking(is(defined(by(the(NIAAA(as(consumption(
of(five(or(more(drinks(in(a(single(occasion(five(or(more(times(within(the(past(30(days,(and(in(
addition(to(the(detrimental(physical(effects,(continued(heavy(drinking(puts(an(individual(at(
greater(risk(of(developing(alcohol(use(disorder.(((
(

Alcohol( use( disorders( (AUDs)( are( among( the( most( prevalent( psychiatric( disorders(

worldwide((Grant(et(al.,(2004b,(Wittchen(et(al.,(2011),(leading(to(a(reduced(quality(of(life(in(
affected(individuals((Donovan(et(al.,(2005)(and(significantly(contributing(to(global(disability(
(Whiteford(et(al.,(2013).((AUDs(are(diagnosed(by(11(criteria(set(forth(in(the(fifth(version(of(

(

1(

the( Diagnostic( and( Statistical( Manual( of( Mental( Disorders( (DSMNV)( (Table( 1).( ( To( be(
diagnosed( with( AUD( an( individual( must( meet( at( least( two( of( the( 11( criteria( within( a( 12N
month(period.((New(to(this(edition(of(the(DSMNV,(the(severity(of(diagnosis(differs(based(on(
the( number( of( criteria( met;( 2N3( for( mild,( 4N5( for( moderate,( and( greater( than( 6( for( a(
diagnosis(of(severe(AUD((Hasin(et(al.,(2013).((A(recent(epidemiological(study(of(more(than(
36,000( participants( between( 2012N2013( found( the( 12Nmonth( prevalence( of( AUD( in( the(
United(States(was(13.9%,(with(29.1%(of(participants(meeting(DSMNV(diagnostic(criteria(for(
AUD(within(their(lifetime.((12Nmonth(and(lifetime(AUD(was(higher(in(men((17.6%(and(36%)(
than(women((10.4%(and(22.7%),(and(was(highest(in(individuals(between(the(ages(of(18N29(
(26.7%(and(37%)((Grant(et(al.,(2015).((The(staggering(prevalence(of(excessive(alcohol(use(
has( a( high( economic( cost( to( society,( which( in( 2006( was( greater( than( $223( billion,( and(
included(costs(associated(with(lost(productivity,(healthcare,(and(legal(fees((Bouchery(et(al.,(
2011).(
(
Risk)Factors)for)Alcohol)Use)Disorder)
(

Despite(the(large(personal(and(economic(costs(associated(with(AUD,(less(than(20%(

of(affected(individuals(seek(treatment((Grant(et(al.,(2015).((While(there(are(currently(three(
FDA( approved( medications( for( the( treatment( of( AUD,( the( small( fraction( of( affected(
individuals( that( seek( treatment( is( in( part( due( to( the( poor( efficacy( and( adverse( effects( of(
currently( approved( medications.( ( This( has( led( researchers( to( identify( risk( factors( that(
influence(development(of(AUD,(which,(in(addition(to(contributing(to(the(understanding(of((
(

(

(

2(

(
Table)1.1.))DSMF5)Criteria)for)Diagnosis)of)Substance)Use)Disorder)
)
Diagnosis(of(Alcohol(Use(Disorder(Requires(Meeting(Two(or(More(Criteria(Within(a(
12NMonth(Period:(
1.((Hazardous(Use(
2.((Social/Interpersonal(Problems(Related(to(Use(
3.((Neglected(Major(Roles(to(Use(
4.((Use(Larger(Amounts(for(Longer(Periods(of(Time(
5.((Repeated(Attempts(to(Quit(or(Control(Use(
6.((Much(Time(Spent(Using(
7.((Physical(or(Psychological(Problems(Related(to(Use(
8.((Activities(Given(Up(to(Use(
9.((Withdrawal(Symptoms(
10.((Tolerance(to(Acute(Effects(
11.((Craving(
2N3(Criteria(=(Mild,(4N5(Criteria(=(Moderate,(>6(Criteria(=(Severe(
)
(
(

(

3(

the(disease,(may(help(to(identify(atNrisk(individuals(to(curb(or(prevent(future(development(
of(AUD.((
(

The( risks( associated( with( AUD( come( from( both( environmental( and( genetic(

influences,( and( as( discussed( later,( there( is( a( complex( interaction( between( the( two.((
Environmental( factors( such( as( exposure( to( alcohol( (as( one( cannot( become( dependent( on(
alcohol( without( exposure( (Gelernter( and( Kranzler,( 2009))( ( and( stressful( or( traumatic(
events(are(predictors(for(increased(drinking(and(development(of(AUD(.((Indeed,(acute(and(
chronic( stress( experienced( in( adulthood( leads( to( increased( alcohol( consumption( and(
vulnerability(to(AUD((Sinha,(2008),(but(additionally(stress(or(trauma(experienced(early(in(
development( can( have( longNlasting( effects( on( hypothalamicNpituitaryNadrenal( (HPA)( axis(
functioning,( leading( to( increased( risk( of( AUD( in( adulthood( (Sinha,( 2008,( Enoch,( 2011).((
However,( the( mechanisms( by( which( early( life( exposure( to( stress( or( trauma( increases( the(
risk( of( AUD( in( adulthood( are( complex,( as( not( every( maltreated( child( develops(
psychopathology.( ( As( discussed( later,( this( suggests( that( genetics( interact( with(
environmental(influences(to(shape(risk.(
(

In( addition( to( environmental( factors,( there( is( a( significant( genetic( component( to(

AUD( that( was( originally( indicating( by( the( groundbreaking( findings( of( family,( twin,( and(
adoption( studies,( and( then( further( elucidated( by( the( use( of( modernNday( genetic(
approaches.( ( Astute( observers( over( the( course( of( early( history( noticed( that( excessive(
alcohol( use( “runs( in( families”( (Devor( and( Cloninger,( 1989).( ( Observations( in( the( clinical(
field(support(this(notion,(including(those(made(by(Crothers((1909)(over(the(course(of(a(35N
year(career,(observing(that(of(the(over(4400(“inebriates”(he(treated,(over(70%(had(a(family(
member( whom( also( suffered( from( the( disorder( (Crothers,( 1909).( ( Meta( analysis( on( the(

(

4(

following( decades( worth( of( research( examining( family( histories( in( affected( individuals(
provided(further(support(for(the(familial(transmission(of(AUD,(proposing(that(the(offspring(
of(individuals(with(AUD(were(approximately(three(to(five(times(more(likely(to(develop(AUD(
during(their(lifetime(than(offspring(of(nonNaffected(individuals((Cotton,(1979).(
(

Indeed,( one( of( the( most( reliable( predictors( of( AUD( is( a( positive( family( history,( but(

due( to( shared( environments( between( families( it( is( difficult( to( specifically( quantify( the(
genetic( contribution( of( AUD( using( these( studies( (McGue,( 1999).( ( Therefore,( some( of( the(
best( studies( to( tease( apart( the( genetic( component( of( AUD( from( environmental( influences(
are(twin(and(adoption(studies.((Twin(studies(set(out(to(examine(traits(in(monozygotic(and(
dizygotic(twins.((Since(monozygotic(twins(are(genetically(identical(and(dizygotic(twins(are(
about( 50%( genetically( identical,( a( trait( that( has( a( large( genetic( component( will( have( a(
greater( concordance( among( monozygotic( than( dizygotic( twins( (Devor( and( Cloninger,(
1989).((When(examining(AUD(among(twins,(higher(concordance(rates(have(been(reported(
in( monozygotic( vs.( dizygotic( twins( in( a( large( sample( of( over( 8900( Swedish( twins( across(
multiple( birth( cohorts( ranging( from( 1902N1949( (Kendler( et( al.,( 1997)( and( in( a( U.S.Nbased(
study( containing( over( 3500( twins( (Prescott( and( Kendler,( 1999).( ( These( studies,( coupled(
with(numerous(other(studies(examining(AUD(concordance(among(twins,(indicate(that(the(
genetic( component( of( AUD( is( large( (Devor( and( Cloninger,( 1989).( ( ( In( fact,( a( significant(
strength( of( examining( monozygotic( and( dizygotic( twins( is( the( ability( to( calculate(
heritability,( the( proportion( of( the( trait( attributed( to( genetic( factors,( which( for( AUD( is(
estimated(between(50N60%((McGue,(1999).(((
(

Another(design(that(aims(to(separate(the(genetic(and(environmental(components(of(

a( trait( are( adoption( studies,( which( examine( offspring( of( affected( individuals( reared( in(

(

5(

environments(away(from(the(biological(parent.((Goodwin(et(al.((1973)(examined(a(sample(
of( 133( male( adoptees,( 55( of( which( had( a( biological( parent( with( AUD,( and( found( that(
significantly( more( adoptees( with( a( parent( with( AUD( had( a( history( of( drinking( problems(
(Goodwin(et(al.,(1973).((Further(adoption(studies(have(confirmed(the(finding(that(adopted(
children( of( alcoholics( have( higher( rates( of( AUD( than( adopted( children( of( nonNalcoholics,(
(McGue,(1999),(although(gender(differences(have(been(observed,(such(that(male(adoptees(
with( a( biological( parent( with( AUD( were( at( greater( risk( (Devor( and( Cloninger,( 1989,(
Goodwin(et(al.,(1977).(
(

The(genetic(component(of(AUD(identified(through(family,(twin,(and(adoption(studies(

led( to( the( search( for( “risk( genes;”( genes( harboring( genetic( variants( such( as( single(
nucleotide(polymorphisms((SNPs)(that(associate(with(development(of(AUD(in(a(population(
sample.((Some(of(the(most(replicable(AUDNassociated(SNPs(are(found(within(genes(encoding(
enzymes( that( metabolize( alcohol( and( its( toxic( downstream( byproduct( acetaldehyde.((
Accumulation(of(acetaldehyde(leads(to(flushing,(dizziness,(and(nausea.((Functional(genetic(
variation( within( two( genes,( ADH1B( (alcohol( dehydrogenase( 1B)( and( ALDH2( (aldehyde(
dehydrogenase(2),(results(in(overactive(and(underactive(enzymatic(function,(respectively.(
In( turn,( the( altered( enzymatic( function( leads( to( an( overNaccumulation( of( acetaldehyde,(
which(is(responsible(for(the(adverse(“flushing(reaction”(that(occurs(when(people(carrying(
the( polymorphisms( in( either( of( these( genes( consume( alcohol( (Crabb( et( al.,( 1989).( ( The(
genetic( variants( within( ADH1B( and( ALDH2( are( protective,( as( subjects( carrying( these(
mutations(have(lower(rates(of(AUD(due(to(the(reduced(ability(to(consume(alcohol(without(
becoming(ill((Thomasson(et(al.,(1991).((Additional(functional(polymorphisms(located(within(

(

6(

genes(encoding(alcohol(metabolizing(enzymes(have(also(been(linked(to(AUD,(particularly(in(
a(cluster(of(genes(located(on(chromosome(4((Gelernter(and(Kranzler,(2009).(
(

As( discussed( in( subsequent( sections,( alcohol( is( a( nonNspecific( drug( that( exerts( its(

behavioral(effects(by(targeting(many(neurotransmitter(receptors(and(systems.((SNPs(within(
genes(encoding(the(targets(for(the(molecular(actions(of(alcohol(would(therefore(be(obvious(
candidates( to( link( to( development( of( AUD.( ( Indeed,( greater( risk( for( AUD( has( been(
associated( with( SNPs( located( in( genes( encoding( targets( of( alcohol( including( the( μNopiod(
receptor((OPRM1),(muscarinic(acetylcholine(receptor(M2((CHRM2),(dopamine(D2(receptor(
(DRD2),( serotonin( transporter( (SLC6A4),( NR2A( subunit( of( the( NMDA( receptor( (GRIN2A),(
neurosteroidNsynthesizing(enzymes(5αNreductase(type(I((SRD5A1)(and(aldoNketo(reductase(
family(1,(member(3((AKR1C3),(among(many(others((Gelernter(and(Kranzler,(2009,(Dick(and(
Bierut,( 2006,( Milivojevic( et( al.,( 2014,( Domart( et( al.,( 2012,( Rietschel( and( Treutlein,( 2013).((
However,( recent( metaNanalysis( examining( SNPs( in( over( 50( candidate( genes( found( that(
several( common( variants( associated( with( AUD( could( not( be( replicated( in( the( larger(
compiled( sample.( ( The( only( significant( AUDNassociated( SNP( that( withstood( the( metaN
analysis( was( rs279858( in( GABRA2,( which( encodes( the( α2( subunit( of( the( GABAA( receptor(
(Olfson( and( Bierut,( 2012).( ( This( synonymous( SNP( resides( in( exon( 5( and( is( a( TNtoNC(
substitution(where(the(CNallele(is(overrepresented(in(individuals(with(AUD((Covault(et(al.,(
2004,( Edenberg( et( al.,( 2004).( ( The( GABRA2( gene( resides( within( a( cluster( of( four( GABAA(
receptorNencoding(genes(on(chromosome(4p12,(with(the(AUDNassociated(SNP(located(in(a(
haplotype( block( of( SNPs( in( strong( linkage( disequilibrium( spanning( the( 3’( end( of( GABRA2(
and(the(5’(end(of(the(adjacent(GABRG1(gene((Covault(et(al.,(2008),(and(associations(between(
haplotypeNtagging( SNPs( in( this( region( with( AUD( have( been( some( of( the( most( wellN

(

7(

replicated.( ( However,( the( molecular( functions( of( genetic( variation( within( this( region( that(
lead( to( increased( risk( of( AUD( have( remained( elusive,( potentially( due( to( the( limitation( of(
applicable(model(systems(since(this(synonymous(SNP(may(not(have(functional(effects(itself,(
but( rather( may( be( in( linkage( with( a( functional( variant.( Intriguingly,( GABRA2( genetic(
variation(is(associated(with(differences(in(fast(betaNfrequency(brain(activity(measured(via(
electroencephalogram((Edenberg(et(al.,(2004),(and(activation(of(brain(areas(associated(with(
addiction(to(reward(or(alcohol(cues((Villafuerte(et(al.,(2012,(Kareken(et(al.,(2010,(Heitzeg(et(
al.,(2014),(suggesting(that(genetic(variation(within(this(chromosomal(region(that(is(tagged(
by( rs279858( in( GABRA2( may( in( part( exert( effects( at( the( level( of( brain( development( and(
connectivity.(
(

Complex( interactions( between( genes( and( environment( also( contribute( to( risk( of(

AUD,( although( currently( identified( interactions( between( genetic( variants( and(
environmental(influences(are(limited.((One(reported(gene(x(environment(interaction(is(with(
a( functional( repeat( polymorphism( located( in( SLC6A4,( which( encodes( the( serotonin(
transporter.( ( This( variant( gives( rise( to( “short”( and( “long”( alleles( where( the( short( allele( is(
associated( with( reduced( transcriptional( activity( and( serotonin( transporter( function.((
Originally( identified( to( moderate( the( influence( of( stressful( life( events( on( depressive(
symptoms((Caspi(et(al.,(2003),(the(short(allele(has(since(been(found(to(moderate(the(effect(
of( pastNyear( negative( life( events( on( alcohol( consumption,( such( that( carriers( of( the( short(
allele( that( experienced( negative( life( events( reported( greater( frequencies( of( drinking( and(
heavy(drinking((Covault(et(al.,(2007).((Another(gene(x(environment(interaction(identified(to(
moderate( risk( of( AUD( is( within( gene( encoding( the( corticotropinNreleasing( hormone(
receptor(1((CRHR1),(which(is(a(component(of(the(HPANaxis.((Individuals(homozygous(for(the(
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CNallele(of(the(haplotypeNtagging(SNP(rs1876831(in(CRHR1(that(reported(higher(prevalence(
of( stressful( life( events( had( a( higher( percentage( of( lifetime( heavy( drinking,( drank( greater(
amounts(of(alcohol(per(occasion,(and(reported(earlier(ages(of(drinking(onset((Blomeyer(et(
al.,( 2008,( Schmid( et( al.,( 2010).( ( The( HPANaxis( is( an( intriguing( system( to( explore( other(
candidate( gene( x( environment( interactions,( since( longNlasting( dysregulation( of( HPANaxis(
activity( in( some,( but( not( all,( individuals( that( are( exposed( to( early( life( stress/trauma(
suggests( an( underlying( genetic( component.( ( One( gene( that( has( recently( been( a( primary(
center( of( focus( due( to( its( association( with( the( development( of( psychiatric( disorders(
including( depression,( anxiety,( and( postNtraumatic( stress( disorder( in( traumaNexposed(
individuals(is(FKBP5,(which(encodes(the(FK506(binding(protein(51,(which(is(a(regulator(of(
glucocorticoid( receptor( activity( (Zannas( and( Binder,( 2014b,( Binder,( 2009).( ( Research(
identifying( a( gene( x( environment( interaction( with( FKBP5( on( alcohol( consumption( and(
examination(of(molecular(effects(of(genotype(are(discussed(extensively(in(chapters(four(and(
five.(((
(
Pharmacologic)Actions)of)Acute)Alcohol)on)Neuronal)GABAA)and)NMDA)Receptors)
)

Alcohol( was( originally( hypothesized( to( exert( its( acute( behavioral( effects( through(

interactions(with(and(perturbations(of(lipids(in(the(neuronal(membrane,(in(what(is(known(
as(the(“lipid(theory.”(However,(these(findings(were(refuted(due(to(the(high(concentrations(
of( alcohol( needed( to( observe( biologic( effects( on( membrane( lipids( (Peoples( et( al.,( 1996).((
Alcohol( has( since( been( hypothesized( to( exert( its( acute( behavioral( effects( through(
interactions(with(membraneNbound(proteins,(mainly(neurotransmitter(receptors.((Although(
classified(as(a(depressant,(acute(alcohol(exposure(produces(both(sedative(and(stimulatory(
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behavioral( effects,( likely( due( to( its( pharmacological( actions( on( a( multitude( of(
neurotransmitter(systems,(including(modulation(of(dopamine,(serotonin,(acetylcholine,(and(
glycine(signaling((Spanagel,(2009).((Due(to(the(behavioral(effects(of(acute(alcohol(and(the(
symptoms(of(alcohol(withdrawal(syndrome,(its(modulation(of(γNaminobutyric(acid(type(A(
(GABAA)( and( NNmethylNDNasparate( (NMDA)( ligandNgated( ionotropic( receptor( function( has(
been(studied(in(depth.(
(

GABA(is(the(primary(inhibitory(neurotransmitter(in(the(human(brain.((The(majority(

of( fast( inhibitory( neurotransmission( is( mediated( via( GABA’s( actions( on( ionotropic( GABA(
typeNA(receptors((GABAA).((GABAA(receptors(are(heteropentameric,(composed(of(a(diverse(
set( of( 19( subunits( (α1N6,( β1N3,( γ1N3,( δ,( ε,( θ,( π,( and( ρ1N3),( each( with( four( transmembrane(
domains,(that(surround(a(pore(permeable(to(chloride((Olsen(and(Sieghart,(2009).((The(most(
common( GABAA( receptor( subunit( composition( is( two( α,( two( β,( and( 1( γ( subunit,( with( the(
α1β2γ2(and(α2β3γ2(combinations(being(the(most(abundant(in(adult(cortex((Rudolph(et(al.,(
2001).((Expression(of(subunits(varies(by(brain(region(and(over(the(course(of(development(
(Fillman(et(al.,(2010),(leading(to(heterogeneity(of(GABAA(receptors(with(estimates(of(over(
500( different( receptor( subtypes( (Sieghart( and( Sperk,( 2002).( ( Interestingly,( the( subunit(
stoichiometry( is( a( major( determinant( of( the( electrophysiological( and( pharmacological(
properties(of(the(receptor((Barnard(et(al.,(1998).((Electrophysiologically,(expression(of(α1N6(
subunits(together(with(the(β3(and(γ2(subunits(in(recombinant(GABAA(receptors(in(mouse(
fibroblasts( or( HEKN293( cells( changed( the( receptor’s( sensitivity( to( GABA( and( channel(
kinetics,( including( activation,( deactivation,( and( desensitization( rates( (Picton( and( Fisher,(
2007).( ( The( α( subunit( is( not( solely( responsible( for( determining( receptor( properties,( as(
differences( in( GABA( sensitivity( and( channel( kinetics( have( also( been( observed( when(
(
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expressing(either(the(γ2(or(the(δ(subunit(together(with(the(α1(and(β3(subunits((Haas(and(
Macdonald,( 1999).( ( Pharmacologically,( a( number( of( compounds( exert( effects( on( GABAA(
receptors,( including( benzodiazepines,( barbiturates,( and( steroids,( among( others,( and( the(
efficacy( of( these( modulatory( compounds( varies( for( receptors( comprised( of( different(
subunits( (Sieghart( and( Sperk,( 2002).( ( As( an( example,( the( binding( site( for( classical(
benzodiazepines( such( as( diazepam( resides( between( the( α( and( γ( subunits( of( the( GABAA(
receptor,(and(depending(on(which(subunits(are(expressed,(can(give(rise(to(benzodiazepineN
sensitive( and( –insensitive( receptor( subtypes( (Sieghart,( 1995).( ( Together,( these( findings(
suggest( that( the( diversity( of( GABAA( receptor( subunits( can( give( rise( to( a( variety( of(
functionally(distinct(receptors.(
(

Alcohol( was( originally( hypothesized( to( interact( with( GABAA( receptors( due( to(

similarities( in( the( effects( of( alcohol,( benzodiazepines,( and( barbiturates,( including(
anxiolysis,( sedation,( hypnosis,( impaired( motor( control,( and( impaired( cognitive( function(
(Hevers(and(Luddens,(1998,(Kumar(et(al.,(2009).((Furthermore,(patients(being(treated(for(
alcoholNwithdrawal( symptoms( are( given( benzodiazepines( but( need( greater( doses( than(
those( usually( effective,( indicating( development( of( crossNtolerance( between( drugs( and(
suggesting( shared( molecular( mechanisms( of( action( (Harris,( 1990).( ( Rodent( neurons( have(
been( used( extensively( to( investigate( the( electrophysiological( effects( of( acute( alcohol( on(
GABAA(receptors,(with(varying(results(that(highlight(the(complexity(of(both(the(molecular(
actions(alcohol(and(the(brain.((Current(opinion(is(that(alcohol(potentiates(GABAA(receptorN
mediated( chloride( influx( at( concentrations( that( are( physiologically( relevant( to( human(
consumption( (below( 100mM),( although( results( vary( by( the( brain( region( examined,(
experimental( method,( and( the( concentration( of( alcohol.( ( Studies( using( hippocampal,(
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cortical,( cerebellar,( and( amygdala( slice( preparations( have( shown( that( alcohol’s( effect( on(
GABANgated(chloride(current(is(heterogeneous,(with(some(studies(reporting(a(potentiating(
effect(of(acute(alcohol(and(others(showing(no(effect((Weiner(and(Valenzuela,(2006,(Kumar(
et( al.,( 2009).( ( A( possibility( for( the( reported( inconsistencies( of( alcohol’s( effects( at( GABAA(
receptors( could( be( that( only( a( subset( of( neurons( are( susceptible( to( alcohol,( suggested( by(
the(results(of(Signore(and(Yeh((2000),(who(reported(that(in(cortical(pyramidal(neurons(a(
majority(of(cells(were(insensitive(to(alcohol,(with(only(20%(of(cells(showing(potentiation(in(
response( to( 25mM( acute( alcohol( exposure( (Signore( and( Yeh,( 2000).( ( Similar( results(
suggesting( cellNspecific( sensitivity( to( alcohol( were( obtained( using( cultured( mouse(
hippocampal( and( cortical( cells,( which( showed( a( potentiating( effect( of( alcohol( in( roughly(
70%(of(cells(examined((Aguayo,(1990).((Inconsistencies(may(also(arise(from(the(diversity(of(
GABAA( receptor( subtype,( where( only( subpopulations( of( GABAA( receptors( are( sensitive( to(
alcohol.( ( Using( oocytes,( Wallner( et( al.( (2003)( reported( that( GABAA( receptors( that( contain(
the(δNsubunit,(which(are(primarily(located(extrasynaptically(in(neurons,(are(potentiated(by(
very( low( concentrations( of( alcohol( that( are( achieved( with( social( drinking( (Wallner( et( al.,(
2006).( ( Taken( together,( these( two( results( suggest( that( finding( neurons( that( respond( to(
alcohol( in( the( brain( may( be( challenging,( and( could( explain( some( of( the( discrepancies( in(
reports( examining( the( effects( of( acute( alcohol.( ( Furthermore,( the( potentiating( effects( of(
alcohol(at(the(GABAA(receptor(appear(to(be(biphasic.((In(rat(hippocampal(tissue,(Sanna(et(al.(
(2004)( reported( that( alcohol( has( a( direct( effect( on( both( spontaneous( and( evoked( GABA(
responses(within(the(first(10(minutes(of(exposure,(but(the(effect(is(not(observed(after(this(
early( stage( in( the( presence( of( finasteride,( which( blocks( synthesis( of( neurosteroids,(
suggesting(that(the(potentiating(effect(of(alcohol(on(GABAA(receptors(is(direct(early(on(but(
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at( later( time( points( indirectly( requires( brain( steroidogenesis( (Sanna( et( al.,( 2004).( ( These(
findings(highlight(the(complexity(of(alcohol’s(actions(at(the(GABAA(receptor,(and(suggest(a(
benefit( to( using( human( neurons( to( further( elucidate( mechanisms( of( alcohol’s( inhibitory(
effects(on(the(brain.(((
(

Glutamate( is( the( primary( excitatory( neurotransmitter( in( the( human( brain.( ( Fast(

excitatory( neurotransmission( is( mediated( via( glutamate’s( actions( at( ionotropic( glutamate(
receptors,( of( which( there( are( currently( three( known( classes( identified( by( their( synthetic(
ligands;( αNaminoN3NhydroxyN5NmethylN4Nisoxazolepropionic( acid( (AMPA),( kainate,( and( NN
methylNDNaspartate( (NMDA)( (Traynelis( et( al.,( 2010).( ( While( alcohol( has( been( shown( to(
modulate(all(three(types(of(ionotropic(glutamate(receptors,(NMDA(receptors(in(particular(
have(been(a(primary(focus(for(alcohol(research(due(to(their(unique(contribution(to(cellular(
physiology,( including( synaptic( transmission,( synaptic( plasticity,( and( excitotoxicity( (Nagy,(
2004).( ( NMDA( receptors( are( heterotetramers,( comprised( of( two( obligatory( NR1( subunits(
and( two( additional( subunits,( conventionally( consisting( of( NR2( (AND),( although( recent(
studies( have( elucidated( functional( roles( for( modulatory( NR3( subunits( (CullNCandy( and(
Leszkiewicz,(2004,(Cavara(and(Hollmann,(2008).((The(subunits(of(the(NMDA(receptor(form(
an( ion( channel( permeable( to( cations( with( a( high( permeability( to( calcium,( which( has(
important(intracellular(functions.((NMDA(receptors(are(activated(under(specific(conditions(
that(distinguish(them(from(AMPA(and(kainate(receptors.((First,(NMDA(receptors(require(the(
binding(of(both(the(agonist(glutamate,(which(binds(to(the(NR2(subunit,(and(the(coNagonist(
glycine( (or( serine),( which( binds( to( the( NR1( subunit.( ( Furthermore,( at( normal( resting(
membrane( potential( conventional( NMDA( receptors( are( blocked( by( a( magnesium( ion( that(
resides( in( the( channel( pore,( which( is( only( removed( upon( cellular( depolarization,( making(

(

13(

the( NMDA( receptor( a( “coincidence( detector”( since( it( is( only( activated( under( specific(
conditions((Nagy,(2008b).((Similar(to(GABAA(receptor(previously(discussed,(the(subunits(of(
the(NMDA(receptor(dictate(the(channel(properties,(including(channel(opening(and(closing(
kinetics( and( its( pharmacological( targets.( ( For( example,( NMDA( receptors( containing(
NR1/NR2A( subunits( have( faster( deactivation( kinetics( than( receptors( containing(
NR1/NR2B,( while( inclusion( of( the( NR2B( subunit( makes( the( receptor( susceptible( to( the(
antagonizing(actions(of(ifenprodil((CullNCandy(and(Leszkiewicz,(2004).(
(

Early( studies( using( implanted( electrodes( in( mammals( found( that( acute( alcohol(

exposure( at( concentrations( relevant( to( human( consumption( altered( the( firing( rate( of(
neurons( in( multiple( brain( areas( (Klemm( et( al.,( 1976,( Klemm( and( Stevens,( 1974).((
Investigations( into( the( specific( mechanisms( for( the( altered( firing( rate( led( researchers( to(
discover( that( the( NMDA( receptorNmediated( currents( are( reproducibly( and( potently(
attenuated( by( low( doses( of( alcohol.( ( Some( of( the( earliest( work( implicating( the( NMDA(
receptor( as( a( target( for( acute( alcohol( was( done( in( rat( hippocampal( cells,( where(
pharmacologically( isolated( NMDA( receptorNmediated( currents( were( found( to( be( rapidly(
and(reversibly(inhibited(by(low(doses(of(alcohol(to(a(greater(extent(than(other(ionotropic(
glutamate(receptors((Lovinger(et(al.,(1990,(Lovinger(et(al.,(1989).((Continued(investigation(
into( alcohol’s( actions( at( NMDA( receptors( revealed( that( subunit( stoichiometry( is( a(
determinant( of( alcohol’s( inhibitory( effects( on( NMDA( currents.( ( For( example,( NMDA(
receptors(expressed(in(oocytes(assembled(with(NR1/NR2A(and(NR1/NR2B(subunits(were(
inhibited( more( than( receptors( assembled( with( NR1/NR2C( and( NR1/NR2D( subunits(
(Mirshahi(and(Woodward,(1995).((Additionally,(investigation(of(native(NMDA(receptors(in(
cultured( rodent( neurons( found( that( the( attenuating( effect( of( alcohol( at( NMDA( receptors(
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corresponded(to(the(receptor’s(ability(to(be(antagonized(by(ifenprodil,(which(acts(on(NR2BN
containing( receptors,( suggesting( that( NR2BNcontaining( receptors( are( particularly(
susceptible(to(the(actions(of(alcohol((Lovinger,(1995).((The(mechanisms(by(which(alcohol(
inhibits( the( NMDA( receptor( are( poorly( understood,( as( no( direct( binding( site( has( been(
clearly( identified,( although( hypothetical( binding( sites( have( been( suggested( to( reside(
between( transmembrane( domains( 3( and( 4( (Moykkynen( and( Korpi,( 2012,( Smothers( and(
Woodward,(2006).((A(promising(idea(on(how(alcohol(regulates(NMDA(receptors(is(through(
intracellular( mechanisms.( ( NMDA( receptor( subunits,( in( particular( NR2B,( have( long(
intracellular( CNterminal( domains( that( dictate( the( receptors( trafficking,( localization,( and(
function( via( numerous( postNtranslational( modulatory( sites( (Chen( and( Roche,( 2007).((
Indeed,( acute( alcohol( was( found( to( regulate( Fyn( kinaseNmediated( phosphorylation( of( the(
intracellular( tail( of( the( NR2B( subunit( in( rodent( brain( slices( following( 10( minutes( of(
exposure,(which(lead(to(an(increase(in(channel(function(and(a(tolerance(to(the(acute(effects(
of( alcohol( (Yaka( et( al.,( 2003a).( ( Interestingly,( alcohol’s( affect( on( Fyn( kinaseNmediated(
phosphorylation(of(the(NR2B(subunit(was(found(in(the(hippocampus(but(not(the(prefrontal(
cortex,( suggesting( brainNregion( specific( postNtranslational( modifications( of( the( NMDA(
receptor(by(acute(alcohol.(
(
Molecular)Adaptations)of)GABAA)and)NMDA)Receptors)to)Chronic)Alcohol(
(

The( development( of( tolerance( to( the( acute( effects( of( alcohol( is( one( of( the( criteria(

listed( in( the( DSMNV( for( a( diagnosis( of( alcohol( use( disorder.( ( Tolerance( is( defined( as( a(
diminished(behavioral(response(to(a(drug(over(repeated(exposures.((At(the(molecular(level(
tolerance( is,( in( part,( mediated( via( adaptations( that( occur( within( the( targets( of( alcohol,(

(

15(

including( membraneNbound( ion( channels( such( as( the( GABAA( and( NMDA( receptor.( The(
adaptations( attempt( to( return( normal( functioning( to( these( receptors( in( the( chronic(
presence( of( alcohol,( characterized( as( 24( hours( of( more( of( exposure( to( the( drug(
(Pietrzykowski(and(Treistman,(2008).((The(molecular(changes(that(result(in(altered(GABAA(
and( NMDA( receptor( function( are( a( type( of( homeostatic( plasticity,( allowing( the( brain( to(
retain( a( balance( between( excitatory( and( inhibitory( signaling( that( has( been( dysregulated(
(Clapp(et(al.,(2008).(
(

GABAA(receptors(downNregulate(their(function(following(chronic(alcohol(exposure(to(

counteract( the( persistent( potentiating( effects( of( the( drug( at( these( receptors.( ( Early( work(
demonstrated(that(chronic(exposure(to(alcohol(in#vivo(and(in#vitro#greatly(reduced(agonistN
evoked( GABAANmediated( chloride( flux( (Morrow( et( al.,( 1988,( Buck( and( Harris,( 1991).((
Consistent( with( these( results,( rats( chronically( treated( with( alcohol( showed( a( 30%(
attenuation(of(GABAANmediated(chloride(currents(in(hippocampal(cells(compared(to(sham(
treated( animals( measured( using( whole( cell( patch( clamp( electrophysiology.( ( Interestingly,(
the( reduced( GABAA( receptor( chloride( flux( was( not( observed( in( other( brain( regions(
including(the(frontal(cortex,(parietal(cortex,(and(inferior(colliculus,(suggesting(brain(regionN
specific(modification(of(GABAA(receptors(following(chronic(alcohol((Kang(et(al.,(1996).((The(
mechanisms( by( which( GABAA( receptors( alter( their( function( to( adapt( to( the( alcoholN
containing( environment( may( include( subunit( switching,( since( the( subunit( composition(
dictates( the( receptor’s( functional( properties.( ( Expression( of( GABAA( subunits( following(
chronic( alcohol( has( been( examined( in( animal( models( and( human( postNmortem( brain(
samples.( ( The( most( consistent( findings( of( these( studies( are( an( upregulation( of( the( α4(
subunit( and( a( downregulation( of( the( α1( subunit( (Clapp( et( al.,( 2008,( Devaud( et( al.,( 1995).((
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Interestingly,( expression( of( these( subunits( in( oocytes( revealed( that( GABAA( receptors(
containing( the( α4( subunit( have( faster( channel( deactivation( rates,( while( α1( subunit(
containing(receptors(have(longer(open(duration((Picton(and(Fisher,(2007),(supporting(the(
idea( that( subunits( are( switched( to( compensate( for( the( potentiating( effects( of( alcohol.((
Another( method( by( which( GABAA( receptors( may( adapt( to( chronic( alcohol( is( via(
posttranslational(modifications.((Tyrosine(kinase(phosphorylation(of(the(γ2(and(β2,(but(not(
the(α1(subunit,(was(observed(following(chronic(alcohol(exposure(in(cultured(cortical(mouse(
neurons( (Marutha( Ravindran( and( Ticku,( 2006).( ( Furthermore,( mutant( mice( lacking( a(
specific(isoform(of(protein(kinase(C((PCK)(showed(reduced(responses(to(alcohol(exposure(
(Harris( et( al.,( 1995),( suggesting( that( PKCNmediated( modifications( may( be( a( method( by(
which(GABAA(receptors(adapt(to(an(environment(with(alcohol(present.(
(

NMDA( receptors( also( undergo( modifications( in( response( to( chronic( alcohol(

exposure.( ( Electrophysiological( evidence( suggests( that( NMDA( receptor( function( is(
enhanced(in(the(presence(of(chronic(alcohol(in(order(to(counteract(the(inhibitory(effects(of(
the(drug(at(these(receptors.((Early(in#vitro(evidence(of(increased(NMDA(receptor(function(
was( obtained( using( cultured( mammalian( neurons( chronically( treated( with( alcohol( (4N7(
days),( reporting( that( NMDA( receptorNmediated( calcium( currents( in( cortical( and(
hippocampal(neurons(were(greater(in(cultures(treated(with(alcohol((Smothers(et(al.,(1997,(
Ahern( et( al.,( 1994).( ( Electrophysiological( changes( to( chronic( alcohol( exposure( are(
accompanied(by(an(upregulation(of(genes(encoding(NMDA(receptor(subunits(in(cultured(rat(
cortical(and(hippocampal(neurons((Nagy(et(al.,(2003,(Hu(et(al.,(1996),(while(an(upregulation(
of( the( NR2A( and( NR2B( subunits( were( seen( in( the( frontal( cortex( and( hippocampus( of(
chronically(alcohol(treated(rats((Follesa(and(Ticku,(1995).((Interestingly,(there(is(increased(
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binding(of(radiolabeled(NMDA(receptor(antagonists(in(human(postNmortem(brain(samples(
derived(from(alcoholics((Freund(and(Anderson,(1996),(which(suggests(that(the(number(of(
NMDA(receptors(is(increased(in(response(to(chronic(alcohol.((Indeed,(increased(number(of(
NMDA( receptors( and( increased( synapse( size( were( observed( in( rodent( hippocampal(
cultures( exposed( to( alcohol( for( 4( days((CarpenterNHyland( et( al.,( 2004,( Clapp( et( al.,( 2008).((
The( precise( mechanisms( by( which( NMDA( receptor( subunit( expression( is( upregulated( in(
response( to( chronic( alcohol( remain( poorly( understood,( although( one( study( found(
demethylation(of(the(NR2B(subunit(gene((grin2b)(in(primary(mouse(hippocampal(cultures(
following(5(days(of(alcohol(exposure((Marutha(Ravindran(and(Ticku,(2005),(suggesting(that(
alcoholNrelated(changes(in(methylation(status(may(play(a(role.((It(is(important(to(note(that(
not(all(studies(reported(changes(in(NMDA(subunit(expression(to(alcohol((Nagy,(2008b).((In(
fact,( using( a( primate( model( of( chronic( alcohol( exposure,( which( is( more( applicable( than(
rodent( models( to( the( human( condition,( a( decrease( in( NMDA( receptor( subunit( expression(
was(observed(in(prefrontal(cortex(following(months(of(alcohol(selfNadministration((Acosta(
et( al.,( 2010).( ( In( agreement( with( this( result,( decreased( mRNA( expression( of( the( genes(
encoding( the( NR1,( NR2A,( and( NR2B( subunits( was( observed( in( postNmortem( human( brain(
samples( derived( from( alcoholics( with( cirrhosis( of( the( liver( (Ridge( et( al.,( 2008),( and(
decreased( NR1( protein( expression( was( found( in( the( locus( coeruleus( of( alcoholics(
(Karolewicz(et(al.,(2008).(
(

The(homeostatic(adaptations(that(occur(in(GABAA(and(NMDA(receptors(in(response(

to( chronic( alcohol( can( be( deleterious( to( the( individual( upon( cessation( of( alcohol(
consumption,( leading( to( adverse( symptoms( experienced( during( alcohol( withdrawal,(
including( seizures.( ( Due( to( the( attenuation( of( GABAA( and( the( enhancement( of( NMDA(
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receptors,(the(brain(enters(a(state(of(hyperexcitability(when(alcohol(is(suddenly(withdrawn(
(Clapp( et( al.,( 2008).( ( For( example( hippocampal( explant( cultures( were( found( to( be(
hyperexcitable( following( withdrawal( from( chronic( alcohol( exposure,( and( this(
hyperexcitability(was(NMDANreceptor(dependent((Hendricson(et(al.,(2007).((In(agreement(
with( this,( NMDA( receptor( antagonists( have( been( shown( to( block( alcohol( withdrawal(
associated(seizures(and(prevent(alcohol(withdrawalNassociated(neurotoxicity(in(chronically(
treated( cerebellar( granule( cells( (Hoffman( et( al.,( 1995).( ( In( humans,( alcohol( withdrawal(
symptoms(are(treated(with(GABAA(receptorNpotentiating(pharmacological(agents(including(
the( benzodiazepine( diazepam( (Finn( and( Crabbe,( 1997).( ( Taken( together,( these( findings(
clearly( indicate( the( involvement( of( molecular( adaptations( within( GABAA( and( NMDA(
receptors(in(alcohol(withdrawal(symptoms.(
(
Pharmacologic)Treatments)for)Alcohol)Use)Disorder(
(

Despite(the(prevalence(of(alcohol(use(disorder(in(modern(society(there(are(currently(

only(three(FDANapproved(treatments(for(the(disorder,(and(these(medications(do(not(work(
for( everyone,( likely( due( to( the( heterogeneous,( complex( nature( of( AUDs( that( leads( to(
diversity( among( affected( individuals( (Litten( et( al.,( 2012).( The( poor( outcomes( and( side(
effects(related(to(current(approved(treatments(are(some(factors(that(contribute(to(the(small(
number(of(treatmentNseeking(alcoholics,(with(less(than(20%(of(affected(individuals(seeking(
treatment((Grant(et(al.,(2015).((The(oldest(FDANapproved(treatment,(disulfiram,(which(was(
approved(for(use(treating(AUD(in(1950,(acts(by(inhibiting(aldehyde(dehydrogenase,(leading(
to(an(accumulation(of(acetaldehyde(if(the(individual(consumes(alcohol,(causing(unpleasant(
feelings( such( as( flushing,( headache,( and( nausea( (Heilig( and( Egli,( 2006).( ( Although( the(
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unpleasant( feelings( are( strong( deterrents( to( drink,( many( doctors( are( not( in( favor( of(
prescribing(disulfiram(due(to(the(poor(success(rate,(given(that(individuals(can(simply(stop(
taking(the(medication(before(drinking((Miller,(2008).((The(second(FDA(approved(treatment(
approved( in( 1994,( naltrexone,( acts( as( an( antagonist( to( the( μ( isoform( of( opiod( receptors(
thereby( blocking( the( pleasurable( effects( of( alcohol( consumption( (Miller,( 2008).( ( In(
numerous( studies( treatment( with( naltrexone( was( found( to( be( efficacious( in( reducing( the(
risk( of( relapse( to( heavy( drinking( (Heilig( and( Egli,( 2006),( and( interestingly( its( efficacy( in(
preventing( relapse( is( moderated( by( a( polymorphism( in( the( gene( encoding( the( μ( opiod(
receptor((OPRM1)((Oslin(et(al.,(2003),(suggesting(that(naltrexone(treatment(may(be(more(
beneficial(in(some(individuals.((The(third(treatment(is(acamprosate,(which(was(approved(by(
the( FDA( in( 2004( (Miller,( 2008)( and( acts( as( a( regulator( of( excitatory( and( inhibitory(
neurotransmission( by( targeting( GABA,( NMDA,( and( metabotropic( glutamate( receptors(
(Heilig(and(Egli,(2006).((Acamprosate(is(currently(the(most(widely(prescribed(medication(
for(AUD(due(its(safety(and(efficacy(in(maintaining(abstinence(from(alcohol(use((Mason(and(
Heyser,( 2010).( ( Similar( to( naltrexone,( efficacy( of( acampraste( in( treating( AUD( was(
moderated(by(polymorphisms(within(two(genes(encoding(subunits(of(the(GABAA(receptors(
(GABRA6(and(GABRB2)((Ooteman(et(al.,(2009),(implicating(that(genetic(background(may(be(
a(source(of(variability(between(responders(and(nonNresponders(to(medications,(and(further(
suggesting(that(genetic(screens(may(be(advantageous(in(prescribing(treatments(for(AUD.(((
(

As( previously( described,( chronic( alcohol( use( results( in( compensatory( changes( in(

excitatory/inhibitory( neurotransmission( via( changes( in( many( receptors( including( GABAA(
and( NMDA( receptors.( ( Acamprosate( is( currently( the( only( FDA( approved( medication( that(
targets(the(known(receptors(that(are(significantly(modulated(by(chronic(alcohol.((Current(
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knowledge(of(what(systems(alcohol(targets(and(modulates(has(led(studies(to(investigation(
of( compounds( that( modulate( neurotransmission( as( future( treatments( for( AUD.( ( Such(
potential(medications(include(baclofen,(which(modulates(presynaptic(metabotropic(GABAB(
receptors,(ondansetron,(which(targets(a(class(of(serotonin(receptors((5NHT3),(varenicline,(
which( targets( nicotinic( acetylcholine( receptors,( and( topiramate,( which( is( currently( FDAN
approved( for( use( as( an( anticonvulsant( and( acts( by( modulating( a( number( of( receptors(
including( glutamatergeric( kainate( and( NMDA( receptors,( GABAA( receptors,( as( well( as(
voltage( gated( sodium( and( potassium( channels( (Heilig( and( Egli,( 2006,( Miller,( 2008).((
Additional( research( examining( the( molecular( effects( of( alcohol( on( the( human( brain( may(
identify( novel( targets( of( alcohol( that( lead( to( better( treatment( options.( ( Furthermore,( as(
indicated( by( studies( examining( genetic( moderators( of( naltrexone( and( acamprosate(
treatments((Oslin(et(al.,(2003,(Ooteman(et(al.,(2009),(pharmacogenomics(research(promises(
better(patientNmedication(matching(and(should(play(a(large(role(in(the(future(treatment(of(
AUD.((This(has(recently(been(demonstrated(for(topiramate,(where(efficacy(of(the(drug(for(
reducing( heavy( drinking( in( alcoholics( was( moderated( by( a( polymorphism( in( the( GRIK1(
gene,( which( encodes( the( GluK1( subunit( of( the( kainate( receptor,( a( target( for( topiramate’s(
pharmacologic(action.((In(this(study,(Kranzler(et(al.((2014)(reported(that(homozygotes(for(
the( rs2832407( CNallele( treated( with( topiramate( reduced( their( heavy( drinking( days(
significantly(more(than(placebo,(an(effect(that(was(not(observed(in(carriers(of(the(ANallele(
(Kranzler( et( al.,( 2014a),( and( importantly( the( effect( of( topirmatae( on( reduction( of( heavy(
drinking(days(was(maintained(3N(and(6Nmonths(after(treatment(in(rs2832407(C/C(subjects(
(Kranzler(et(al.,(2014b).(
(
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Induced)Pluripotent)Stem)Cells)in)the)Study)of)Psychiatric)Disorders(
(

Much(of(what(we(know(about(the(molecular(actions(of(alcohol(on(the(brain(has(been(

derived( from( the( study( of( rodent( models( and( postNmortem( human( brain( samples,( which(
may( not( accurately( reflect( responses( in( human( cells( or( the( human( condition( of( AUD.((
Therefore,( an( in# vitro( model( system( of( phenotypicallyN( and( geneticallyNcharacterized(
human( neural( cells( would( be( beneficial( for( the( examination( of( the( molecular( effects( of(
alcohol( and( AUDNassociated( genetic( variants( in( human( tissue.( ( The( advent( of( induced(
pluripotent( stem( cell( technologies( has( revolutionized( the( field( of( stem( cell( research,( with(
promising(use(for(the(study(of(genetically(heterogeneous(and(difficultNtoNmodel(psychiatric(
disorders.( ( Induced( pluripotent( stem( cells( (iPSCs)( were( first( generated( in( 2006( by(
reprogramming(mouse(fibroblasts(to(a(state(of(pluripotency(through(the(expression(of(four(
transcription( factors( (OCT3/4,( KLF4,( SOX2,( and( cNMyc)( via( viral( transduction( (Takahashi(
and( Yamanaka,( 2006).( ( Human( iPSCs( were( generated( the( following( year( using( the( same(
methodology( (Takahashi( et( al.,( 2007).( ( Cellular( reprogramming( resets( the( epigenetic(
landscape(to(state(similar(to(that(observed(in(human(embryonic(stem(cells,(although(iPSC(
methylation( patterns( differ( between( cell( lines( and( harbor( signatures( from( their( tissue( of(
origin( (Kim( et( al.,( 2010,( Lister( et( al.,( 2011).( ( Despite( differences( in( epigenetic( profiles(
between( embryonic( and( induced( stem( cells,( a( defining( characteristic( of( iPSCs( is( that( they(
have( the( capacity( to( differentiate( into( all( cell( types( from( the( three( germ( layers,( including(
neural( cells,( making( them( a( powerful( tool( for( in# vitro( examination( of( difficult( to( obtain(
human(neural(tissue((FIGURE(1.1).(((
(

To( date,( numerous( protocols( have( been( used( to( differentiate( iPSCs( into( various(

neuronal(cell(types,(including(cultures(that(are(enriched(for(glutamate((Zeng(et(al.,(2010),((

(
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Figure)1.1.))Application)of)Induced)Pluripotent)Stem)Cells)
)

((
(
PatientNderived( somatic( cells( can( be( reprogrammed( to( a( state( of( pluripotency( through(
expression( of( transcription( factors;( generating( patientNspecific( induced( pluripotent( stem(
cells( (iPSC).( ( Through( various( protocols,( iPSCs( can( be( driven( to( differentiate( into( any( cell(
type(derived(from(the(three(embryonic(germ(layers.((These(differentiated(cells(can(then(be(
used(as(in#vitro(models(of(disease(or(for(toxicology(and(drug(screening(studies,(as(well(as(
used( for( regenerative( medicine( in( cell( replacement( therapies.( ( Picture( taken( from(
Yamanaka((2009)(“A#Fresh#Look#at#iPS#Cells.”(
(

(
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dopamine((Swistowski(et(al.,(2010),(interneuron((Liu(et(al.,(2013),(and(serotonin(neurons(
(Shimada( et( al.,( 2012),( providing( researchers( a( minimally( invasive( method( to( explore(
molecular( phenotypes( of( psychiatric( disorders( in( human( neural( cultures.( ( Although( the(
field( is( in( its( infancy,( iPSC( technology( has( been( used( to( study( numerous( psychiatric(
disorders( where( in#vitro( models( were( previously( limited( or( even( unobtainable,( including(
complex( neurogenetic( disorders( such( as( Angelman( and( PraderNWilli( syndrome(
(Chamberlain( et( al.,( 2010,( Germain( et( al.,( 2014),( schizophrenia( (Brennand( et( al.,( 2011),(
nonNsyndromic( autism( spectrum( disorder( (Mariani( et( al.,( 2015),( DISC1Nrelated( mental(
disorders( (Wen( et( al.,( 2014),( and( bipolar( disorder( (Madison( et( al.,( 2015),( among( others.((
However,( research( utilizing( iPSCs( to( explore( drug( addictions( such( as( AUD,( including( the(
molecular( effects( of( drug( exposure( or( addictionNassociated( genetic( variants,( is( lacking,(
potentially( due( to( the( challenges( posed( by( the( large( environmental( influence( and(
genetically(heterogeneous(nature(of(AUD.(
(
Thesis)Objectives(
(

iPSC( technologies( are( promising( new( tools( in( the( study( of( psychiatric( disorders(

including(AUD.((However,(work(examining(their(utility(in(exploration(of(drug(addiction(is(
limited,( and( is( nonexistent( in( the( study( of( AUD.( ( Nonetheless,( if( iPSCNderived( neural(
cultures(express(functional(targets(of(alcohol(and(are(able(recapitulate(molecular(effects(of(
alcohol( exposure( identified( in( rodent( or( postNmortem( human( samples,( iPSC( technologies(
promise( new( insights( into( mechanisms( of( AUD.( ( Exploring( the( utility( of( iPSCs( for( AUD(
research(is(the(central(objective(of(this(thesis(work.((To(achieve(this(objective,(the(following(
questions(are(addressed:(1)(Do(human(iPSCNderived(neural(cells(express(functional(targets(
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of(alcohol,(and(does(the(effect(of(acute(and(chronic(alcohol(exposure(recapitulate(findings(
observed( in( rodent( and( human( postNmortem( model( systems?( ( 2)( Can( iPSC( neural(
differentiation( provide( new( insights( into( the( molecular( effects( associated( with( genetic(
variation(within(the(AUDNrisk(gene(GABRA2?((3)(Is(genetic(variation(within(the(psychiatric(
disorderNassociated( gene( FKBP5( predictive( of( alcohol( consumption( in( humans( and( 4)( can(
iPSCNderived(neural(cells(recapitulate(reported(effects(of(FKBP5(genetic(variation(on(mRNA(
expression( previously( observed( in( peripheral( blood( cells?( ( The( results( presented( in( this(
dissertation(support(the(utilization(of(iPSCs(for(researching(the(molecular(effects(of(alcohol(
and( AUDNassociated( polymorphisms( on( human( neural( cells( in#vitro( by( arguing( that( iPSCN
derived(neural(cells(express(functional(targets(of(alcohol(and(display(adaptations(to(acute(
and( chronic( alcohol( exposure( previously( reported( in( other( model( systems.( ( Furthermore,(
polymorphisms(associated(with(development(of(AUD(and(increased(alcohol(consumption(in(
a(large(human(sample(can(be(examined(in#vitro(using(human(iPSC(neural(differentiation.(
(

(
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Chapter)2.)
Pilot)Study)of)iPSFDerived)Neural)Cells)to)Examine)Biologic)Effects)of)Alcohol)on)
Human)Neurons)In#Vitro#
The(following(chapter(is(a(duplicate(version(of(a(published(manuscript:(Lieberman,(R.,(
Levine,(E.(S.,(Kranzler,(H.(R.,(Abreu,(C.,(&(Covault,(J.((2012).(Alcoholism,(Clinical(and(
Experimental(Research,(36(10),(1678N1687.(
(

)
Abstract)
(
Background:((Studies(of(the(effects(of(alcohol(on(NMDA(receptor(function(and(gene(
expression( have( depended( on( rodent( or( postNmortem( human( brain( models.( ( Ideally,( the(
effects( of( alcohol( might( better( be( examined( in( living( neural( tissue( derived( from( human(
subjects.( ( In( this( study,( we( used( new( technologies( to( reprogram( human( subjectNspecific(
tissue(into(pluripotent(cell(colonies(and(generate(human(neural(cultures(as(a(model(system(
to( examine( the( molecular( actions( of( alcohol.( ( Methods:( ( Induced( pluripotent( stem( (iPS)(
cells( were( generated( from( skin( biopsies( taken( from( 7( individuals,( 4( alcohol( dependent(
subjects( and( 3( social( drinkers..( ( We( differentiated( the( iPS( cells( into( neural( cultures( and(
characterized( them( by( immunocytochemistry( using( antibodies( for( the( neuronal( marker(
beta( IIINtubulin,( glial( marker( s100β,( and( synaptic( marker( synpasin1.( ( Electrophysiology(
was( performed( to( characterize( the( iPSNderived( neurons( and( measure( the( effects( of( acute(
alcohol(exposure(on(the(NMDA(receptor(response(in(chronically(alcohol(exposed(and(nonN
exposed( neural( cultures( from( one( nonNalcoholic.( ( Finally,( we( examined( changes( in( mRNA(
expression(of(the(NMDA(receptor(subunit(genes(GRIN1,#GRIN2A,#GRIN2B,#and(GRIN2D(after(
7( days( of( alcohol( exposure( and( after( 24Nhour( withdrawal( from( chronic( alcohol( exposure.((
Results:((Immunocytochemistry(revealed(positive(staining(for(neuronal,(glial,(and(synaptic(
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markers.( iPSNderived( neurons( displayed( spontaneous( electrical( properties( and( functional(
ionotropic(receptors.((Acute(alcohol(exposure(significantly(attenuated(the(NMDA(response,(
an( effect( that( was( not( observed( after( 7( days( of( chronic( alcohol( exposure.( After( 7( days( of(
chronic( alcohol( exposure,( there( were( significant( increases( in( mRNA( expression( of( GRIN1,#
GRIN2A,#and(GRIN2D#in(cultures(derived(from(alcoholic(subjects(but(not(in(cultures(derived(
from(nonNalcoholics.((Conclusions:((These(findings(support(the(potential(utility(of(human(
iPSNderived(neural(cultures(as(in#vitro(models(to(examine(the(molecular(actions(of(alcohol(
on(human(neural(cells.(
)
Introduction)
)

Alcohol(use(disorders,(including(alcohol(abuse(and(dependence,(are(among(the(most(

prevalent( mental( disorders( in( the( United( States,( with( approximately( 8.5%( of( the( US(
population(being(affected(by(them(during(a(oneNyear(period((Grant(et(al.,(2004a).((Despite(
the(high(prevalence(of(these(disorders,(the(molecular(mechanisms(underlying(many(of(the(
behavioral( effects( of( alcohol( and( those( that( lead( to( the( development( of( tolerance( and(
dependence(are(not(well(understood((Lewohl(et(al.,(2000,(Hanchar(et(al.,(2006).(
(

LigandNgated(ion(channels,(including(the(NNmethylNDNaspartate((NMDA)(and(GABAA(

receptors(are(targets(for(the(actions(of(alcohol((Vengeliene(et(al.,(2008)(and(these(may(play(
a( role( in( the( development( of( alcohol( use( disorders.( ( In( the( central( nervous( system( (CNS),(
NMDA(receptors(play(important(roles(in(synaptic(transmission,(synaptic(plasticity((such(as(
longNterm(potentiation),(and(excitotoxicity((Nagy,(2004).((The(conventional(NMDA(receptor(
is( a( tetrameric( structure( consisting( of( two( NR1( and( two( NR2( (NR2AND)( subunits( (Bigge,(
1999)( that( surround( a( cation( channel( with( a( high( permeability( to( calcium( (Cavara( and(
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Hollmann,( 2008).( ( Under( normal( resting( conditions( the( NMDA( receptor( is( blocked( by(
magnesium( (Mg2+)( ions,( which( reside( inside( the( channel( pore.( ( This( blockade( is( removed(
upon( membrane( depolarization( in( conjunction( with( the( combined( binding( of( the( agonist(
glutamate( and( the( coNagonist( glycine.( ( Because( these( channels( are( activated( only( when(
electrical(and(chemical(signals(are(present(simultaneously,(NMDA(receptors(are(thought(to(
act(as(coincidence(detectors((Nagy,(2008b).(
Research(using(both(in#vivo(and#in#vitro#models(has(established(that(both(acute(and(
chronic(exposure(to(alcohol(affects(the(NMDA(receptor.((Acutely,(alcohol(acts(as(an(NMDA(
antagonist((Tomberg,(2010),(leading(to(significant(decreases(in(the(size(of(NMDA(excitatory(
postNsynaptic(potentials((EPSPs)((Nie(et(al.,(1994)(and(inhibition(of(NMDANdependent(longN
term(potentiation((LTP)((Puglia(and(Valenzuela,(2010).((Chronic(exposure(to(alcohol(leads(
to(an(increased(density(of(receptors(and(facilitation(of(NMDA(receptor(functioning,(due(to(
receptor( subunit( phosphorylation( and( increased( expression( of( various( NMDA( receptor(
subunit( mRNAs( (Nagy,( 2008b).( ( Significantly( increased( expression( after( chronic( alcohol(
exposure(has(been(observed(in(NR1(subunit(mRNA(in(the(amygdala((Floyd(et(al.,(2003)(and(
protein(in(the(hippocampus((Maler(et(al.,(2005),(in(NR2A(and(NR2B(subunit(mRNA(in(the(
cortex(and(hippocampus((Follesa(and(Ticku,(1995)(and(protein(in(the(hippocampus((Maler(
et( al.,( 2005).( ( After( a( 48Nhour( withdrawal( period,( NR1,( NR2A,( and( NR2B( mRNA( levels(
returned(to(baseline(in(the(hippocampus(and(cortex((Follesa(and(Ticku,(1995),(and(protein(
levels( were( returned( to( baseline( in( the( amygdala( (Roberto( et( al.,( 2006)( and( the( cortex(
(Kalluri(et(al.,(1998).((The(changes(observed(in(NMDA(receptor(expression(and(function(are(
believed( to( contribute( to( the( development( of( alcohol( tolerance( and( dependence,( and( the(
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CNS(hyperexcitability(and(excitotoxicity(observed(during(alcohol(withdrawal((Nelson(et(al.,(
2005,(Nagy,(2008a,(Nagy,(2008b)(
(

Other( studies( have( compared( postNmortem( human( brain( tissue( derived( from(

alcoholics( and( non( alcoholics( (Lewohl( et( al.,( 1997,( Lewohl( et( al.,( 2000).( ( NMDA( receptor(
NR1,(NR2A,(and(NR2B(subunit(mRNA(expression(in(both(the(superior(frontal(and(primary(
motor( cortices( was( significantly( lower( in( alcoholic( individuals( with( cirrhosis( of( the( liver(
than( either( nonNalcoholic( controls( or( alcoholics( without( coNmorbid( disease( (Ridge( et( al.,(
2008).( ( Studies( using( postNmortem( human( brain( tissue( bypass( the( questions( of( relating(
animal( models( to( humans.( ( However,( using( postNmortem( brain( tissue( does( not( allow( for(
examination(of(electrophysiological(effects(of(alcohol(or(controlled(exposure(to(alcohol(on(
gene( expression.( ( In( addition,( factors( including( gender,( brain( pH,( age( of( death,( ethnicity,(
history(of(medication,(and(postNmortem(interval(also(contribute(to(variability(among(postN
mortem(samples((Hynd(et(al.,(2003,(Preece(and(Cairns,(2003).((
(

One(way(potentially(to(bypass(the(difficulties(that(arise(with(the(use(of(animal(and(

postNmortem( human( brain( models( is( to( derive( pluripotent( cells( from( samples( taken( from(
living(participants,(and(then(differentiate(these(pluripotent(cells(into(the(tissue(of(interest.((
Takakashi( and( Yamanaka( reported( that( it( was( possible( to( reprogram( mouse( or( human(
fibroblasts( into( a( pluripotent( state( by( virally( introducing( 4( factors( into( the( cell( culture,(
generating( induced( pluripotent( stem( (iPS)( cells( (Takahashi( et( al.,( 2007,( Takahashi( and(
Yamanaka,(2006).((Subsequently,(other(groups(have(used(protocols(developed(for(human(
embryonic( stem( (hES)( cells( to( differentiate( iPS( cells( into( neural( cultures( containing(
neurons( and( glia( (Hu( et( al.,( 2010,( Johnson( et( al.,( 2007).( ( iPS( cell( derivation( and( neural(
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differentiation( provides( a( minimally( invasive( method( to( obtain( and( examine( subjectN
specific(neural(tissue.(
(

The(ability(to(generate(neurons(from(participant(fibroblasts(has(made(it(possible(to(

examine( and( study( living( neurons( from( individual( subjects( with( different( diseases(
(Chamberlain(et(al.,(2008).((Current(research(has(focused(on(the(use(of(iPS(cell(technologies(
to( examine( mechanisms( of( neurodegenerative( disease( such( as( amyotrophic( lateral(
sclerosis,(spinal(muscular(atrophy,(and(Parkinson’s(disease((Yamanaka,(2009),(and(genetic,(
neurodevelopmental( diseases( including( Angelman( syndrome( and( PraderNWilli( syndrome(
(Chamberlain( et( al.,( 2010).( ( To( our( knowledge,( there( are( no( reports( of( research( using(
human( iPSNderived( neural( cells( as( a( model( for( the( molecular( actions( of( alcohol( and( the(
development(of(alcohol(use(disorders.(((
(

Here,(we(present(results(focusing(on(the(NMDA(receptor(to(explore(the(potential(use(

of( human( iPSNderived( neural( cells( to( examine( the( biological( and( molecular( effects( of(
alcohol.((Electrophysiological(recordings(revealed(that(iPSNderived(neurons(in(our(cultures(
were( able( to( generate( action( potentials,( exhibited( spontaneous( synaptic( activity,( and(
expressed( functional( GABAA,( AMPA,( and( NMDA( receptors.( Chronic( effects( of( alcohol(
exposure(were(also(detectable(using(electrophysiological(and(gene(expression(analysis.(((
(
Materials)and)Methods)
iPS#Cell#Derivation#and#Culture#
(

Fibroblasts( cell( lines( were( generated( from( skin( punch( biopsies( taken( from(

participants( enrolled( in( clinical( studies( of( the( effects( of( alcohol( in( social( drinkers( and( a(
treatment(trial(for(problem(drinkers(at(the(University(of(Connecticut(Health(Center((UCHC).((
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Participants( signed( a( consent( form( that( was( approved( by( the( UCHC( institutional( review(
board( and( a( punch( biopsy( sample( was( taken( from( the( inner,( upper( arm.( ( Biopsy( samples(
were(finely(minced(and(cultured(in(Dulbecco’s(Modified(Eagle(medium((DMEM,(Invitrogen,(
Carlsbad,( CA,( USA)( supplemented( with( 20%( fetal( bovine( serum( (FBS,( Invitrogen)( to(
establish( primary( fibroblast( cultures.( ( Fibroblast( lines( used( in( the( current( report( were(
generated(from(2(women(and(5(men.((Four(of(the(participants(met(criteria(for(current(DSMN
IV( alcohol( dependence,( including( tolerance( to( alcohol,( while( three( participants( were(
classified( as( nonNalcohol( dependent( social( drinkers.( Cell( lines( derived( from( nonNalcohol(
dependent(social(drinkers(are(labeled(1,(2,(and(3,(while(alcoholNdependent(participants(are(
labeled(4,(5,(6,(and(7.((The(two(cell(lines(derived(from(women(are(numbers(4(and(6.(
(

Human( fibroblast( cells( were( reprogrammed( by( the( UCHC( Stem( Cell( Core( using(

retrovirus( constructs( expressing( 5( reprogramming( factors( (OCT4,# SOX2,# KLF4# cPMYC,# and(
LIN28).( ( iPS( cell( colonies( were( identified( based( on( characteristic( morphology(
approximately( 2N4( weeks( after( viral( transduction.( ( Selected( colonies( were( expanded( as(
separate( clones( and( the( expression( of( pluripotency( markers( SSEAN3/4( and( NANOG( was(
verified(by(the(UCHC(Stem(Cell(Core(using(immunocytochemistry.(
(

iPS( cells( were( cultured( and( expanded( by( growth( on( a( layer( of( irradiated( mouse(

embryonic( fibroblasts( (MEFs)( using( human( embryonic( stem( (hES)( cell( media( containing(
Dulbecco’s( Modified( Eagle( Medium( with( F12( (DMEM/F12,( 1:1( ratio)( (Invitrogen)(
supplemented( with( 20%( Knockout( Serum( Replacer( (Invitrogen),( 1x( nonNessential( amino(
acids((Invitrogen),(1mM(LNglutamine(solution((Invitrogen),(0.1mM(βNmercaptoethanol((MP(
Biomedicals,(Solon,(OH,(USA),(and(4ng/mL(basic(fibroblast(growth(factor((bFGF)((Millipore,(
Billerica,( CA,( USA).( ( Colonies( were( observed( on( a( daily( basis,( and( any( colonies( exhibiting(
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spontaneous(differentiation(were(removed.((iPS(media(was(replaced(on(a(daily(basis.((iPS(
cells(were(passed(every(7(days(onto(irradiated(MEFs(using(a(1mg/mL(dispase((Invitrogen)(
in(DMEM/F12.(
((
iPS#Cell#Neural#Differentiation#
(

iPS(cells(were(differentiated(into(neural(cells(using(an(established(protocol((#SOPN

CHN207( Rev( A)( developed( by( the( WiCell( Institute( (www.wicell.org,( Madison,( WI,( USA)( for(
the(neural(differentiation(of(hES(cells.((Confluent(iPS(colonies(were(harvested(from(10(cM(
plates( using( 1mg/mL( dispase( in( DMEM/F12.( ( iPS( cells( were( cultured( in( suspension( for( 4(
days( in( 75mL( lowNadhesion( flasks( using( hES( cell( media( without( the( addition( of( bFGF( to(
allow( for( the( formation( of( embryoid( bodies( (EBs).( ( Half( of( the( media( was( changed( daily.((
After( 4( days,( EBs( were( collected,( centrifuged,( and( washed( in( phosphate( buffered( saline(
(PBS)( and( placed( into( new( 75mL( low( adhesion( flasks( in( a( neural( induction( media(
[DMEM/F12( supplemented( with( 1x( N2( supplement( (Invitrogen),( 1x( nonNessential( amino(
acids(and(2µg/mL(heparin((SigmaNAldrich,(St.(Louis,(MO,(USA)](to(allow(for(the(formation(
of(neural(epithelial((NE)(cells.((Half(of(the(media(was(changed(every(other(day.((After(2N4(
days( in( suspension,( NE( cells( were( collected( and( plated( onto( laminin( (20µg/mL( in(
DMEM/F12)(coated(6Nwell(cell(culture(plates(to(allow(the(NE(cells(to(adhere(to(the(surface.((
Cells( were( cultured( in( neural( induction( media,( and( half( of( the( media( was( changed( every(
other( day.( ( NE( cells( plated( on( laminin( were( cultured( for( 10N14( days.( ( During( this( time,(
formation(of(neural(tubeNlike(rosettes(was(observed(in(the(culture.((NE(cells(were(collected(
by( mechanical( detachment,( centrifuged,( and( reNsuspended( in( neural( induction( media( and(
incubated(in(75mL(low(adhesion(flasks(for(7N14(days(with(half(of(the(media(changed(every(
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other( day.( ( NE( cells( were( then( collected,( pelleted,( and( reNsuspended( in( neural(
differentiation(media([Neurobasal(media((Invitrogen)(supplemented(with(1x(nonNessential(
amino( acids,( 4x( B27( Supplement( (Invitrogen),( 1µM( dibutyrylNcAMP( (Enzo( Life( Sciences,(
Farmingdale,( NY,( USA),( and( 200µM( ascorbic( acid( (SigmaNAldrich)].( ( NE( cells( were( then(
mechanically( dissociated( by( pipetting( and( plated( onto( 13mm( glass( coverslips( (Fisher(
Scientific,( Pittsburg,( PA,( USA)( preNcoated( with( polyornithine( (0.1mg/mL( in( water)( and(
Matrigel( (0.67mg/mL( in( DMEM/F12)( (BD( Biosciences,( Bedford,( MA,( USA)( coated( at( a(
density( of( 100,000( cells( per( coverslip.( ( Cells( were( allowed( to( adhere( to( coverslips( for( 24(
hours,( and( then( cultured( in( neural( differentiation( media( supplemented( with( 10ng/mL(
brain(derived(neurotrophic(factor((BDNF)((Peprotech,(Rocky(Hill,(NJ,(USA),(10ng/mL(glial(
derived(neurotrophic(factor((GDNF)((Peprotech),(10ng/mL(insulinNlike(growth(factor((IGF)(
(Peprotech),(and(1µg/mL(laminin((SigmaNAldrich)(to(allow(for(the(differentiation(of(neural(
cells.((Half(of(the(media(was(changed(3(times(per(week,(and(neural(cells(were(cultured(for(
12(weeks(or(more.(((
#
Chronic#alcohol#treatment:( ( Cultures( were( fed( daily( for( 7( days( with( neural( differentiation(
media( containing( 50( mM( ethanol( (0.23( mg/dl).( ( Evaporation( of( alcohol( following( daily(
media( changes( in( unsealed( culture( plates( is( expected( to( produce( a( gradual( reduction( of(
alcohol( each( day.( ( ( Evaporation( of( alcohol( was( examined( in( sister( culture( dishes( not(
containing(neural(cells(by(measurement(of(media(alcohol(concentrations(at(2,(4,(6,(8,(10(and(
24(hours(postNfeeding(using(an(AM1(Alcohol(Analyzer((Analox(Instruments(Ltd,(The(Vale,(
London,(UK).((Alcohol(concentration(was(gradually(reduced(with(a(~19Nhour(halfNlife,(such(
that( by( the( end( of( 24( hours( the( average( alcohol( concentration( was( 18.1±2.0( mM( (0.07(
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mg/dl).( ( This( daily( replenishment( of( alcohol( followed( by( gradual( loss( to( evaporation( in(
unsealed(culture(dishes(provides(a(pattern(of(exposure(more(similar(to(that(in(human(daily(
heavy( drinkers( than( would( continuous( exposure( to( 50( mM( ethanol( in( a( sealed( culture(
system.(
Immunocytochemistry#
(

Neural( cultures( were( fixed( with( 4%( paraformaldehyde( in( PBS( (Invitrogen)( for( 45(

min(and(stained(with(mouse(monoclonal(antibody(to(beta(IIINtubulin((Millipore,(1:500),(and(
either( rabbit( polyclonal( antibody( to( s100β( (Abcam,( Cambridge,( MA,( USA( 1:250)( or(
synapsin1( (Millipore,( 1:500).( ( All( primary( antibodies( were( diluted( in( 0.1%( bovine( serum(
albumin( in( PBS.( ( Appropriate( donkey( antiNmouse( and( donkey( antiNrabbit( alexa( fluor( 488(
and(594((Invitrogen,(1:600)(secondary(antibodies(were(used(for(visualization.(((
(
Electrophysiology##
(

Electrophysiological(recordings(were((obtained(from(neurons(from(subject(1((a(nonN

alcoholic)( using( previously( described( techniques( (LemtiriNChlieh( and( Levine,( 2010).((
Neurons(were(selected(for(recording(based(on(neural(morphology((neurite(projections(and(
pyramidalNshaped( soma).( ( Artificial( cerebrospinal( fluid( (aCSF)( containing( 125mM( NaCl,(
2.5mM(KCl,(1.25mM(NaH2PO4,(1mM(MgCl2N6H2O,(25mM(NaHCO3,(2mM(CaCl2,(and(25mM(
dextrose(was(perfused(into(the(recording(chamber(at(1mL/min(at(room(temperature.((To(
examine( NMDA( responses( to( locally( applied( glutamate,( the( bath( solution( contained( the(
AMPA(receptor(antagonist(DNQX((10µM)(under(Mg2+(free(conditions(to(relieve(the(voltageN
dependent(Mg2+(block(of(NMDA(receptors.(
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To( examine( the( generation( of( action( potentials,( spontaneous( synaptic( activity,( and(
AMPA(and(NMDA(responses,(an(internal(recording(solution(was(used(containing(4mM(KCl,(
125mM( KNGluconate,( 10mM( HEPES,( 10mM( phosphocreatine,( 1mM( EGTA,( 0.2mM( CaCl2,(
4mM( Na2NATP,( and( 0.3mM( NaNGTP( (pH( 7.3).( ( To( examine( GABA( responses,( the( pipette(
solution(contained(130mM(KCl,(10mM(HEPES,(10mM(phosphocreatine,(1mM(EGTA,(0.1mM(
CaCl2,( 1.5mM( MgCl2,( 4mM( Na2NATP,( and( 0.3mM( NaNGTP( (pH( 7.3),( which( allowed( GABAN
induced( synaptic( currents( to( be( recorded( at( normal( resting( membrane( potential.( ( Whole(
cell(current(clamp(recordings(were(used(to(examine(the(ability(of(cells(to(generate(action(
potentials(and(to(observe(AMPA(responses(to(50µM(glutamate((in(the(presence(of(Mg)(and(
NMDA(responses(to(a(combination(of(50µM(glutamate(and(10µM(glycine((in(the(presence(of(
DNQX(and(the(absence(of(Mg2+).((Whole(cell(voltage(clamp(recordings(were(used(to(examine(
spontaneous(synaptic(activity(in(the(neural(culture(as(well(as(to(observe(responses(to(50µM(
GABA.( ( To( elicit( AMPA,( NMDA,( and( GABA( responses,( a( micropipette( containing( the(
appropriate( solution( was( placed( adjacent( to( the( recorded( cell.( ( The( solution( was( puffed(
onto(the(cell(using(5psi(of(positive(pressure.(
(

To( examine( the( effects( of( acute( alcohol( exposure( on( the( NMDA( response( in( both(

control( and( chronically( ethanolNtreated( neural( cultures,( a( micropipette( filled( with( 50µM(
glutamate(and(10µM(glycine(was(placed(next(to(a(patched(neuron.((Whole(cell(recordings(
were(done(in(current(clamp(mode.((aCSF(used(contained(10µM(DNQX(and(did(not(contain(
Mg2+.( ( The( glutamate/glycine( solution( was( puffed( onto( the( cell( every( 30( sec( and( the(
responses(were(recorded.((A(baseline(recording(was(taken(for(5(min,(and(then(a(Mg2+(free(
aCSF( supplemented( with( 50mM( alcohol( was( perfused( into( the( recording( chamber.( ( aCSF(
containing( alcohol( was( perfused( onto( the( cell( for( 5( min,( with( the( glutamate/glycine( puff(
(
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occurring(every(30(sec.((Peak(amplitude(of(the(responses(in(the(final(2(min(of(the(baseline(
period(and(the(final(2(min(of(the(acute(alcohol(exposure(period(were(calculated(using(the(
Axon( program.( ( Alcohol( effects( were( analyzed( via( paired( tNtest( using( Graphpad( Prism(
software.(
(

To(observe(the(effects(of(acute(alcohol(exposure(on(GABAA(and(AMPA(responses,(the(

same(paradigm(was(used(as(described(above,(except(the(solution(being(puffed(onto(the(cell(
was( either( 50( µM( GABA( or( 50( µM( glutamate( to( elicit( GABAA( or( AMPA( responses,(
respectively.((AMPA(responses(were(observed(using(an(external(solution(containing(1mM(
Mg2+(without(the(addition(of(DNQX.(((
#
Effects#of#Alcohol#on#NMDA#Subunit#mRNA#Expression#
(

To( examine( the( effects( of( chronic( alcohol( exposure( on( NMDA( subunit( mRNA(

expression,( iPSNderived( neural( cells( from( 7( subjects( (4( alcoholics( and( 3( nonNalcoholics)(
were(cultured(for(15N18(weeks(and(subjected(to(three(treatment(conditions;(a(7Nday(sham(
treatment,( a( 7Nday( alcohol( treatment,( and( a( 7Nday( alcohol( treatment( with( a( 24Nhr(
withdrawal( period( (n=4N7( coverslips( per( subject( per( condition).( Neural( differentiation(
media( with( or( without( 50( mM( alcohol( was( replaced( daily.( ( In( the( condition( examining(
withdrawal,(after(7(days(of(alcohol(treatment,(alcoholNcontaining(media(was(replaced(with(
normal(neural(differentiation(media(for(24(hours.(((
RNA( was( extracted( from( neural( cultures( using( TRIzol( Reagent( (Invitrogen)(
following(the(manufacturer’s(directions(and(cDNA(was(synthesized(from(2µg(RNA(from(all(
conditions( using( a( High( Capacity( cDNA( Reverse( Transcription( Kit( (Applied( Biosystems,(
Foster(City,(CA,(USA).((
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(

Neural(cell(culture(cDNA(was(analyzed(by(real(time(polymerase(chain(reaction((RTN

PCR)( using( an( Applied( Biosystems( 7500( instrument( and( TaqMAN( Assay( on( Demand(
(Applied( Biosystems)( probes( and( primers( for:( GRIN1( (Hs00609557_m1),# GRIN2A(
(Hs00168219_m1),# GRIN2B# (Hs00168230_m1),# and( GRIN2D( (Hs00181352_m1).((
Expression(of(these(genes(was(normalized(relative(to(the(expression(of(the(housekeeping(
gene( GUSB( (Applied( Biosystems,( 4326320E)( coNamplified( with( target( genes.( ( PCR( cycles(
were(as(follows:(95°C(for(10(min(followed(by(40(cycles(of(95°C(for(15(sec(and(60°C(for(60(
sec.( ( A( standard( curve( consisting( of( a( 4Nlevel( 2Nfold( serial( dilution( series( of( pooled( cDNA(
taken(from(all(samples(in(the(experiment(was(used(to(determine(relative(mRNA(expression(
levels.((Expression(after(7(days(of(alcohol(exposure(and(7(days(of(alcohol(exposure(plus(a(
24Nhour( withdrawal( period( was( normalized( to( each( subject’s( sham( condition.( ( Data( were(
analyzed( for( statistical( significance( with( mixed( model( repeated( measures( test( using( SPSS(
software.(
(
(

(

Results)
Human#iPS#Cell#Neural#Differentiation(
(

To(generate(subjectNspecific(tissue,(we(differentiated(iPS(cells(derived(from(7(human(

subjects,( 4( of( whom( met( criteria( for( current( alcohol( dependence,( including( alcohol(
tolerance,( into( neural( cell( cultures( using( an( established( protocol( for( the( neural(
differentiation( of( hES( cells( (Figure( 2.1ANF).( ( After( 10( weeks( in( neural( differentiation(
medium,(iPSNderived(cell(cultures(contained(betaNIII(tubulin(and(s100β(positive(cells((
(

(
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Figure)2.1.))Neural)Differentiation)Timeline)

)
((A)(Timeline(of(neural(differentiation(includes(culturing(iPS(cell(colonies((B)(to(confluency(
for( 7( days,( followed( by( culture( in( suspension( for( 4( days( to( allow( for( the( formation( of(
embryoid( bodies,( followed( by( incubation( in( neural( induction( media( and( growth( on( a(
laminin( substrate( to( trigger( the( formation( of( neuroepithelial( cells( displaying( neural( tubeN
like(rosette(structures,(which(are(expanded(in(suspension((C)(culture(for(several(days(prior(
to( plating( dissociated( cells( on( coverslips.( ( Dissociated( cells( are( cultured( in( a( neural(
differentiation(media(containing(the(growth(factors(BDNF,(GDNF,(and(IGF(to(promote(the(
differentiation( of( neural( cells( (D,( arrows( indicate( neural( cell( bodies,( red( arrow( indicates(
recording(electrode(for(performing(electrophysiology).((Dissociated(neural(cells(were(then(
cultured(for(12N18(weeks(in(neural(differentiation(media.((At(10Nweeks(postNplating(neural(
cultures( displayed( neuronal( lineage( marker( beta( IIINtubulin( and( glial( cell( lineage( s100β(
positive( cells( (E),( indicating( that( iPS( cells( differentiated( into( cultures( containing( a( mixed(
culture( of( neurons( and( glia.( Focal( synapsinN1( immunostaining( along( beta( III( tubulin( (F)(
positive( processes( were( observed( indicating( the( formation( of( synaptic( specializations(
within(the(culture.(
(
(

(
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(Figure(2.1E),(indicating(that(human(iPS(cells(were(successfully(differentiated(into(cultures(
containing( neurons( and( glia.( ( Further( immunostaining( revealed( positive( synapsinN1(
staining( (Figure( 2.1F),( suggesting( that( synaptic( specializations( were( forming( within( iPSN
derived(neural(cultures.(((
(
Electrophysiology(
(

(We( examined( electrophysiological( properties( of( neurons,( selected( for( recording(

based( on( morphology( (neurite( projections( and( pyramidalNshaped( soma),( in( iPSNderived(
neural( cultures( from( one( nonNalcoholic( subject,( including( the( ability( to( generate( action(
potentials(and(spontaneous(synaptic(activity.((Cells(that(did(not(generate(action(potentials(
(7(of(58(cells(examined)(were(excluded(from(further(analysis.((Consistent(with(reports(on(
the( developmental( time( course( of( hES( cellNderived( neural( cells( (Johnson( et( al.,( 2007),( we(
observed( that,( after( several( weeks( in( culture,( neurons( developed( resting( membrane(
potentials(of(N50(to(N60mV,(and(beginning(at(10N12(weeks(postNplating,(iPSNderived(neurons(
generated( trains( of( action( potentials( in( response( to( current( injection( (Figure( 2.2A).((
Spontaneous(synaptic(activity(with(both(fast(and(slow(components(typical(of(glutamatergic(
synaptic(transmission(was(observed((Figure(2.2B).(

(

To( further( characterize( iPSNderived( neurons,( we( examined( whether( functional(
GABAA,( AMPA,( and( NMDA( ionotropic( receptors( were( expressed.( ( Functional( GABAA(
receptors(were(observed(using(voltageNclamp(mode(where(a(50µM(GABA(puff(produced(an(
inward(current(response((Figure(2.2C).((In(total,(20(of(20(cells(tested(responded(to(GABA.((
Functional(AMPA(receptors(were(observed(in(currentNclamp(mode(where(50µM(glutamate((
)

(

)
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Figure)2.2.))Electrophysiological)Properties)of)iPSFDerived)Neurons)

(
WholeNcell( patch( recordings( from( 12Nweek( iPSNderived( neurons( from( a( nonNalcohol(
dependent( subject( demonstrate( functional( neuronal( properties,( including( generation( of(
action( potentials,( spontaneous( synaptic( activity,( and( ionotropic( receptor( currents.( ( (A)(
Neurons( generate( trains( of( action( potentials( in( response( to( current( injection.( ( (B)(
Spontaneous( synaptic( activity( (Inset)( closeNup( of( a( spontaneous( event( demonstrates( fast(
and(slow(kinetic(components(of(the(event.(((C)(GABA(receptor(current(response(to(a(200(ms(
puff(of(50μM(GABA(indicates(that(functional(GABA(receptors(are(present((arrow(indicates(
when(GABA(was(applied).(((D)(Depolarization(response(to(a(200(ms(puff(of(50μM(glutamate(
in(the(presence(of(Mg2+(indicates(that(functional(AMPA(receptors(are(expressed.((Response(
was(completely(abolished(when(the(AMPA(antagonist(DNQX((10µM)(was(perfused(into(the(
recording( chamber( (arrows( indicate( when( glutamate( was( applied).( ( (E)( NMDA( channel(
mediated(depolarization(in(response(to(a(200(ms(puff(of(50μM(glutamate(and(10(μM(glycine(
in( a( magnesiumNfree( recording( solution( that( contained( the( AMPA( receptor( antagonist(
DNQX( (10µM).( ( The( response( was( completely( abolished( when( NMDA( receptor( antagonist(
CPP( (6µM)( was( perfused( into( the( recording( chamber( (Dashed( arrows( indicate( when(
glutamate(plus(glycine(solution(was(applied).((
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puffs(produced(a(depolarization(of(the(membrane(in(the(presence(of(1mM(Mg2+.(In(total,(9(
of( 9( cells( tested( responded( to( glutamate( administration( under( these( conditions.( ( This(
response( to( glutamate( was( blocked( by( the( administration( of( the( AMPA( antagonist( DNQX(
(Figure( 2.2D).( To( identify( NMDA( glutamate( receptor( responses,( a( Mg2+( free( recording(
solution(containing(DNQX(to(block(AMPA(receptor(activity(was(used.((The(puffing(pipette(
contained( 50µM( glutamate( plus( 10µM( glycine( and( produced( a( depolarization( of( the(
membrane.( ( This( response( was( blocked( when( the( NMDA( antagonist( CPP( (6µM)( was(
administered( in( the( bath( solution( (Figure( 2.2E).( ( In( total,( 27( of( 29( cells( examined(
demonstrated(functional(NMDA(responses.((
(

We( next( explored( the( effects( of( acute( alcohol( exposure( on( the( NMDA( response,(

which( in( other( model( systems( was( attenuated( by( acute( exposure( to( alcohol( (Nie( et( al.,(
1994,(Puglia(and(Valenzuela,(2010).(((In(iPSNgenerated(neurons,(an(acute(exposure(to(50mM(
alcohol( significantly( attenuated( the( peak( amplitude( of( NMDA( responses( (p=0.036,( Figure(
2.3C).((To(further(explore(the(use(of(human(iPSNderived(neural(cells(as(a(model(to(examine(
the( effects( of( alcohol( exposure,( we( explored( whether( tolerance( to( acute( alcohol( exposure(
could( be( observed( in( the( culture( after( chronic( alcohol( treatment.( ( Neural( cultures( were(
treated( daily( with( 50mM( alcohol( for( 7( days( and( alcohol( withdrawn( for( 1( hr( following(
transfer( of( coverslips( to( the( recording( chamber,( and( the( acute( effects( of( alcohol( were(
measured.((In(neurons(exposed(to(alcohol(for(7(days,(reNexposure(to(50mM(alcohol(did(not(
attenuate( the( NMDA( response( (p=0.77,( Figure( 2.3D).( ( In( contrast( to( results( for( NMDA(
receptors,(no(significant(changes(were(observed(following(acute(50(mM(alcohol(exposure(
for( GABAA( (n=4,( p=0.27,( data( not( shown)( or( AMPA( receptors( (n=5,( p=0.19,( data( not(
shown).((As(we(did(not(observe(significant(changes(in(responses(of(these(receptors(to(acute((
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Figure) 2.3.) ) Acute) Alcohol) Attenuation) of) NMDA) Response) is) Not) Observed) After) 7F
Days)of)Alcohol)Exposure.)

(
WholeNcell( patch( clamp( recordings( from( neurons( derived( from( a( nonNalcohol( dependent(
subject.(((A)(Example(of(the(time(course(illustrating(the(inhibition(of(the(NMDA(response(by(
acute( alcohol( exposure( (50( mM)( in( a( naïve( neuron.( (B)( Example( of( the( lack( of( effect( of(
alcohol(on(NMDA(receptors(following(7Nday(exposure(to(50(mM(alcohol.(((C)(Group(data(for(
the(effect(of(acute(alcohol(which(significantly(reduced(the(amplitude(of(the(NMDA(response(
(n=8,(paired(tNtest,(p=(.036).(((D)(Group(data(for(7Nday(alcohol(preNtreated(cells(showing(no(
significant( effect( of( bath( applied( alcohol( on( NMDA( response( (n=10,( paired( tNtest,( p=( .77).(
Differences( in( the( mean( amplitude( of( the( baseline( depolarization( between( naïve( and(
chronically( treated( cells( (panels( C( and( D)( relate( in( large( measure( to( variation( in( the(
distance(of(the(puffing(pipette(from(the(patched(cells(examined.(
(
(

(
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alcohol( exposure,( we( did( not( examine( the( effect( of( a( 7Nday( chronic( alcohol( treatment( on(
GABAA(or(AMPA(responses(to(acute(alcohol.(
#
Effect#of#Repeated#Alcohol#Exposure#on#NMDA#Subunit#mRNA#Expression(
(

To(examine(whether(chronic(alcohol(treatment(produced(changes(in(NMDA(subunit(

mRNA( expression,( 15N18( week( old( human( iPSNderived( neural( cultures( derived( from( 4(
alcoholic( and( 3( nonNalcoholic( donor( subjects( were( fed( daily( with( media( containing( 0( or(
50mM(alcohol(and(the(levels(of(expression(relative(to(sham(treated(cells(were(examined(for(
the(NMDA(receptor(subunit(genes(GRIN1((NR1(subunit),(GRIN2A,((NR2A(subunit),(GRIN2B,(
(NR2B(subunit)(and(GRIN2D((NR2D(subunit)((Figure(2.4).((For(neural(cultures(derived(from(
alcoholic(subjects,(significant(treatment(effects(were(seen(after(7(days(of(alcohol(exposure(
for(GRIN1#(F(1,37)=10.8,(p=0.002),((GRIN2A#(F(1,39)=13.5,(p=0.001),#and(GRIN2D#(F(1,37)=16.1,(
p<0.001)( mRNA( levels.( A( trend( towards( significance( was( seen( for( GRIN2B( (F(1,37)=3.7,(
p=0.06).( ( Following( a( 24Nhour( withdrawal( period,( the( expression( of( GRIN1( in( alcoholicN
derived( cultures( remained( significantly( elevated( (F(1,40)=5.0,( p=0.03),( the( expression( of(
GRIN2A# continued( to( increase( (F(1,40)=33.6,( p<0.001),( and( the( expression( of( GRIN2B( and(
GRIN2D( returned( to( baseline( levels( (F(1,43)=0.2,( p=0.64,( and( F(1,40)=0.6,( p=0.44,(
respectively).((In(contrast,(following(7Nday(alcohol(exposure(of(neural(cultures(derived(from(
nonNalcohol(dependent(subjects(there(was(no(change(in(the(expression(of(the(four(NMDA(
subunit( genes( (GRIN1( F(1,29)=1.0,( p=0.32,( GRIN2A#F(1,25)=0.06,( p=0.82,( GRIN2B( F(1,29)=0.75,(
p=0.39,( GRIN2D( F(1,27)=0.26,( p=0.62).( ( Withdrawal( effects( on( mRNA( concentration( were(
available( for( only( 2( of( 3( cultures( derived( from( nonNalcoholics,( precluding( a( meaningful(
analysis(of(that(condition.((
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SubjectNtoNsubject(differences(in(responses(were(noted((Fig.(2.5(AND),(with(a(greater(
proportion(of(alcoholic(subjects((4(out(of(4)(showing(at(least(a(50%(increase(in(expression(
for(one(or(more(NMDA(receptor(subunits(compared(to(nonNalcoholics((1(of(3)(after(a(7Nday(
exposure.(((
)
Discussion)
(
(
The(objective(of(this(study(was(to(explore(the(potential(utility(of(human(iPS(cells(as(a(
model( to( examine( the( biological( actions( of( alcohol( on( human( neural( cells.( We( found( that(
NMDA( receptor( function( and( mRNA( expression( in( human( iPSNderived( neural( cells(
responded(to(acute(and(chronic(alcohol(exposure(similarly(in(several(respects(to(that(seen(
in( rodent( models.( ( Specifically,( acute( exposure( attenuated( the( NMDA( but( not( AMPA(
receptor(response,(consistent(with(previous(findings((Puglia(and(Valenzuela,(2010,(Nie(et(
al.,( 1994,( Nagy,( 2004,( Dodd( et( al.,( 2000).( ( In( contrast( we( did( not( observe( acute( alcohol(
enhancement(of(GABAA(responses,(which(has(been(observed(in(some,(but(not(all,(reports(of(
alcohol( effects( in( dissociated( cell( rodent( cultures( (Kumar( et( al.,( 2009,( Yamashita( et( al.,(
2006).( GABAA( responses( to( acute( alcohol( may( in( part( be( dependent( on( indirect( effects( of(
alcohol(on(GABAA(receptors(mediated(by(neuroactive(steroids((Sanna(et(al.,(2004).((We(also(
observed( that( 7Nday( alcohol( exposure( significantly( increased( NMDA( receptor( subunit(
mRNA(expression,(which(parallels(previous(findings(in(rodent(models((Nagy,(2008b,(Hu(et(
al.,(1996,(Follesa(and(Ticku,(1995).((Our(results(suggest(that(human(iPSNderived(neural(cells(
may( provide( a( useful( experimental( model( to( examine( mechanisms( underlying( changes( in(
NMDA( function( and( expression( in( response( to( acute( and( chronic( alcohol,( which( remain(
incompletely(understood((Hu(et(al.,(1996,(Hanchar(et(al.,(2006).(
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Figure) 2.4.) ) NMDA) Receptor) Subunits) are) Upregulated) After) Chronic) Alcohol)
Exposure)in)Neural)Cells)Derived)from)Alcoholics)

(
Neural( cells( (age( 12N15( weeks)( derived( from( 7( different( subjects,( 3( nonNalcoholics(
and( 4( alcoholics,( were( treated( daily( with( 50( mM( alcohol( for( 7( days( and( levels( of( GRIN1,#
GRIN2A,#GRIN2B,(and(GRIN2D#mRNA(expression(was(analyzed(using(RTNPCR.((No(significant(
changes( were( observed( in( the( expression( of( these( NMDA( receptor( subunit( genes( after( 7N
day( alcohol( exposure( (relative( to( the( sham( condition)( in( neural( cells( derived( from( the(
group( of( nonNalcoholic( donor( subjects( (left( group( of( data( panels( AND).( ( In( contrast(
significant(increases(in(mRNA(levels(compared(to(the(sham(condition(were(seen(for(neural(
cells( derived( from( the( alcoholic( subject( group( for( NMDA( subunit( genes( (A)( GRIN1,( (B)(
GRIN2A,#and((D)(GRIN2D,(while(a(trend(towards(significance(was(observed(for((C)(GRIN2B#
(p=0.06).( ( Scatter( plot( symbols( represent( results( from( individual( culture( wells( together(
with(mean(and(SEM((significance(level(compared(with(sham(condition(*(<(0.05,(**(<0.01,(***(
<0.001).)
(
((

(
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Figure) 2.5.) Variability) Between) Subjects) in) NMDA) Subunit) mRNA) changes) following)
Alcohol)Exposure)and)Withdrawal.)

)
Individual( subject( data( normalized( to( each( subject’s( average( sham( NMDA( receptor( gene(
expression( normalized( to( GUSB.( ( iPSNderived( neural( cells( from( nonNalcohol( dependent(
(NonNAD)( subjects( are( indicated( on( the( left( side( of( the( xNaxis,( while( neural( cell( generated(
from(alcoholNdependent((AD)(subjects(are(indicated(on(the(right.((Only(one(nonNAD(subject(
demonstrated(an(increase(in(NMDA(mRNA(expression(following(7(days(of(alcohol(exposure.((
In( contrast,( under( these( conditions,( all( four( AD( subjects( demonstrated( increased(
expression(of(GRIN1,(which(returned(to(baseline(levels(in(three(of(the(four(subjects.((Three(
AD(subjects(demonstrated(increased(GRIN2A(expression,(which(continued(to(increase(after(
24(hours(of(withdrawal(in(all(three(subjects.((Two(AD(subjects(showed(increases(in(GRIN2B(
and( GRIN2D( expression;( with( the( exception( of( GRIN2B( in( one( AD( subject,( these( changes(
returned(to(baseline(after(withdrawal.(((Symbols:(open(bars(–(sham(condition;(solid(bars(–(
7Nday( of( alcohol( exposure;( gray( bars( –( 7Nday( alcohol( +( 24Nhour( withdrawal;( error( bars(
represent(SEM).(
(
(

(
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Perhaps( more( significantly,( iPSNderived( neural( cells( may( provide( a( model( to(
examine( betweenNsubject( differences( in( molecular( and( physiologic( responses( to( acute( or(
chronic( alcohol( exposure,( and( in( gene( function( with( respect( to( betweenN( subject( genetic(
variation.( Although( preliminary,( our( results( suggest( that( patterns( of( NMDA( mRNA(
expression( change( following( repeated( alcohol( treatments( vary( from( subject( to( subject.((
Further,( increases( in( expression( may( be( more( common( in( neural( cells( derived( from(
alcoholic(subjects((than(from(nonNalcoholics.(This(finding(suggests(that(heritable(traits(may(
render(gene(expression(in(the(NMDA(system(more(reactive(to(effects(of(alcohol(in(persons(
predisposed( to( AD( and( may( thereby( contribute( to( the( development( of( tolerance( to( the(
inhibitory( effects( of( alcohol( on( the( NMDA( receptor( activity.( ( Although( the( list( of( genetic(
markers( associated( with( alcohol( dependence( is( expanding( (Edenberg( and( Foroud,( 2006,(
Enoch(et(al.,(2009b,(Kimura(and(Higuchi,(2011), the(biological(correlates(of(polymorphisms(
reported( to( be( associated( with( alcohol( dependence( are( in( large( part( unknown.( ( iPS( cell(
technologies( may( ( provide( a( powerful( tool( with( which( to( study( the( functional( effects( on(
neural(tissue(of(alleles(identified(with(alcohol(dependence(risk.(
Future(research(might(also(use(iPS(cells(as(models(to(examine(drug(therapies(for(the(
treatment( of( alcohol( use( disorders( or( symptoms( associated( with( alcohol( withdrawal.( ( A(
promising(potential(use(for(iPS(cell(technologies(is(to(identify(new(drugs(and(drug(targets,(
as(well(as(to(screen(drugs(for(offNtarget(toxicities((Cundiff(and(Anderson,(2011).((Three(of(
the(most(widely(prescribed(medications(to(treat(alcohol(use(disorders(include(disulfiram,(
which( disrupts( alcohol( metabolism,( naltrexone,( which( antagonizes( opioid( receptors,( and(
acamprosate,( which( disrupts( glutamate( signaling.( ( However,( each( of( these( drugs( has(
adverse(effects(associated(with(their(use,(and(treatment(efficacy(varies(among(individuals,(
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and(this(variation(may(be(associated(with(different(genotypes((Miller,(2008,(Johnson(et(al.,(
2011,( Ray( et( al.,( 2009).( ( Additional( research( is( currently( focusing( on( additional( drugs( for(
the( treatment( of( alcohol( use( disorders,( such( as( topiramate,( which( targets( glutamate( and(
GABAA(receptors((Miller,(2008,(Johnson,(2010).((Our(results(show(that(functional(glutamate(
and(GABAA(receptors(are(expressed(in(iPSNderived(neural(cultures.((Because(the(use(of(iPS(
cell( technologies( allows( us( to( obtain( neural( cultures( from( individuals( with( different(
genotypes,(we(propose(that(these(cells(could(be(used(as(models(to(evaluate(drug(therapies(
and( their( adverse( effects( in( the( treatment( of( alcohol( use( disorders.( ( While( the( use( of( iPS(
cells( to( model( pathophysiology( and( to( screen( potential( drug( therapies( is( still( in( its( early(
stages,(further(research(can(be(expected(to(clarify(the(potential(benefits(and(limitations(of(
this(approach.(
(The(use(of(human(iPS(cells(to(study(the(action(of(alcohol(is(a(novel(and(promising(
means(to(evaluate(group(differences(in(the(response(to(alcohol(exposure,(However,(much(
remains( to( be( learned( about( this( approach( and( additional( research( is( needed( to( address(
our(study’s(limitations.(Our(electrophysiologic(studies(were(limited(to(the(examination(of(
cells(from(a(single(nonNalcoholic(subject.((Examination(of(receptor(responses(from(cultures(
derived( from( multiple( alcoholic( and( nonNalcoholic( subjects( are( needed( to( provide(
electrophysiologic( validation( of( the( expression( results.( Secondly,( we( isolated( NMDA(
responses( using( a( low( magnesium( solution( containing( DNQX,( which( allowed( the( natural(
agonists( (glutamate( and( glycine)( to( activate( the( receptor.( ( Others( have( reported( that(
inhibition(of(NMDA(receptor(currents(in(response(to(alcohol(is(greater(in(the(presence(of(
magnesium(when(the(synthetic(agonist(NMDA(is(used((Martin(et(al.,(1991).((Future(studies(
may(benefit(from(investigating(the(effect(of(alcohol(under(such(conditions.((Third,(our(puff(
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application(of(neurotransmitters(produced(a(local(dilution(of(alcohol(during(recordings(to(
examine( alteration( of( receptor( responses( by( bathNapplied( alcohol.( ( Use( of( a( multiNbarrel(
pipette( for( puff( application( could( limit( dilution( of( local( alcohol( concentration( during(
receptor(activation(in(such(experiments.(Fourth,(as(with(any(in#vitro(study,(the(neural(cells(
we(examined(were(not(in(their(native(environment(and(variation(in(culture(conditions(or(
wellNtoNwell( variability( may( impact( patterns( of( gene( expression( (Newman( and( Cooper,(
2010).( Fifth,( although( the( genetic( sequence( differences( contributing( to( risk( of( alcohol(
dependence(in(neural(cells(derived(from(AD(individuals(are(likely(to(be(maintained(in(iPS(
cells,( the( environmental( effect( of( chronic( alcohol( exposure( in( AD( donor( subjects( (e.g.(
epigenetic,( transcriptional( or( postNtranslational( effects( of( alcohol( on( neural( cells)( are( not(
likely(to(be(preserved(during(reprogramming.((Sixth,(the(results(generated(from(our(pilot(
data( do( not( identify( whether( changes( in( mRNA( expression( directly( lead( to( changes( in(
NMDA(receptor(activity.((PostNtranslational(effects(of(alcohol(on(NMDA(receptors(have(also(
been( reported.( ( Fyn( kinaseNmediated( phosphorylation( of( tyrosine( residues( on( the( long(
intracellular(tail(of(the(NR2B(subunit(is(stimulated(by(acute(alcohol(exposure(and(is(thought(
to(contribute(to(the(development(of(acute(tolerance(to(the(inhibitory(effects(of(alcohol(on(
the(NMDA(receptor((Yaka(et(al.,(2003b,(Miyakawa(et(al.,(1997).(((Finally,(although(our(pilot(
study(has(focused(on(an(examination(of(the(effects(of(alcohol(on(the(expression(of(NMDA(
receptor(genes,(study(of(other(neurotransmitter(systems,(including(GABAA,(in(iPS(derived(
neurons(will(also(be(important.(
In(summary,(this(study(demonstrates(that(human(iPSNderived(neural(cells(provide(a(
promising(new(model(system(to(examine(the(molecular(and(biological(effects(of(alcohol(on(
human(nervous(tissue.((To(our(knowledge,(this(is(the(first(study(to(examine(the(effects(of(
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acute(and(chronic(alcohol(exposure(on(human(neurons(derived(from(iPS(cells.((Using(this(
subjectNspecific( tissue,( future( research( should( aim( to( identify( and( examine( molecular(
differences( in( neural( cultures( derived( from( individuals( differentiated( by( the( presence( of(
alcohol(tolerance(and(genetic(markers(of(risk(for(alcohol(dependence.(
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Chapter)3.)
GABRA2)Alcohol)Dependence)Risk)Allele)is)Associated)with)Reduced)Expression)of)
Chromosome)4p12)GABAA)Subunit)Genes)in)Human)Neural)Cultures)
The(following(chapter(is(a(duplicate(version(of(a(published(manuscript:(Lieberman,(R.,(
Kranzler,(H.(R.,(Joshi,(P.,(Shin,(D.(G.,(&(Covault,(J.((2015).(Alcoholism:(Clinical(and(
Experimental(Research,(39(9),(1654N1664.(
(
Abstract)
Background:))Genetic(variation(in(a(region(of(chromosome(4p12(that(includes(the(GABAAN
subunit( gene( GABRA2( has( been( reproducibly( associated( with( alcohol( dependence( (AD).((
However,(the(molecular(mechanisms(underlying(the(association(are(unknown.((This(study(
examined(correlates(of(in#vitro(gene(expression(of(the(ADNassociated(GABRA2(rs279858*CN
allele(in(human(neural(cells(using(an(induced(pluripotent(stem(cell((iPSC)(model(system.(
Methods:( ( We( examined( mRNA( expression( of( chromosome( 4p12( GABAA( subunit( genes(
(GABRG1,#GABRA2,#GABRA4,(and(GABRB1(in(36(human(neural(cell(lines(differentiated(from(
iPSCs(using(quantitative(PCR(and(Next(Generation(RNA(Sequencing.((mRNA(expression(in(
adult(human(brain(was(examined(using(the(BrainCloud(and(Braineac(datasets.(
Results:) ) We( found( significantly( lower( levels( of( GABRA2# mRNA( in( neural( cell( cultures(
derived( from( rs279858*CNallele( carriers.( ( Levels( of( GABRA2# RNA( were( correlated( with(
those( of( the( other( three( chromosome( 4p12( GABAA( genes,( but( not( other( neural( genes.((
Cluster( analysis( based( on( the( relative( RNA( levels( of( the( four( chromosome( 4p12( GABAA(
genes(identified(two(distinct(clusters(of(cell(lines,(a(lowNexpression(cluster(associated(with(
rs279858*CNallele( carriers( and( a( highNexpression( cluster( enriched( for( the( rs279858*T/T(
genotype.((In(contrast,(there(was(no(association(of(genotype(with(chromosome(4p12(GABAA(
gene(expression(in(postNmortem(adult(cortex(in(either(the(BrainCloud(or(Braineac(datasets.(
(
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Conclusions:((ADNassociated(variation(in(GABRA2(is(associated(with(differential(expression(
of(the(entire(cluster(of(GABAA(subunit(genes(on(chromosome(4p12(in(human(iPSCNderived(
neural( cell( cultures.( ( The( absence( of( a( parallel( effect( in( postNmortem( human( adult( brain(
samples( suggests( that( ADNassociated( genotype( effects( on( GABAA( expression,( although( not(
present(in(mature(cortex,(could(have(effects(on(regulation(of(the(chromosome(4p12(GABAA(
cluster(during(neural(development.((
(
Introduction(
(

GABA((γNaminobutyric(acid)(is(the(major(inhibitory(neurotransmitter(in(the(human(

brain((Olsen(and(Sieghart,(2009).((The(fast(inhibitory(effect(of(GABA(in(the(mature(nervous(
system(is(mediated(through(GABA(typeNA((GABAA)(receptors(,(which(are(heteropentameric(
ligandNgated( ion( channels( permeable( to( chloride( (Hevers( and( Luddens,( 1998).( ( GABAA(
receptors( are( distributed( throughout( the( brain( and( composed( of( a( diverse( set( of( 19(
subunits((α1N6,(β1N3,(γ1N3,(δ,(ε,(θ,(π,(and(ρ1N3)(that(vary(in(expression(across(brain(regions(
(for(a(review,(see((Olsen(and(Sieghart,(2009).((The(various(GABAA(receptor(subtypes(differ(
in( subunit( stoichiometry,( a( major( determinant( of( their( diverse( pharmacological( and(
electrophysiological( properties( (Barnard( et( al.,( 1998,( Olsen( and( Sieghart,( 2009).( ( The(
majority( of( GABAA( receptors( contain( two( α,( two( β,( and( 1( γ( subunit,( with( the( α1β2γ2( and(
α2β3γ2(combinations(comprising(75N85%(of(GABAA(receptors(in(adult(cortex((Rudolph(et(
al.,(2001).(
(

In( the( human( genome,( the( majority( of( GABAA( subunit( genes( are( clustered( on( four(

chromosomes:(4p12((β1,(α4,(α2,(γ1),(5q34((β2,(α6,(α1,(γ2),(15q11((β3,(α5,(γ3)(and(Xq28((θ,(
α3,( ε)( (Steiger( and( Russek,( 2004).( ( Homologous( clusters( of( genes( are( found( on( mouse(
(
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chromosomes(5,(11,(7(and(X(and(are(thought(to(have(derived(from(a(single(ancestral(αβγ(
cluster( by( gene( duplication( (Russek,( 1999).( ( ( Positioning( of( GABAA( genes( in( tandem( is(
believed( to( facilitate( coordinated( and( tissueNspecific( coNregulation( of( gene( expression( by(
allowing(clustered(genes(to(share(regulatory(elements((Steiger(and(Russek,(2004,(Barnard(
et(al.,(1998).((CoNregulation(of(genes(encoding(the(GABAA(receptor(subunits(is(evidenced(by(
variation( in( RNA( levels( in( postNmortem( human( brain( samples( over( a( range( of(
developmental(ages.((At(earlier(stages(of(development,(chr4p12(GABAA(genes(are(expressed(
at( higher( levels( than( chromosome( 5q34( genes.( ( However,( during( development,( chr4p12(
genes(are(down(regulated(while(chromosome(5q34(genes(are(up(regulated((Fillman(et(al.,(
2010).( ( Similarly,( in( rhesus( monkeys,( there( is( a( developmental( up( regulation( of( the( α1(
subunit( and( a( down( regulation( of( the( α2( subunit( in( the( dorsolateral( prefrontal( cortex,(
which( coincide( with( decreases( in( the( decay( time( of( miniature( inhibitory( postNsynaptic(
potentials((Hashimoto(et(al.,(2009).(((
(

Alcohol(use(disorders(are(prevalent,(affecting(more(than(8%(of(the(U.S.(population(

(Grant(et(al.,(2004a).((They(have(multiple(and(complex(etiologies(including(a(strong(genetic(
component,( with( heritability( estimates( ranging( from( 50N60%( (Gelernter( and( Kranzler,(
2009).((Among(the(most(widely(studied(genetic(associations(with(alcohol(dependence((AD)(
are( those( involving( single( nucleotide( polymorphisms( (SNPs)( contained( in( a( ~140( kb(
haplotype( block( spanning( the( 3’Nregion( of( GABRA2( and( the( adjacent( intergenic( GABRA2P
GABRG1(region(on(chr4p12((Covault(et(al.,(2008,(Edenberg(et(al.,(2004,(Covault(et(al.,(2004).((
The(association(of(SNPs(in(this(region(with(AD(has(been(replicated(in(multiple(studies(and(
across( different( populations( (Ittiwut( et( al.,( 2012,( Enoch( et( al.,( 2009a,( Lappalainen( et( al.,(
2005,( Bauer( et( al.,( 2007,( Fehr( et( al.,( 2006,( Soyka( et( al.,( 2008,( Li( et( al.,( 2014),( but( lack( of(
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replication(has(also(been(reported((Matthews(et(al.,(2007,(Lydall(et(al.,(2011).((SNPs(in(this(
haplotype( block( have( also( been( associated( with( drug( dependence( (Agrawal( et( al.,( 2006),(
suggesting( that( variability( in( replication( may( relate( in( part( to( differing( coNmorbidities(
among( samples.( ( ( The( most( commonly( examined( tagNSNP( in( this( region,( rs279858,( a(
synonymous(SNP(in(exon(5(of(GABRA2,(was(the(only(candidate(marker(associated(with(AD(
in( a( genomeNwide( analysis( of( candidate( genes( (Olfson( and( Bierut,( 2012).( ( The( molecular(
mechanism( by( which( GABRA2( polymorphisms( influence( risk( for( AD( is( unknown.( ( The(
absence(of(a(linked(coding(variant(suggests(that(ADNassociated(variation(in(this(region(is(in(
linkage( disequilibrium( with( an( asNyetNunidentified( functional( variant( that( influences( the(
developmentally( regulated( expression( of( GABRA2# or( adjacent( chr4p12( GABAA( subunit(
genes.( ( This( could( result( in( subtle( differences( in( neural( connectivity( and( subsequent(
behavioral( effects.( ( Support( for( this( hypothesis( comes( from( reports( that( SNPs( in( GABRA2(
are( associated( with( intermediate( neural( phenotypes,( including( fast( beta( frequency(
electroencephalographic( (EEG)( activity( (Edenberg( et( al.,( 2004,( Lydall( et( al.,( 2011),(
increased( activation( of( the( insular( cortex( during( reward( anticipation( (Villafuerte( et( al.,(
2012),(differences(in(activation(of(the(medial(frontal(cortex(and(ventral(tegmental(area(by(
alcohol( cues( (Kareken( et( al.,( 2010)( and( increased( activation( of( the( nucleus( accumbens( in(
reward(anticipation(paradigms((Heitzeg(et(al.,(2014).(
(

To( explore( molecular( effects( of( ADNassociated( variants( in( the( GABRA2( haplotype(

block,( we( used( an( induced( pluripotent( stem( cell( (iPSC)( model( system( (Takahashi( and(
Yamanaka,(2006,(Takahashi(et(al.,(2007).((Generation(of(iPSCs(from(individuals(with(known(
genotypes( and( subsequent( differentiation( into( neural( cells( provides( an( opportunity( to(
explore( molecular( phenotypes( of( ADNassociated( genetic( variants( in# vitro.( ( We( examined(
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neural(cell(cultures(differentiated(from(36(iPSC(lines(from(21(donor(subjects(with(different(
GABRA2( rs279858( genotypes( and( RNA( expression( of( genes( encoding( GABAA( receptor(
subunits( was( examined.( ( Our( results( indicate( that( chr4p12( AD( risk( alleles( are( associated(
with(differences(in(RNA(expression(of(all(four(GABAA(genes(located(in(this(region(in(this(in#
vitro(model(system.((
(
Materials)and)Methods(
iPSC#Generation#(
(

Fibroblast( cell( lines( were( generated( from( skin( punch( biopsies( donated( by(

participants( enrolled( in( a( study( of( the( effects( of( alcohol( in( social( drinkers( (9( males)(
(Milivojevic(et(al.,(2014)(or(in(a(clinical(trial(for(heavy(drinkers((10(males(and(2(females)(
(Kranzler( et( al.,( 2014a)( at( the( University( of( Connecticut( Health( Center( (UCHC).( ( All(
fibroblast( samples( were( from( Caucasian( donors.( ( Fibroblasts( were( reprogrammed( to(
pluripotency( by( the( UCHC( Stem( Cell( Core( using( retrovirus( constructs( expressing( five(
factors( (OCT4,# SOX2,# KLF4,# cPMYC,# and( LIN28)( for( 34( lines( or( sendai( virus( constructs(
expressing( four( factors( (OCT4,# SOX2,# KLF4,# cPMYC)( for( 2( lines.( ( 2( to( 4( weeks( after( viral(
transduction,(individual(iPSC(colonies(were(identified(by(morphological(characteristics(and(
selected( clones( were( expanded( and( cultured( as( separate( cell( lines( in( human( embryonic(
stem(cell(media(on(a(feeder(layer(of(irradiated(mouse(embryonic(fibroblasts.(((
(
Neural#Differentiation(
(

Neural( cells( generated( from( 36( iPSC( lines( were( examined,( including( two(

independent(lines(from(each(of(15(donors(and(one(line(each(from(an(additional(6(donors.((
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iPSCs( were( differentiated( into( forebrain( lineage( neural( cultures( using( an( embryoid( bodyN
based( protocol( developed( by( the( WiCell( Institute( (#SOPNCHN207( Rev( A,( www.wicell.org,(
Madison,(WI).((For(details(on(the(neural(differentiation(methods(used(see((Lieberman(et(al.,(
2012).( ( Mature( cultures( (12( weeks( postNneural( plating)( generated( using( this( protocol(
contain(a(mixture(of(glial(cells(and(neurons(with(spontaneous(electrical(activity,(functional(
ionotropic( GABAA( and( glutamate( receptors,( and( the( ability( to( generate( action( potentials(
(Lieberman(et(al.,(2012).((A(comparison(of(transcriptome(profiles(for(human(iPSCNderived(
forebrain(lineage(neural(cultures(and(human(postNmortem(brain(tissue(suggests(that(6N12(
week( iPSC( neural( cultures( have( a( gene( expression( profile( most( similar( to( first( trimester(
forebrain(tissue((Brennand(et(al.,(2014,(Mariani(et(al.,(2012).(((
#
Reverse#TranscriptionP#Quantitative#Polymerase#Chain#Reaction#(RTPqPCR)#
(

Neural( cultures( 12N17( weeks( postNplating( were( mechanically( harvested( and( RNA(

extracted( using( TRIzol( (Life( Technologies,( Carlsbad,( CA).( ( RNA( concentrations( were(
determined( using( a( NanoDrop( 2000( spectrophotometer( (Thermo( Fischer( Scientific,(
Pittsburgh,( PA)( and( cDNA( was( synthesized( using( a( High( Capacity( cDNA( Reverse(
Transcription( kit( (Life( Technologies)( using( 2( μg( of( total( RNA.( ( Relative( transcript( levels(
represented( in( the( resulting( cDNA( were( measured( by( realNtime( qPCR( using( an( Applied(
Biosystems( 7500( instrument( and( FAMNlabeled( TaqMAN( Assays( (Life( Technologies)( for:(
GABRA1( (Hs00971228_m1),# GABRA2( (Hs00168069_m1),# GABRA4( (Hs00608034_m1),#
GABRB1# (Hs00181306_m1),# GABRG1# (Hs00381554_m1),# GABRG2( (Hs00381554_m1),#
GABRD# (Hs00181309_m1),# RBFOX3( (Hs01370653_m1),# GAD2( (Hs00609534_m1),( and(
SLC17A7#(Hs00220404_m1).((VICNlabeled(GUSB((β–glucuronidase,(4326320E)(was(used(as(

(
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a(withinNwell(reference(gene(for(normalization.((Each(sample(was(assayed(in(triplicate(and(
a( standard( curve( using( cDNA( generated( from( mature( iPSCNderived( neural( cells( from( one(
subject(was(included(on(each(qPCR(assay(plate(to(allow(pooling(of(relative(RNA(expression(
levels(among(all(samples.((CT(values(for(target(genes(and(the(internal(reference(gene(were(
converted(to(relative(expression(levels(using(the(standard(curve(method,(which(compares(
each( experimental( sample( with( a( calibrator( reference( RNA( sample( whose( RNA( level( for(
each( probe( is( defined( as( 1( (Wong( and( Medrano,( 2005).( ( PCR( cycles( were:( 95°C( for( 10(
minutes,(then(40(cycles(of(95°C(for(15(seconds(and(60°C(for(30(seconds.(
(
Allelic#Expression#
(

TaqMan( (Life( Technologies)( FAMN( and( VICNlabeled( genotyping( probe( and( primer(

sets( targeting( exonic( SNPS( in( GABRG1( (rs976156,( C__8723970_1_),( GABRA2( (rs279858,(
C__2073557_1_),( GABRA4( (rs7660336,( C__11278069_10),( GABRB1( (rs10028945,(
C__2119811_30),( and( AKR1C3( (rs12529,( C__8723970_1_)( were( used( to( examine( allelic(
expression(bias(of(the(chr4p12(GABAA(cluster.((20μL(TaqMan(reactions(containing(2μL(of(
cDNA(from(iPSCNderived(neural(cells(or(genomic(DNA(from(human(fibroblasts(were(carried(
out( in( triplicate( using( Universal( Master( Mix( II( (Life( Technologies)( and( an( Applied(
Biosystems(7500(instrument.(((ΔCT(values(were(generated(as(the(difference(between(FAMN(
and( VICNprobes( for( the( iPSCNderived( neural( cell( cDNA( samples( or( heterozygote( fibroblast(
gDNA(for(each(SNP.((Consistent(with(other(studies((Lin(et(al.,(2012,(Serre(et(al.,(2008),(we(
used(a(threshold(for(allelic(imbalance(as(a(50%(increase(in(RNA(from(one(of(the(two(alleles(
(i.e.(±0.5ΔCT).(
(

(
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PostPmortem#human#brain#datasets.#
(

To(compare(our(results(from(in#vitro(neural(cultures(with(adult(human(brain(GABAA(

gene( expression( in# vivo,( we( examined( data( from( two( publically( available( postNmortem(
datasets:( Brain( Cloud( and( Braineac.( For( the( Brain( Cloud( sample( the( microarray( gene(
expression(dataset((http://braincloud.jhmi.edu)((Colantuoni(et(al.,(2011)(was(merged(with(
SNP(genotype(data(for(each(sample((dbGap(dataset(phs000417.v2.c1).(We(selected(all(adult(
Caucasian( cases( age( 18N80( yo( (mean=43.1)( with( an( RNA( integrity( number( ≥7.0( (mean(
RIN=8.25),(resulting(in(a(sample(of(n=60.((The(SNP(dataset(did(not(include(rs279858,(but(
rather( a( nearby( marker,( rs279856,( tightly( linked( to( rs279858( in( Caucasians( (r2=0.91;(
http://www.broadinstitute.org/mammals/haploreg/haploreg_v3.php).( ( The( Braineac(
dataset( [http://braineac.org/;( UK( Brain( Expression( Consortium,( (Trabzuni( et( al.,( 2011)](
consists( of( microarray( gene( expression( datasets( for( each( of( 134( Caucasian( subjects(
together(with(whole(genome(SNP(data.((Donors(ranged(in(age(from(16N102(yo((mean=59.0)(
and(RNA(samples(had(an(average(RIN(of(3.85((range=1N8.5).((The(Braineac(public(dataset(
does( not( allow( the( selection( of( a( subset( of( subjects( based( on( age( or( RIN.( ( Both( rs279858(
and(rs279856(were(reported(in(this(dataset(and(were(in(complete(LD((r2=1.0).((
(
RNA#Sequencing#
(

RNA( from( 4( wells( per( neural( culture( was( pooled( as( input( for( Next( Generation(

Sequencing((NGS).((RINs(ranged(from(7N9.7,(with(an(average(of(8.63.((PolyNA(selected((n=5)(
or( ribosomalNRNA( depleted( (n=11)( RNA( was( used( to( generate( randomly( primed( libraries(
(200N500( bp( inserts).( ( ( NGS( was( conducted( at( the( Genomics( Core( of( the( Yale( Stem( Cell(
Center( using( Illumina( TruSeq( Chemistry( for( library( preparation( and( the( Illumina( HiSeq(

(
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2000( platform( to( generate( 100Nbp( reads( (average( 44( million( reads( per( sample).((((((
Sequence( reads( were( aligned( using( Bowtie( ( and( TopHat( (Trapnell( et( al.,( 2009)( and( gene(
expression( levels( quantified( using( Cufflinks( (Trapnell( et( al.,( 2010)( using( a( computational(
pipeline(in(the(Department(of(Computer(Science(and(Engineering,(UConnNStorrs.((Sequence(
tag(reads(were(aligned(to(reference(human(genome(hg19(and(results(normalized(for(exon(
length(and(the(total(sequence(read(number(for(each(sample(to(generate(Reads(Per(Kilobase(
of(exon(per(Million(mapped(reads((RPKM).(((
#
Statistical#Analysis(
(

Statistical( analysis( was( conducted( using( SPSS( software( v22( (IBM,( Armonk,( NY).((

Linear( mixedNeffects( models( were( used( to( compare( gene( expression( as( a( function( of(
genotype( or( cluster( membership( to( account( for( biological( replicates( for( a( subset( of( lines(
(biological( replicates( were( available( for( 15( lines( for( qPCR( data( and( 6( lines( for( RNA(
sequence(data).((Analysis(was(repeated(using(a(single(value(per(donor(subject(by(averaging(
biological( replicates( and( using( tNtests( for( comparison( of( group( means.( ( Statistically(
significant( contrasts( identified( using( mixedNeffects( models( were( also( seen( using( tNtests.((
Pearson(correlations(and(twoNstep(cluster(analysis(were(used(to(examine(the(correlation(in(
expression( of( GABAA( genes( and( to( group( samples( based( on( patterns( of( chromosome( 4(
GABAA( gene( expression.( ( OneNway( ANOVA( was( used( to( compare( adult( brain( RNA(
expression(as(a(function(of(genotype.((P(values(of(≤0.05(were(considered(significant.(
(
Results)
GABRA2#RNA#Expression#Differs#by#rs279858#Genotype(

(
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(

MixedNeffects(models(examining(RTNqPCR(GABRA2(RNA(levels(revealed(a(significant(

effect( of( GABRA2( rs279858( genotype( (F=3.7,( df=2,15.8,( p=0.046).( ( Neural( cell( cultures(
derived( from( rs279858*CNallele( donor( subjects( had( lower( levels( of( GABRA2( RNA( than( TN
allele( homozygotes,( Figure( 3.1A( (T/T( vs.( C/T( F=4.9,( df=1,20,( p=0.039,( T/T( vs.( C/C( F=6.1,(
df=1,12.1,( p=0.03,( C/C( vs.( C/T( F=0.10,( df=1,10.8,( p=0.76).( ( In( contrast,( there( was( no(
significant( effect( of( rs279858( genotype( on( RNA( expression( of( RBFOX3# (Figure( 3.1B,(
F=0.562,(df=2,19.3,(p=0.58),(which(encodes(the(neuronNspecific(transcription(factor(NeuN,(
suggesting( that( the( betweenNsample( differences( in( GABRA2( expression( were( not( due( to(
variability(in(the(capacity(of(iPSC(lines(to(differentiate(into(neurons.(
(

((

RNA# levels# for# Chromosome# 4p12# GABAA# Genes# are# Correlated# and# Identify# Two# Clusters# of#
iPSC#Lines.(
(

RTNqPCR( analysis( revealed( a( significant( correlation( of( RNA( expression( among( the(

four(consecutive(chr4p12(GABAA(subunit(genes((GABRG1,#GABRA2,#GABRA4,(and(GABRB1)(
in( iPSCNderived( neural( cultures( (Table( 3.1).( ( This( suggests( that( ADNassociated( genetic(
variation(in(GABRA2(may(have(regional(effects(on(the(expression(of(all(four(GABAA(subunit(
genes.((There(were(no(correlations(between(RNA(levels(for(any(of(the(chr4p12(GABAA(genes(
and( GABRD# (chr1p36,( encoding( the( GABAA( δ( subunit),( or( RBFOX3( (chr17q25,( encoding(
NeuN).(
(

Cluster( analysis( identified( two( groups( among( the( 36( neural( cell( lines:( 17( in( a( lowN(

expression( Cluster( 1( and( 19( in( a( highNexpression( Cluster( 2.( ( There( was( a( significant(
association( between( cluster( membership( and( GABRA2( rs279858( genotype( (χ2=( 9.9,( df=2,(
p=0.007):(Cluster(1(cell(lines(had(a(greater(frequency(of(C(alleles(than(those(in(Cluster(2((

(
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Figure)3.1.))GABRA2)RNA)Expression)by)rs279858)Genotype)

(
(
(A)(qPCR(data(from(36(iPSNderived(neural(cell(lines(reveals(a(significant(effect(of(GABRA2(
rs279858( genotype( on( GABRA2( RNA( levels.( ( Expression( was( significantly( lower( in(
rs279858(CNallele(carriers(than(in(lines(from(T/T(individuals.(((B)(There(was(no(difference(
in(RNA(expression(of(RBFOX3((NeuN)(as(a(function(of(rs279858(genotype.((*(p<0.05)(
(
(

(
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(
(
Table)3.1.((Correlations)Among)Chromosome)4p12)GABAA)Subunit)mRNA)Expression)Levels)
(
GABRG1# GABRA2# GABRA4# GABRB1# GABRD#
RBFOX3#
#
Chr(4p12( Chr(4p12# Chr(4p12# Chr(4p12# Chr(1p36# Chr(17q25#
GABRG1#
1(
.865**(
.727**(
.781**(
.137(
N.165(
GABRA2#
.865**(
1(
.699**(
.713**(
.109(
N.098(
GABRA4#
.727**(
.699**(
1(
.748**(
.105(
N.061(
GABRB1#
.781**(
.713**(
.748**(
1(
.118(
.033(
GABRD#
.137(
.109(
.105(
.118(
1(
.132(
RBFOX3#
N.165(
N.098(
N.061(
.033(
.132(
1(
**(p<0.01((Pearson(Correlation,(2Ntailed)(

(
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((0.76(vs.(0.34;(χ2=(12.9,(df=1,(p=0.003)((Table(3.2).((Scatter(plots(comparing(RNA(levels(for(
GABRA2( to( those( for( GABRG1,( GABRA4,( or( GABRB1( RNA,( Figure( 3.2,( illustrate( group(
differences( in( chr4p12( GABAA( subunit( gene( expression( levels( between( the( two( clusters(
(Figure(3.2(ANC).((MixedNeffects(models(identified(significant(differences(in(RNA(expression(
between( Cluster( 1( and( Cluster( 2( for( each( of( the( chr4p12( GABAA( genes( (Figure( 3.3( AND)(
(GABRG1( F=44.6,( df=1,34,( p<0.001,( GABRA2( F=44.5,( df=1,34,( p<0.001,( GABRA4( F=45.9,(
df=1,34,( p<0.001,( GABRB1( F=82.7,( df=1,34,( p<0.001).( ( There( was( no( betweenNcluster(
difference( in( RNA( levels( for( GABRD( (Figure( 3.3E;( F=0.034,( df=1,30,( p=0.86)( or( RBFOX3(
(Figure(3.3F;(F=0.41,(df=1,29,(p=0.53).(
#
RNA#Sequencing#
(

RNANSeq( data( were( available( from( other( projects( for( 10( of( the( iPSNderived( neural(

cell(lines.((Sequence(data(for(biological(replicates(from(6(of(these(lines(were(also(available(
(i.e.( a( subset( of( iPSC( lines( were( differentiated( into( neural( cells( on( 2( distinct( occasions).((
Including(biological(replicates,(RNANSeq(data(were(available(for(16(mature(neural(cultures(
derived(from(10(iPSC(lines.(((
(

RNANSeq(results(confirmed(the(qPCR(findings(of(lower(expression(of(chr4p12(GABAA(

genes(in(neural(cell(cultures(from(Cluster(1(vs.(Cluster(2((Figure(3.4B(2N5)((GABRG1(F=22.2,(
df=1,7.6,( p=0.002;( GABRA2( F=7.7,( df=1,8.2,( p=0.024;( GABRA4( F=15.7,( df=1,7.8,( p=0.004;(
GABRB1( F=6.0,( df=1,8.5,( p=0.039).( ( There( was( no( significant( difference( (p>0.50)( in( the(
expression( of( genes( encoding( GABAA( subunits( located( on( chromosomes( 5q34( (GABRG2,#
GABRB2),(15q12((GABRB3),(or(1p36((GABRD)((Figure(3.4C(1N4),(or(in(the(expression(of(the(
cationNchloride(transporters(NKCC1((encoded(by(SLC12A2)(and(KCC2((encoded(by((

(
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Table)3.2.((GABRA2)rs279858)Genotype)by)Chromosome)4p12)GABAA)Gene)
Expression)Levels)
(
(
GABRA2(rs279858(
Cluster(#(
Genotype((
Allele((
Count((Frequency)a(
Count((Frequency)b(
(
C/C(
C/T(
T/T(
C(
T(
1(
10((0.59)(
6((0.35)(
1((0.06)(
26((0.76)(
8((0.24)(
2(
4((0.21)(
5((0.26)(
10((0.53)(
13((0.34)(
25((0.66)(
a(cluster(x(genotype(χ2=(9.9,(df=2,(p=0.007(((
b(cluster(x(allele(χ2=(12.9,(df=1,(p=0.003(
(
(

(
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Figure) 3.2.) ) Clustering) of) Cell) Lines) by) Chromosome) 4p12) GABAA) Expression) in)
Differentiated)Neural)Cells)
)

)
)
Scatterplots( of( qPCR( RNA( levels( contrasting( (A)( GABRA2( vs.( GABRG1,( (B)( GABRA2( vs.(
GABRA4,(and((C)(GABRA2(vs.(GABRB1(RNAs(for(36(iPSNderived(neural(cell(lines.((RNA(levels(
for(Cluster(1(cultures((x(symbol)(were(lower(for(all(4(genes(than(those(for(Cluster(2(cultures(
(gray(circles).((
(
(

(
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Figure)3.3.))RNA)Levels)for)Chromosome)4p12)GABAA)Genes)by)Cluster)Group)
)

)
)
RNA(levels(for(chr4p12(GABAA(genes(measured(by(qPCR(were(significantly(lower(in(Cluster(
1( cell( lines( (n=17)( than( in( Cluster( 2( cell( lines( (n=19):( ( (A)( GABRG1,( (B)( GABRA2,( (C)(
GABRA4,( and( (D)( GABRB1.( ( There( were( no( significant( differences( in( RNA( levels( between(
clusters(for((E)(GABRD(or((F)(RBFOX3((NeuN).(((***(p<0.001)(
(
(

(
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SLC12A5)((Figure(3.4C(5N6),(which(regulate(the(intracellular(chloride(concentration(during(
development(and(determine(whether(GABA(is(an(inhibitory(or(excitatory(neurotransmitter(
(Stein(et(al.,(2004).((Similarly,(with(the(exception(of(GABRA2(and(GABRB1(genes,(there(were(
no( significant( differences( between( Cluster( 1( and( Cluster( 2( neural( cultures( in( the( level( of(
RNA(for(a(panel(of(74(neural(patterning(genes(used(by(other(investigators((Brennand(et(al.,(
2014)( to( compare( developmental( characteristics( of( iPSCNderived( neural( cultures(
(supplemental(Table(1).((These(results(suggest(that(the(two(clusters(had(a(similar(degree(of(
neuronal(maturation(and(forebrain(lineage(features.((Interestingly,(there(was(no(difference(
in(expression(of(the(two(genes(directly(adjacent(to(the(chr4p12(GABAA(cluster,(GNPDA2#and(
COMMD8# (Figure( 3.4B( 1( and( 6),( located( ∼1.3( Mb( and( 25( kb( from( GABRG1( and( GABRB1,(
respectively( (Figure( 3.4A).( ( Taken( together,( these( findings( strongly( suggest( that( genetic(
variation( in( the( GABRA2( ADNassociated( haplotype( block( influences( developmental(
regulation(of(the(entire(cluster(of(chr4p12(GABAA(subunit(genes(in(this(iPSCNderived(neural(
culture(model.((Further,(our(findings(were(replicable(across(multiple(neural(differentiations(
of( individual( iPSC( lines,( as( there( were( no( differences( observed( in( GABAA( expression(
patterns(from(the(iPSCNderived(neural(cells(differentiated(on(different(dates.(((
(
Lack#of#Association#of#Genotype#and(GABAA#Expression#in#Adult#PostPMortem#Brain#(
(

We( examined( the( expression( of( chr4p12( GABAA( genes( in( a( set( of( 60( adult( postN

mortem( Caucasian( brain( samples( using( a( whole( genome( microarray( gene( expression(
dataset([http://braincloud.jhmi.edu;((Colantuoni(et(al.,(2011)],(merged(with(SNP(array(data(
for(each(sample((dbGap(dataset(phs000417.v2.c1).((Because(rs279858(was(not(available(in(
the(SNP(dataset(for(these(samples,(we(examined(4p12(GABAA(gene(expression(as(a(function(

(
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Figure)3.4.))RNAFSeq)Confirms)qPCR)Results)and)Delineates)Differences)in)Expression)
of)Chromosome)4p12)GABAA)Genes)

(
RNANseq(data(from16(iPSCNderived(neural(cell(lines(generated(from(10(donor(subjects.(((A)(
Schematic( depicting( the( orientation( of( the( chr4p12( GABAA( cluster( and( adjacent( genes.((
Arrows( indicate( the( direction( of( transcription,( with( the( approximate( distance( shown(
between( each( gene.( ( (B)( There( were( significant( differences( in( expression( between( neural(
cell( lines( in( Cluster( 1( and( Cluster( 2( for( the( chr4p12( GABAA( genes( GABRG1;( GABRA2;(
GABRA4;( GABRB1,( but( not( for( the( genes( directly( adjacent( to( the( chr4p12( GABAA( cluster(
GNPDA2,((and((COMMD8.)(C)(GABAA(genes(located(on(other(chromosomes(did(not(differ(in(
expression(between(neural(cell(lines(in(Cluster(1(and(Cluster(2((GABRG2,(GABRB2,(GABRB3,(
GABRD).((Genes(encoding(cationNchloride(transporter(proteins(also(did(not(differ(between(
Cluster(1(and(Cluster(2((SLC12A2(and(SLC12A5).(((*(p<0.05;(**(p<0.005)(
(
(

(
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(of(the(GABRA2(intron(4(SNP,(rs279856(located(3.3(kb(from(rs279858(and(in(nearNcomplete(
linkage( disequilibrium( with( it( (r2=0.91)( in( Caucasians.( ( There( was( no( significant(
relationship(of(rs279856(genotype(with(GABRA2(RNA(expression((F=0.67,(df=2,57,(p=0.52).(((
Similar( results( were( obtained( examining( expression( data( for( a( collection( of( postNmortem(
adult( brain( samples( from( 134( subjects( of( European( descent( [http://braineac.org/;( UK(
Brain( Expression( Consortium,( (Trabzuni( et( al.,( 2011)].( ( There( was( no( association( of(
rs279858( genotype( with( GABRA2( RNA( expression( in( either( frontal( cortex( (F=0.43,(
df=2,124,(p=0.65)(or(hippocampus((F=1.25,(df=2,119,(p=0.29).((((
#
Complex#Genetic#Regulation#of#the#Chromosome#4p12#GABAA#Cluster#
When( we( examined( the( withinNcluster( expression( of( GABRA2( as( a( function( of(
rs279858(genotype(in(the(set(of(36(iPSCNderived(neural(cultures,(we(found(that(expression(
did(not(differ(by(genotype(among(cell(lines(within(Cluster(1(or(2((Figure(3.5).((The(lack(of(a(
geneNdose(effect(was(not(unexpected(in(Cluster(1,(given(the(very(low(expression(phenotype(
and( small( variability( between( lines( (Figure( 3.2).( ( In( contrast,( we( expected( that( an(
autosomal(Mendelian(cisN(or(transNacting(effect(of(a(rs279858Nlinked(functional(variant(on(
RNA( levels( would( be( observable( in( Cluster( 2( cultures( because( GABRA2( expression( was(
readily(detectable(with(significant(betweenNsample(variation(in(Cluster(2(lines.(((
A( potential( alternative( genetic( model( more( consistent( with( these( results( would(
include(a(cisNacting(genetic(locus(influencing(expression(of(the(chr4p12(GABAA(gene(cluster(
paired(with(a(random,(mitoticallyNstable,(allelic(expression(bias.((In(this(model,(a(stochastic(
clonal( allelic( expression( bias( for( the( chromosome( carrying( a( cisNacting( repressive(
functional( variant( linked( with( the( rs279858*CNallele( would( determine( Cluster( 1( vs.( 2(

(
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membership(for(a(given(iPSC(line.(Support(for(a(model(that(includes(allelic(expression(bias(
in(this(region(was(obtained(using(RTNqPCR(and(TaqMan(alleleNspecific(probes(to(examine(
neural(cell(RNA(from(16(Cluster(2(cell(lines(heterozygous(for(exonic(SNPs(in(at(least(one(of(
the( chr4p12( GABAA( genes( (GABRG1,( GABRA2,#GABRA4( and( GABRB1).##We( observed( allelic(
imbalance( [a( 50%( or( greater( increase( in( RNA( from( one( of( the( two( alleles,( i.e.( >±0.5ΔCT(
(Serre( et( al.,( 2008,( Jeffries( et( al.,( 2012)]( in( chr4p12( GABAA( RNA( expression( compared( to(
fibroblast(genomic(DNA(in(7(of(16(lines((44%).((In(contrast,(0(of(11(lines((0%)(heterozygous(
for( an( exonic( SNP( in( the( AKR1C3#gene( (chr10p15)( showed( an( imbalance( in( expression( of(
the(two(alleles((Fisher’s(exact(test,(p=0.02).((Of(the(lines(that(were(heterozygous(at(two(or(
more( chr4p12( GABAA( genes,( 6( of( 8( lines( displayed( concordant( allelic( expression( across(
markers((i.e.,(either(a(greater(than(±0.5ΔCT(difference(for(each(gene(marker(or(no(bias(for(
each(gene).((Both(of(the(lines(that(were(discordant(over(the(interval(displayed(allelic(bias(in(
3(of(4(GABAA(genes,(but(with(the(most(distal(gene((GABRG1(in(one(line,(GABRB1(in(the(other(
line)( showing( less( than( a( 0.5ΔCT( difference.( ( In( the( case( of( donor( 727( (rs279858*T/T(
genotype),(neural(cells(differentiated(from(two(independent(iPSC(clones((727N6(and(727N8)(
had(allelic(bias(for(opposite(chromosomes(over(this(region((Figure(3.6).((This(is(consistent(
with( a( random,( mitoticallyNstable( clonal( event( occurring( at( the( time( of( iPSC( generation(
producing( complementary( allelic( bias( in( the( chr4p12( GABAA( genomic( interval( for( the( 2(
independent(iPSC(lines(from(this(subject.((
(
Discussion(
(

iPSC( technologies( provide( novel( model( systems( to( examine( the( molecular( and(

cellular(effects(of(diseaseNassociated(genetic(variation(using(diseaseNrelevant(cell(types(not((

(
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Figure)3.5.))Expression)of)GABRA2)RNA)by)rs279858)Genotype)in)Cluster)1)vs.)Cluster)
2)Neural)Cell)Lines)
)

)
)
Cluster( 1( iPSCNderived( neural( cell( lines( had( lower( levels( of( GABRA2( RNA( and( a( greater(
number(of(CNallele(carriers(than(Cluster(2(lines,(but(levels(of(GABRA2(RNA(did(not(show(a(
rs279858(allele(dose(effect(between(cell(lines(within(each(cluster.(
(
(

(
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Figure) 3.6.) ) Random) Allelic) Expression) Bias) of) Chromosome) 4p12) GABAA) Genes) in)
independently)derived)iPSCFneural)cultures)from)a)Cluster)2)Subject)
)

)
)
Allele(biased(gene(expression(in(mature(neural(cultures(generated(from(two(independently(
derived(iPSC(lines((727N6(and(727N8)(from(a(Cluster(2(donor(homozygous(for(the(TNallele(at(
GABRA2( rs279858( but( heterozygous( at( exonic( SNPs( in( the( other( three( chr4p12( GABAA(
genes( (rs976156( GABRG1( exon( 3( Thr88Thr,( rs7660336( GABRA4( 3UTR,( and( rs10028945(
GABRB1(3UTR).(An(opposite(pattern(of(allelic(bias((ΔCT(between(FAM(and(VIC(probes)(was(
observed( comparing( lines( 727N6( and( 727N8( for( each( of( the( heterozygous( SNPs( in( (A)(
GABRG1,((B)(GABRA4,(and((C)(GABRB1.((Expression(of(opposite(alleles(for(each(gene(in(the(
two( lines( spanning( the( 4p12( GABAA( gene( region( indicates( the( presence( of( a( random(
process(during(iPSC(induction(that(can(produce(bias(in(expression(from(either(the(maternal(
or(paternal(chromosome.(((
(
(
(
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otherwise( readily( available.( ( In( the( current( study,( we( generated( neural( cultures( from( 36(
iPSC(lines(derived(from(21(donor(subjects(characterized(by(rs279858,(a(synonymous(TNtoNC(
polymorphism( in( exon( 5( of( GABRA2.( ( Previous( research( has( shown( associations( between(
the( rs279858*C( allele( and( increased( risk( for( AD( (Ittiwut( et( al.,( 2012,( Enoch( et( al.,( 2009a,(
Lappalainen( et( al.,( 2005,( Bauer( et( al.,( 2007,( Fehr( et( al.,( 2006,( Soyka( et( al.,( 2008,( Li( et( al.,(
2014),(marijuana(and(illicit(drug(dependence((Agrawal(et(al.,(2006),(anxiety((Enoch(et(al.,(
2006),(and(differences(in(the(risk(of(relapse(or(likelihood(of(drinking(following(treatment(
for( substance( abuse( (Bauer( et( al.,( 2012,( Bauer( et( al.,( 2007).( ( Despite( these( multiple(
behavioral( associations( of( GABRA2( variation( in( humans,( the( cellular( and( molecular(
components(underlying(the(associations(are(not(understood.(
We(found(that(relative(levels(of(RNA(for(the(chr4p12(GABAA(subunit(genes(GABRG1,#
GABRA2,# GABRA4,( and( GABRB1( were( significantly( interNcorrelated( in( neural( cultures(
derived( from( iPSC( lines.( ( RNA( levels( for( these( GABAA( subunits( identified( distinct( lowN
expression( and( highNexpression( clusters( of( cell( lines.( ( The( lowNexpression( cluster( had( a(
higher( frequency( (0.76( vs.( 0.34)( of( ADNassociated( GABRA2# rs279858*C( alleles( than( the(
highNexpression( cluster.( ( Examination( of( nextNgeneration( RNA–Seq( data( available( for( 10(
neural(cell(lines(allowed(us(to(extend(our(analysis(to(include(the(expression(of(GABAA(genes(
located(on(multiple(chromosomes.((RNANSeq(data(confirmed(our(qPCR(results(showing(low(
expression(of(chr4p12(GABAA(genes(in(cell(lines(that(comprise(Cluster(1,(and(extended(our(
findings(by(showing(that(GABAA(subunit(genes(located(on(other(chromosomes(showed(no(
difference(in(expression(as(a(function(of(expression(cluster.((Furthermore,(transcripts(of(the(
GNPDA2((glucosamineN6Nphosphate(deaminase(2)(and(COMMD8((COMM(domainNcontaining(
protein( 8)( genes( that( flank( the( chromosome( 4( GABAA( cluster( were( readily( detected( in(
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samples(in(which(the(four(GABAA(genes(were(minimally(expressed.((Together,(these(RNAN
Seq(and(qPCR(results(suggest(that(the(effects(of(the(ADNassociated(GABRA2(polymorphism(
on(gene(regulation(are(specific(for(the(∼1.4(Mb(region(containing(the(chr4p12(GABAA(gene(
cluster.(
Our(results(suggest(that(the(GABRA2(haplotype(block(containing(rs279858(harbors(a(
functional( polymorphism( with( regulatory( effects( that( influence( the( expression( of( all( four(
GABAANsubunit(genes(on(chr4p12(in(parallel.((These(results(are(consistent(with(other(work(
suggesting( the( presence( of( multiNgene( locus( control( elements( within( the( 4p12( and( 5q34(
GABAA(subunit(gene(clusters.((In(two(independently(derived(mouse#GABRA6(knockout(lines,(
in(which(neomycin(insertion(cassettes(were(used(to(target(exon(8(of(GABRA6,(expression(of(
the(two(adjacent(genes,(GABRA1(and(GABRB2,(was(reduced(in(the(forebrain,(suggesting(the(
presence( of( a( locus( control( element( in( the( chromosome( 5q34( GABAA( gene( cluster( (UusiN
Oukari( et( al.,( 2000).( ( In( addition,( human( and( primate( studies( provide( evidence( of( a(
coordinated(developmental(switch(in(the(relative(expression(of(GABAA(subunits((Fillman(et(
al.,(2010,(Hashimoto(et(al.,(2009).(
The(lack(of(association(of(rs279858(with(the(expression(of(chr4p12(GABAA(genes(in(
adult(postNmortem(brain(suggests(that(genetic(variation(in(this(region(may(increase(risk(for(
substanceNrelated( disease( via( developmental( mechanisms.( ( However,( more( research( is(
needed( to( show( a( developmental( influence( of( chr4p12( variation( in# vivo.( ( Evidence( of(
genetic(variation(influencing(development(but(contributing(to(disease(risk(in(adulthood(has(
been( described( for( the( serotonin( transporterNlinked( polymorphic( region,( 5NHTTLPR( of(
SLC6A4.((Carriers(of(the(5NHTTLPR(SNallele(are(more(susceptible(to(anxiety(and(depression(
(Caspi(et(al.,(2010),(have(reduced(functional(and(white(matter(connectivity(of(the(amygdala(
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and( anterior( cingulate( cortex( (Pacheco( et( al.,( 2009,( Pezawas( et( al.,( 2005)( and( show(
enhanced( amygdala( activation( to( fear( stimuli( (reviewed( in( (Munafo( et( al.,( 2008).( ( In(
rodents,( anxietyN( and( depressionNlike( behavior( in( adult( mice( were( only( seen( when( the(
serotonin( transporter( was( disrupted( early( in( development( (Ansorge( et( al.,( 2004),(
suggesting( a( developmental( effect( of( SLC6A4( genotype( on( susceptibility( to( anxiety,(
depression,(and(regional(brain(connectivity(in(adulthood.(
GABAA( receptors( play( key( roles( in( cortical( development.( ( Early( in( development,(
GABAA( receptors( are( excitatory( due( to( a( high( intracellular( chloride( concentration( and(
provide(the(main(excitatory(drive(onto(immature(neural(cells((Lee(et(al.,(2005).((This(early(
excitatory(function(is(important(for(normal(corticogenesis,(cell(proliferation,(and(synaptic(
formation( (Wang( and( Kriegstein,( 2009).( ( Because( GABAA( subunit( stoichiometry( affects(
channel(properties((Olsen(and(Sieghart,(2009),(we(speculate(that(the(genotypeNassociated(
differences( in( GABAA( subunit( expression( may( impact( GABA( signaling( effects( on( cellular(
connectivity(during(development.((Reported(associations(of(GABRA2(genetic(variation(with(
EEG( beta( frequency( oscillations( (Edenberg( et( al.,( 2004,( Lydall( et( al.,( 2011),( increased(
activation( of( the( insula( (Villafuerte( et( al.,( 2012)( and( nucleus( accumbens( (Heitzeg( et( al.,(
2014)(during(reward(anticipation,(and(differences(in(the(activation(of(reward(pathways(by(
alcohol(cues((Kareken(et(al.,(2010)(are(consistent(with(a(developmental(model(of(the(effects(
of(the(ADNassociated(GABRA2(genetic(variant(rather(than(an(alteration(in(ligand(binding.((
Analysis( of( RNA( expression( by( RTNqPCR( produced( two( unexpected( observations.((
First,( although( the( rs279858*CNallele( was( enriched( in( low( expression( Cluster( 1( cell( lines(
(Table(1),(the(withinNcluster(expression(of(chr4p12(GABAA(genes(did(not(differ(by(GABRA2#
genotype( (Figure( 3.5).( Therefore,( the( genotypic( association( with( expression( level(
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illustrated( in( Figure( 3.1A( reflects( the( greater( frequency( of( rs279858*CNallele( carriers( in(
Cluster(1(vs.(Cluster(2((0.94(vs.(0.47),(suggesting(that(the(genetic(effect(linked(to(rs279858(
strongly( determines( Cluster( membership.( ( The( absence( of( an( rs279858( genotype( effect(
within(Cluster(2(cell(lines(suggests(that(a(simple(Mendelian(genetic(model(is(not(sufficient.((
One( model( consistent( with( our( results( includes( a( cisNacting( genetic( locus( (in( linkage(
disequilibrium(with(rs279858)(that(influences(the(expression(of(the(chr4p12(GABAA(gene(
cluster( together( with( a( recently( discovered( phenomenon( of( random( clonal( allelicNbiased(
expression(of(a(subset(of(autosomal(nonNimprinted(genes((Chess,(2012).(((Specifically,(we(
hypothesize( that( a( random( stochastic( process( occurring( during( the( reprogramming( of(
individual( fibroblasts( to( generate( iPSC( clones( results( in( random( allelic( bias( for( the(
expression( of( chr4p12( GABAA( genes.( ( In( this( model,( iPSC( allelic( expression( bias( for( the(
chromosome( carrying( a( cisNacting( repressive( functional( variant( linked( with( the(
rs279858*CNallele(would(determine(Cluster(membership(for(a(given(iPSC(line.((
Autosomal( random( stochastic( inactivation( was( initially( described( for( a( group( of(
immune( and( nervous( system( gene( families( (see( Chess,( 2012( for( review)( including(
immunoglobulins,( interleukin( receptors,( odorant( receptors,( and( neural( protocadherin(
genes.((More(recent(genomic(studies(have(revealed(that(random(monoNallelic(expression(is(
widespread(and(involves(a(much(larger(number(of(autosomal(genes((5N20%(in(mammalian(
cells)((Gimelbrant(et(al.,(2007,(Serre(et(al.,(2008).((Mitotically(stable,(random(monoNallelic(
expression( has( been( demonstrated( in( clonal( lymphoblastoid( cell( lines( (Gimelbrant( et( al.,(
2007,( Serre( et( al.,( 2008),( in( clonal( groups( of( cells( in( placental( tissue( (Gimelbrant( et( al.,(
2007),( in( iPSCs( and( iPSCNderived( neural( cultures( (Lin( et( al.,( 2012),( and( in( human( clonal(
neural( stem( cells( derived( from( fetal( brain( and( spinal( cord( (Jeffries( et( al.,( 2012).( ( This(
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process( typically( does( not( result( in( exclusively( monoNallelic( expression( but( rather( clonal(
lines( expressing( either( one( or( both( alleles( at( loci( showing( random( clonal( allelic( bias(
potential((Gimelbrant(et(al.,(2007,(Jeffries(et(al.,(2012).(Functional(outcomes(of(allelic(bias(in(
the( expression( of( cell( surface( proteins( include( the( potential( for( increasing( the( cellular(
diversity(of(immune(and(neural(cells.(((
(

A( second( unexpected( observation( was( the( discordance( in( cluster( assignment( for(

pairs( of( neural( cell( lines( derived( from( 4( individual( donors.( ( The( 36( iPSC( lines( examined(
included(2(independent(iPSC(clones(from(each(of(15(donor(subjects.((Paired(lines(from(11(
donors( (9( rs279858( homozygotes( and( 2( heterozygotes)( were( concordant( (i.e.,( both( lines(
from(a(given(donor(were(grouped(in(the(same(Cluster),(while(paired(lines(from(4(subjects(
(1(rs279858*T/T,(1(C/C,(and(2(T/C)(were(discordant.((We(speculate(that(the(ADNassociated(
rs279858*CNallele(is(in(moderate(but(not(complete(linkage(disequilibrium(with(an(asNyetN
unidentified( repressive( functional( variant,( and( that( iPSCNderived( rs279858( homozygote(
neural(cells(that(are(discordant(in(chr4p12(GABAA(gene(expression(are(in(fact(heterozygous(
for( this( unidentified( functional( variant.( ( Allelic( bias( could( then( reveal( the( cisNeffect( of( the(
functional(repressive(CNallele(linked(variant(in(heterozygotes.((Our(results(demonstrating(a(
modest(allelic(bias(in(expression(of(the(entire(chr4p12(GABAA(gene(region((e.g.,(Figure(3.6)(
suggests( that( allelic( bias( may( partially( explain( the( complex( genetic( regulatory( features( in(
this(region.((((
(

In( summary,( we( found( correlated( gene( expression( of( four( genes( encoding( GABAA(

receptor(subunits(located(in(a(1.4(Mb(region(of(chr4p12,(with(GABAA(gene(expression(levels(
significantly( associated( with( a( tagNSNP( for( this( region( that( has( been( linked( to( AD.( ( The(
endophenotype(of(low(mRNA(expression(for(the(chr4p12(GABAA(gene(cluster(in(this(iPSC(in#
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vitro( model( may( be( a( more( useful( marker( than( the( diagnosis( of( AD( to( identify( functional(
polymorphisms( in( this( region.( ( Our( results( suggest( that( such( functional( variants( may(
produce( behavioral( effects( relevant( to( AD( via( effects( on# GABAA( gene( expression( in( the(
developing(nervous(system.((This(work(supports(the(utility(of(iPSCs(as(a(model(system(to(
explore(previously(unknown(molecular(effects(of(genetic(variation(associated(with(risk(for(
neuropsychiatric(disease.(((Limitations(of(such(models(include(the(need(to(examine(multiple(
donor(and(iPSC(lines(to(address(interN(and(intraNcell(line(variability(and(the(limited(ability(
of( cultures( to( replicate( the( prolonged( and( complex( development( of( the( human( nervous(
system( in#vivo.( ( Finally,( our( finding( that( nearly( half( of( iPSC( lines( produce( neural( cultures(
with( strikingly( low( levels( of( expression( of( the( chr4p12( GABAA( gene( cluster( may( be( of(
interest( to( other( investigators( using( this( model( system( to( examine( neuropsychiatric(
conditions,( particularly( if( only( a( limited( number( of( disease( and( control( donor( lines( are(
compared.(
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Supplemental)Table)3.1.)Comparison)of)RNA)levels)for)neural)patterning)genes)in)
Cluster)1)vs.)Cluster)2)neural)cell)cultures.(
RPKM)(mean))
Gene)symbol)
Patterning)identity)
Cluster)1)(n=6)))))))Cluster)2)
pFvalue)
(n=10))
3.5(
4.7(
.18(
FOXP2&
diencephalon&
22.9(
17.0(
.42(
ASCL1&(MASH1)&
diencephalon&
3.3(
5.5(
.67(
NEUROD4(
(MATH3)&&
diencephalon&
0.02(
0.06(
.24(
TBX5&
diencephalon&
38.8(
27.0(
.35(
POU3F2&(BRN2)&
telencephalon&
67.1(
69.3(
.92(
FOXG1&
telencephalon&
18.6(
26.8(
.35(
LHX2&
telencephalon&
5.4(
7.7(
.51(
NEUROD1&
telencephalon&
1.5(
2.2(
.50(
OTX1&
telencephalon&
27.5(
31.3(
.87(
OTX2&
telencephalon&
12.9(
14.9(
.83(
RELN&
telencephalon&
6.1(
6.3(
.93(
RORB&
telencephalon&
8.1(
5.4(
.38(
SOX5&
telencephalon&
9.4(
12.9(
.42(
EOMES((TBR2)&
telencephalon&
8.6(
8.5(
.96(
TBR1&
telencephalon&
8.5(
15.0(
.20(
EMX2&
telencephalon&
60.2(
58.8(
.78(
CXCR4&
cortex&
n.d.(
n.d.(
(
ACKR3((CXCR7)&
cortex&
19.1(
14.0(
.47(
ARX&
cortex&
0.9(
1.1(
.86(
LHX6&
striatum&
61.8(
37.3(
.37(
DLX1((DLX)&
striatum&
0.2(
0.3(
.49(
GBX2&
mid/hindbrain&
0.7(
1.1(
.54(
HOXB9&
hindbrain&
2.7(
2.8(
.67(
FOXO1&
hindbrain&
0.01(
0.04(
.14(
LBX1&
hindbrain&
0.3(
0.7(
.37(
EGR2((KROX20)&
hindbrain&
7.8(
13.7(
.36(
NEUROG2((NGN2)&
neural&
0.6(
0.6(
.97(
NKX2R1&
GABAergic&
2.0(
1.3(
.40(
GSX2&
GABAergic&
43.7(
18.8(
.15(
SST&
GABAergic&
8.7(
7.5(
.59(
CALB1&
GABAergic&
36.9(
36.7(
.93(
CALB2&
GABAergic&
0.4(
0.4(
.81(
LMX1A&
dopaminergic&
0.02(
0.17(
.08(
LMX1B&
dopaminergic&
0.01(
0.04(
.47(
PITX3&
dopaminergic&
0.00(
0.01(
.35(
FOXA2&
dopaminergic&
0.01(
0.10(
.12(
EN1&
dopaminergic&
(
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3.7(
4.0(
.80(
NURR1&(NR4A2)&
dopaminergic&
0.3(
0.3(
.98(
TH&
dopaminergic&
4.1(
3.4(
.67(
AADC&(DDC)&
dopaminergic&
0.02(
0.03(
.41(
DAT&(SLC6A3)&
dopaminergic&
2.9(
1.2(
.29(
HTR2C&
serotonergic&
0.3(
0.2(
.40(
TPH1&
serotonergic&
0.05(
0.32(
.43(
DBH&
adrenergic&
49.2(
47.2(
.81(
GRIA1&
AMPA&receptor&
46.4(
35.1(
.33(
GRIA2&
AMPA&receptor&
8.4(
7.5(
.60(
GRIA3&
AMPA&receptor&
5.6(
5.1(
.66(
GRIA4&
AMPA&receptor&
1.8(
2.1(
.77(
GRIN1&
NMDA&receptor&
2.3(
1.2(
.16(
GRIN2A&
NMDA&receptor&
0.8(
0.7(
.80(
GRIN2B&
NMDA&receptor&
0.04(
3.5(
.02)
GABRA2&
GABA&receptor&
0.002(
0.3(
.04)
GABRB1&
GABA&receptor&
12.8(
12.9(
.88(
GPHN&&(GEPH)&
inhibitory&synapses&
10.9(
16.3(
.52(
SLC17A7&(VGLUT1)&
glutamate&transport&
3.6(
5.9(
.28(
SLC17A6&(VGLUT2)&
glutamate&transport&
3.8(
2.6(
.31(
SLC32A1&(VGAT)&
GABA&transport&
15.1(
8.0(
.19(
GAD2&(GAD65)&
GABA&synthesis&
39.0(
22.0(
.20(
GAD1&(GAD67)&
GABA&synthesis&
52.7(
47.3(
.62(
ANK2&
adaptor&protein&
2.0(
2.0(
.87(
KCNC1&
potassium&channel&
0.3(
0.4(
.92(
KCNC3&
potassium&channel&
8.5(
9.9(
.33(
SYN1&
presynaptic&
23.5(
21.1(
.70(
DLG4&(PSD95)&
postsynaptic&
122.7(
115.4(
.81(
MAP2&
panRneuronal&
89.3(
82.6(
.35(
NCAM1&
panRneuronal&
121.3(
111.7(
.87(
TUBB3&(TUJ1)&
panRneuronal&
368(
177(
.07(
GFAP&
glia&
0.9(
0.8(
.81(
MBP&
glia&
3.3(
1.2(
.15(
OLIG1&
glia&
1.3(
0.9(
.43(
OLIG2&
glia&
100.3(
83.6(
.66(
SOX2&
NPC&
41.1(
58.2(
.24(
NES&&(NESTIN)&
NPC&
32.2(
29.3(
.66(
PAX6&
NPC&
(
(
(
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(
Chapter)4.)
FKBP5)Genotype)Interacts)with)Early)Life)Trauma)to)Moderate)Heavy)Drinking)in)
College)Students)
The(following(chapter(is(a(duplicate(version(of(a(manuscript(currently(under(review:((
Lieberman,(R.,(Armeli,(S.,(Scott,(D.M.,(Kranzler,(H.R.,(Tennen,(H.,(and(Covault,(J.((American(
Journal(of(Medical(Genetics(Part(B:(Neuropsychiatric(Genetics(

(
(
Abstract)
)
(
Alcohol( use( disorder( (AUD)( is( debilitating( and( costly.( ( Identification( and( better(
understanding( of( risk( factors( influencing( the( development( of( AUD( remain( a( research(
priority.((Although(early(life(exposure(to(trauma(increases(the(risk(of(adulthood(psychiatric(
disorders,( including( AUD,( many( individuals( exposed( to( early( life( trauma( do( not( develop(
psychopathology.( ( Underlying( genetic( factors( may( contribute( to( differential( sensitivity( to(
trauma( experienced( in( childhood.( ( The( hypothalamicNpituitaryNadrenal( (HPA)( axis( is(
susceptible( to( longNlasting( changes( in( function( following( childhood( trauma.( ( Functional(
genetic( variation( within( FKBP5,( a( gene( encoding( a( modulator( of( HPA( axis( function,( is(
associated(with(the(development(of(psychiatric(symptoms(in(adulthood,(particularly(among(
individuals(exposed(to(trauma(early(in(life.((In(the(current(study,(we(examined(interactions(
between( selfNreported( early( life( trauma,( pastNyear( life( stress,( and( a( single( nucleotide(
polymorphism((rs1360780)(in(FKBP5(on(heavy(alcohol(consumption(in(a(sample(of(1845(
college( students( from( two( university( settings.( ( Although( we( found( no( effect( of( early( life(
trauma( on( heavy( drinking( in( rs1360780*TNallele( carriers,( rs1360780*C( homozygotes(
exposed( to( early( life( trauma( had( a( lower( probability( of( heavy( drinking( (p( <( 0.01).( ( The(
absence( of( an( interaction( between( current( life( stress( and( FKBP5( genotype( on( heavy(
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drinking( (p( =( 0.52)( suggests( that( there( exists( a( developmental( period( of( susceptibility( to(
stress(that(is(moderated(by(FKBP5(genotype.((These(findings(implicate(interactive(effects(of(
early(life(trauma(and(FKBP5(genetic(variation(on(heavy(drinking.(
)
Introduction)
(
(
Alcohol( use( disorder( (AUD)( is( a( complex( psychiatric( disorder( affecting( 14%( of( the(
U.S.( population( during( a( oneNyear( period( (Grant( et( al.,( 2015).( ( Identifying( factors( that(
influence( the( development( of( AUD( would( be( beneficial( in( the( identification( of( atNrisk(
individuals( and( potentially( in( the( treatment( of( those( with( AUDs.( ( A( metaNanalysis( of( 124(
studies( showed( that( abuse( and( neglect( experienced( during( childhood( are( significantly(
associated( with( depressive( disorders,( substance( use,( suicide( attempts,( and( risky( sexual(
behavior( (Norman( et( al.,( 2012).( ( Early( life( stress( is( also( associated( with( greater( alcohol(
intake(and(abuse((Enoch,(2011),(which(predispose(to(alcoholNrelated(health(problems(and(
the(development(of(AUD((Kranzler(et(al.,(1990,(Dawson(and(Archer,(1993).((((
Data( from( the( National( Comorbidity( Survey( indicate( that( childhood( adversity(
including( childhood( maltreatment,( trauma,( and( stressful( life( events( such( as( divorce( or(
death( of( a( family( member( are( reported( by( 45%( of( subjects( with( childhoodNonset( and( 26N
32%( of( individuals( with( adultNonset( psychiatric( illness( (Green( et( al.,( 2010).( ( Yet( many(
individuals( exposed( to( early( trauma/stress( do( not( develop( psychopathology.( ( Genetic(
variation( is( likely( one( contributor( to( betweenNperson( sensitivity( or( resilience( to( adverse(
outcomes(following(trauma.(Exposure(to(childhood(stressful(events(can(influence(reactivity(
of(the(hypothalamicNpituitaryNadrenal((HPA)(axis,(effects(that(can(persist(into(adulthood,(as(
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shown(by(dysregulated(release(of(the(glucocorticoid(cortisol(to(acute(stress(in(adults(with(a(
history(of(physical(or(emotional(adversity((Lovallo(et(al.,(2012).(((
Termination( of( the( HPA( axis( stress( response( is( in( part( regulated( via( the(
glucocorticoid(receptor((GR),(a(ligandNactivated(transcription(factor(located(in(the(cytosol(
with(a(high(affinity(for(glucocorticoids((Schatzberg(et(al.,(2014,(de(Kloet(et(al.,(2005).((The(
FK506( binding( protein( (FKBP5),( a( glucocorticoid( receptor( chaperone( encoded( by( FKBP5,(
has( been( implicated( in( the( pathophysiology( of( HPA( axis( abnormalities( associated( with(
traumatic( events.( FKBP5( protein( functions( to( down( regulate( GR( activity( by( reducing( GR(
binding(affinity(for(cortisol(and(inhibiting(GR(translocation(into(the(nucleus((Sinclair(et(al.,(
2013,( Grad( and( Picard,( 2007,( Stechschulte( and( Sanchez,( 2011).( ( HormoneNactivated( GR(
binding( at( regulatory( sites( in( the( FKBP5( gene( leads( to( an( upregulation( of( FKBP5# mRNA(
expression,(creating(an(ultraNshort(feedback(loop(reducing(GR(signaling(and(prolonging(the(
HPA(axis(response((Binder,(2009).((Polymorphisms(in(a(100Nkb(haplotype(block(in(FKBP5#
have( been( associated( with( risk( of( several( stressNrelated( conditions,( including( postN
traumatic( stress( disorder( (PTSD)( (Binder( et( al.,( 2008),( anxiety,( depression( (Binder( et( al.,(
2004,( Lavebratt( et( al.,( 2010),( addictive( disorders( (Levran( et( al.,( 2014,( Huang( et( al.,( 2014,(
Jensen(et(al.,(2015)(and(aggressive(or(violent(behavior((Bevilacqua(et(al.,(2012).((The(most(
widely( studied( tag( SNP( for( this( haplotype( block,( rs1360780( is( located( in( an( enhancer(
region( adjacent( to( a( GR( binding( site( and( has( been( shown( to( have( functional( effects( using(
reporter( gene( assays( (Klengel( et( al.,( 2013).( ( The( minor( TNallele( of( the( rs1360780(
polymorphism( has( been( associated( with( risk( of( traumaNrelated( psychiatric( symptoms(
(Zannas(and(Binder(2014)(and(greater(FKBP5(mRNA(and(protein(levels((Binder(et(al.,(2004,(
Binder,( 2009),( which( are( thought( to( contribute( to( an( altered( HPA( axis( regulation.( ( The(
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association( of( FKBP5( genotype( and( several( stressNrelated( psychiatric( symptoms( depends(
on( an( interaction( of( genotype( with( exposure( to( stressful( life( events( (Zannas( and( Binder(
2014).( ( FKBP5( rs1360780( genotype( interacts( with( early( life( but( not( adult( trauma( in(
predicting( PTSD( symptom( severity( (Binder( et( al.,( 2008,( Xie( et( al.,( 2010,( Boscarino( et( al.,(
2012),( while( FKPB5( genotype( interactions( with( both( early( and( lifetime( stress( have( been(
reported(for(depression(and(suicide((Roy(et(al.,(2010,(Appel(et(al.,(2011,(Zimmermann(et(al.,(
2011).( ( In( the( setting( of( childhood( adversity,( rs1360780( is( associated( with( epigenetic(
effects( including( altered( chromatin( looping( and( DNA( methylation( patterns( in( FKBP5(
(Klengel( et( al.,( 2013),( changes( that( alter( the( expression( of( the( FKBP5( gene.( ( Interactions(
between( rs1360780( genotype( and( selfNreported( childhood( emotional( neglect( predicted(
greater( threatNrelated( amygdala( reactivity( in( adolescents( (White( et( al.,( 2012)( and( adults(
(Holz(et(al.,(2014),(suggesting(that(FKBP5(genotype(×(environment(interactions(may(lead(to(
developmental(changes(in(neural(circuits.(((
Importantly,( the( specific( effects( of( FKBP5#genotype( and( its( interaction( with( stress(
may( vary( by( developmental( age.( ( For( example,( in( a( study( of( 310( infants,( the( rs1360780(
minor(TNallele(was(associated(with(greater(cortisol(reactivity(to(minor(stress((Luijk(et(al.,(
2010).((However,(no(main(effect(of(genotype(was(observed(on(salivary(cortisol(levels(in(a(
sample(of(368(healthy(adults(in(response(to(the(Trier(Social(Stress(Test((TSST)((Mahon(et(
al.,(2013).((In(contrast,(among(young(adults(homozygous(for(the(rs1360780*C(allele,(those(
with(greater(childhood(adversity(showed(an(attenuated(cortisol(response(to(the(TSST.((In(
this(study,(cortisol(response(to(the(TSST(in(TNallele(carriers(did(not(differ(as(a(function(of(
childhood(adversity((Buchmann(et(al.,(2014),(which(suggests(that(the(C/C(genotype(confers(
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protective( effects( on( the( stressNactivated( cortisol( response( in( adults( with( a( history( of(
childhood(adversity.((((
In( the( present( study,( we( investigated( the( association( of( heavy( drinking( in( a( large(
sample( of( AfricanNAmerican( and( Caucasian( college( students( based( on( selfNreported( early(
life( trauma,( current( life( stress,( and( a( well( characterized( single( nucleotide( polymorphism(
(SNP),(rs1360780,(in(the(FKBP5(gene.(((
)
Methods)
)
Participants)and)procedure)
(Undergraduate( students( were( recruited( over( a( 4Nyear( period( (2008N2011)( at( a(
Historically( Black( College( and( University( (HBCU)( and( a( New( England( Public( University(
(NEPU)( through( the( psychology( research( pool( and( campusNwide( broadcast( emails( and(
flyers(inviting(students(to(participate(in(a(study(about(daily(experiences(and(healthNrelated(
behavior.((Only(students(who(reported(drinking(alcohol(at(least(twice(in(the(past(month(and(
had(not(received(treatment(for(alcohol(use(were(eligible.((Participants(were(compensated(
for(their(participation(after(giving(written,(informed(consent(to(participate(in(the(protocol,(
which(was(approved(by(the(institutional(review(boards(at(each(university.((
Participants( at( both( universities( first( completed( a( webNbased( baseline( survey( that(
included( various( demographic( questions,( an( inventory( of( traumatic( life( experiences( prior(
to(age(6(and(negative(life(events(in(the(past(year.((Participants(also(provided(saliva(samples(
for(genotyping.((Approximately(two(weeks(after(completing(the(baseline(survey,(students(
accessed( a( secure( website( each( day( from( 2:30–7:00( PM( for( 30( days( to( complete( a( brief(
survey.( ( This( time( window( was( selected( to( coincide( with( most( undergraduate( students’(
naturally( occurring( end( of( the( school( day,( but( before( typical( evening( activities( began(
(
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(including(drinking).((Relevant(to(our(study,(participants(were(asked(each(day(to(report(on(
their(alcohol(consumption(for(the(past(evening((i.e.,(after(the(previous(day’s(survey)(and(for(
the( current( day.( ( If( a( daily( survey( was( not( completed,( the( participant( was( reminded( by(
email(to(complete(the(next(day's(survey.((Further,(if(participants(failed(to(complete(a(daily(
survey,(during(their(next(login,(the(server(queried(them(about(their(drinking(during(missed(
intervals(lasting(up(to(3(days.(((
The( baseline( sample( at( the( HBCU( consisted( of( 741( students( of( which( 53%( were(
female( and( 96%( were( selfNidentified( African( Americans( (or( of( African( descent).( ( ThreeN
hundred( three( individuals( were( excluded( from( analysis( because( they( did( not( complete( at(
least(15(daily(diary(entries(or(had(missing(data(in(the(relevant(baseline(measures,(resulting(
in( a( final( sample( of( 438( students( (58%( female( and( 97%( of( African( descent)( for( analysis(
with(a(mean(age(of(20.0(years((SD(=(1.6).((Approximately(half(of(the(students((48%)(were(
freshmen( or( sophomores.( ( Excluded( participants( were( more( likely( to( be( male,( χ2(1)( =(
13.41,(p(<(0.001.((The(final(sample(did(not(differ(from(excluded(individuals(on(age,(t(735)(=(
1.02,(p(=(0.31.(
The( baseline( NEPU( sample( consisted( of( 1815( students,( 78.0( of( which( were( selfN
identified( European( Americans,( 11.0%( Asians,( 4.5%( African( Americans,( 4.0%(
Hispanic/Latinos( and( 2.8%( misc./other.( ( Exclusion( of( Asian( and( misc./other( students(
resulted(in(a(sample(of(1600.((An(additional(190(participants(were(excluded(because(they(
did(not(complete(at(least(15(daily(diary(entries(and(3(additional(students(had(missing(data(
in(the(relevant(baseline(measures,(resulting(in(1407(participants(eligible(for(analysis.((The(
final( NEPU( sample( was( 55%( female;( had( a( mean( age( of( 19.2( years( (SD( =( 1.4);( was(
comprised( mostly( of( freshmen( or( sophomores( (74%),( and( was( predominantly( Caucasian(
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[91%( (n( =( 1278)],( with( small( percentages( of( African( Americans( [4.9%( (n( =( 69)]( and(
Hispanics/Latinos( [4.3%( (n( =( 60)].( ( Participants( excluded( from( this( sample( were( more(
likely( to( be( male,( χ2(1)( =( 23.7,( p( <( 0.001,( and( or( racial/ethnic( minorities,( χ2(2)( =( 7.0,( p( =(
0.03.((The(final(sample(did(not(differ(from(excluded(individuals(on(age,(t(1595)(=(.008,(p(=(
0.99.((Across(both(universities,(we(had(a(final(sample(of(1845((54%(female).(
Measures)
(

Alcohol# use( was( measured( each( day( by( asking( participants( how( many( standard(

alcoholic(drinks(they(consumed(the(previous(night((from(0#to(15,(in(oneNdrink(increments,(
with(an(option(for(>15)(as(well(as(the(number(of(drinks,(if(any,(they(had(consumed(on(the(
day(of(the(diary(report(up(to(the(time(of(logging(their(response.((Students(were(reminded(
each( day( that( a( standard( drink( was( defined( as( one( 12Noz( can( or( bottle( of( beer( or( wine(
cooler,(one(5Noz(glass(of(wine,(or(a(1.5Noz(measure(of(liquor(straight(or(in(a(mixed(drink.((If(
participants(missed(a(daily(survey,(they(were(queried(about(drinking(levels(on(the(missed(
day(s)(on(the(next(occasion(that(they(logged(into(the(system((before(they(completed(that(
day’s(survey);(16.4%(and(10.7%(of(the(daily(records(were(backfilled(in(the(HBCU(and(NEPU(
samples,( respectively.( ( We( created( fullNday( records( by( combining( daytime( and( previous(
night(reports(from(consecutive(days.((Lagging(values(from(subsequent(day(reports(allowed(
us(to(use(only(29(of(the(reporting(days.((The(number(of(drinks(was(summed(across(daytime(
and(evening(drinking(and(was(converted(into(a(binary(heavy(drinking(indicator([4+(drinks(
for(women(and(5+(drinks(for(men((NIAAA,(2004)].(
Early# life# trauma( (ELT)( was( measured( using( the( Traumatic( Events( Screening(
Inventory( (TESI)NAdult( Screening( version( 3.2( (Ford( et( al.,( 2000).( ( The( TESI( has( 18( items(
that( assess( various( types( of( trauma,( with( a( total( of( nine( trauma( categories( (i.e.,(
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accident/illness/disaster,( traumatic( loss/separation,( traumatic( physical( victimization,(
traumatic( sexual( victimization,( traumatic( emotional( victimization,( traumatic( domestic(
violence(victimization,(witnessed(trauma,(traumatic(war(victimization,(and(other(traumatic(
event).( ( Participants( indicated( (yes/no)( as( to( whether( the( events( occurred( before( age( 6,(
between( ages( 6( and( 17,( above( age( 18( and( within( the( past( year.( ( We( created( a( binary(
variable(reflecting(the(occurrence(of(at(least(one(early(life(traumatic(event(prior(to(age(6.((#
Past#year#stressful#life#events(were(measured(using(the(Life(Events(Scale(for(Students(
(LESS;((Linden,(1984).((We(used(the(25(unambiguously(negative(items(selected(by(Covault(
et( al.( (2007).( ( Students( were( asked( which( of( the( events( occurred( in( the( past( year;( we(
created(a(composite(by(summing(the(number(of(endorsed(events.(
Genotyping((
(

DNA(was(extracted(from(saliva(samples(using(the(Oragene(DNA(salivary(extraction(

kit( (DNA( Genotek,( Kanata,( Ontario,( Canada)( per( the( manufacturer’s( instructions.( ( The(
FKBP5# SNP( rs1360780( was( genotyped( using( an( Applied( Biosystems( TaqMan( Assay( OnN
Demand( probe( and( primer( set( (C_8852038_10)( with( Universal( Master( Mix( II( (Life(
Technologies,( Carlsbad,( CA)( per( the( manufacturer’s( instructions.( ( We( used( 10μL( PCR(
amplification( reactions( containing( 1μL( DNA( that( were( run( in( 96Nwell( plates( with( the(
following(PCR(conditions:(95°(for(10(minutes,(followed(by(40(cycles(of(95°(for(15(seconds(
and(60°(for(60(seconds.((PostNPCR(fluorescent(plate(reads(were(carried(out(on(an(Applied(
Biosystems( 7500( instrument( and( analyzed( using( Applied( Biosystems( TaqMan( Genotyper(
software.((10%(of(the(samples(were(repeated(with(complete(concordance.((Genotypes(for(
each( racial/ethnic( group( were( in( Hardy( Weinberg( equilibrium( (p( =( 0.93;( 0.26( and( 0.39(
respectively( for( EA,( AA( and( Hispanic( groups).( ( The( minor( allele( frequency( (MAF)( was(
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higher( in( the( AA( subject( group( (0.38;( c2( =( 19.6,( df=2,( p( <( 0.001)( compared( with( the( EA(
(0.31)(or(Hispanic((0.29)(groups(consistent(with(MAF(reported(in(the(1000(genomes(data(
set(for(this(SNP((European(ancestry(0.29(and(African(ancestry(0.39).((The(2Nlevel(genotype(
counts( (rs1360780*C( homozygotes( vs.( rs1360708*T( carrier)( were( as( follows:( European(
American(C/C(=(611,(TNallele(carrier(=(668;(African(American(C/C(=(184,(TNallele(carrier(=(
317;(Hispanic/Latino;(C/C(=(34,(TNallele(carrier(=(31.(
Data)analysis)
(

We( used( generalized( estimating( equations( to( model( the( additive( and( interactive(

effects( of( earlyNlife( trauma,( pastNyear( negative( life( events,( and( the( main( and( interactive(
effects(of(FKBP5(rs1360780(genotype(and(either(earlyNlife(trauma(or(pastNyear(negative(life(
events( to( predict( heavy( drinking( days.( ( Given( the( binary( nature( of( the( outcome( variable(
(heavy( drinking( day:( present/absent),( we( specified( a( logit( link( and( binomial( error(
distribution.( ( Predictors( were( entered( in( 2( blocks:( main( effects( and( 2Nway( interactions.((
Values(shown(in(the(tables(reflect(effects(for(the(block(of(entry((i.e.,(without(the(subsequent(
blocks(included).((FKBP5(rs1360780(genotype(was(collapsed(into(binary(predictors((minor(
TNallele(carrier(vs.(C/C(individuals).((Data(from(both(universities(were(combined(into(one(
sample.((We(controlled(for(school((0(=(HBCU,(1(=(NEPU),(weekly(variation(in(drinking(by(
including( a( weekdayNweekend( contrast( (weekdays( =( 0,( weekend( =( 1),( ethnicity( (with( 2(
dummy( codes( comparing( African( descent( and( Latino/Hispanic( with( Caucasian( [the(
reference(group(coded(0]),(age,(and(year(in(school((with(3(dummy(codes(comparing(each(
year(with(freshmen([the(reference(group(coded(0]).(()
Results)
Descriptive#statistics#
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(

We(had(daily(drinking(reports(on(12,489(days((28.5(days(per(person)(in(the(HBCU(

sample( and( 39,906( days( (28.4( days( per( person)( in( the( NEPU( sample.( ( Overall,( we( had(
52,395( personNdays( for( analysis( nested( within( 1845( participants.( ( Drinking( was( reported(
on(25.8%(and(20.6%(of(the(days(and(heavy(drinking(on(11.6%(and(13.1%(of(the(days(in(the(
HBCU(and(NEPU(samples,(respectively.((EarlyNlife(traumatic(events(were(reported(by(35.5%(
and(21.4%(of(participants(in(the(HBCU(and(NEPU(samples,(respectively.((The(mean(number(
of(stressful(life(events(in(the(past(year(was(5.66((SD(=(3.65)(in(the(HBCU(sample(and(3.94(
(SD(=(2.74)(in(the(NEPU(sample.(
(
Models#predicting#heavy#drinking#days#
Table( 4.1( shows( the( results( for( the( logistic( regression( model( predicting( heavy(
drinking( days.( ( In( block( 1( neither( ELT( nor( FKBP5( genotype( were( associated( with( heavy(
drinking,( but( recent( life( stress( was( a( significant( predictor,( with( higher( levels( of( pastNyear(
negative(events(associated(with(a(greater(probability(of(heavy(drinking.((In(block(2,(only(the(
interaction( between( FKBP5( genotype( and( ELT( was( significant.( ( FollowNup( probing( of( the(
interaction( indicated( a( nonNsignificant( effect( of( early( life( trauma( on( heavy( drinking( in(
FKBP5(rs1360780(TNallele(carriers((B(=(N0.23,(SE(=(0.14,(p(=(0.51,(OR(=(1.25).##In(contrast,(
ELT(had(a(significant(effect(on(heavy(drinking(in(FKBP5(rs1360780(C/C(participants,(such(
that(C/C(participants(reporting(a(positive(history(of(early(life(trauma(had(a(lower(frequency(
of(heavy(drinking((B(=(N0.29,(SE(=(0.15,(p(=(0.003,(OR(=(0.747)((Figure(4.1).((It(should(be(
noted(that(the(school(and(race(contrasts(were(highly(correlated.((However,(examination(of(
variance( inflation( factors( (VIF)( for( these( predictors( indicated( that( they( were( not(
problematic,(i.e.,(the(VIF(values(were(below(6,(which(is(less(than(the(commonly(used(cutNoff(
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(
(
Table)4.1.))Model)Predicting)Heavy)Drinking)Days)

&
&
Block!
1!
&
&
!
&
&
&
&
&
&
&
&!!
2!
&&&

!
B!

!
SE!

!
p!

95%!CI!

&
African&American&(vs.&White)&

R0.997&

0.158& <.001&

R1.306& R0.688&

Odds!
&
Ratio!
0.369&

Latino/Latina&(vs.&White)&
School&(0&=&HBCU,&1&=&NEPU)&
Weekend&(0=weekday;&1&=&weekend)&
Age&
Sophomore&
Junior&
Senior&
Beyond&senior&
Sex&
Negative&life&events&(NLE)&
Early&trauma&
FKBP5&&TRcarrier&&

R0.538&
R0.495&
2.124&
R0.137&
0.314&
0.600&
0.883&
1.139&
R0.426&
0.043&
R0.127&
R0.006&

0.204&
0.164&
0.054&
0.053&
0.085&
0.135&
0.193&
0.273&
0.059&
0.010&
0.071&
0.058&

.008&
.002&
<.001&
.010&
<.001&
<.001&
<.001&
<.001&
<.001&
<.001&
.074&
.918&

R0.939&
R0.816&
2.018&
R0.242&
0.147&
0.335&
0.504&
0.605&
R0.542&
0.024&
R0.267&
R0.120&

R0.138&
R0.174&
2.231&
R0.033&
0.481&
0.866&
1.262&
1.674&
R0.309&
0.062&
0.012&
0.108&

0.584&
0.610&
8.368&
0.872&
1.369&
1.823&
2.418&
3.124&
0.653&
1.044&
0.881&
0.994&

Early&trauma&X&FKBP5&TRcarrier&&
NLE&X&&FKBP5&TRcarrier&&
NLE&X&Early&trauma&

0.524&
0.014&
R0.028&

0.143& <.001&
0.019& .458&
0.020& .173&

0.244&
R0.023&
R0.068&

0.804&
0.051&
0.012&

1.689&
1.014&
0.973&

Lower! Upper!

Note.&B&=&change&in&log&of&odds&for&a&unit&change&in&predictor.&Early&trauma&0&=&no,&1&=&yes;&&
FKBP5:&0&=&CC&genotype,&1&=&TRallele&carrier;&Sex:&0&=&males,&1&=&females;&&
Weekend&R1&=&weekday,&1&=&weekend.&
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Figure) 4.1.) ) Interactive) Effect) of) FKBP5) rs1360780) and) Early) Life) Trauma) in)
Predicting)Heavy)Drinking)
)

)
)
Daily( selfNreports( of( alcohol( consumption( in( a( diverse( sample( of( 1845( college( students(
revealed( no( significant( effect( of( early( life( trauma( on( the( probability( of( heavy( drinking( in(
carriers( of( the( FKBP5( rs1360780*TNallele( (B( =( N0.23,( SE( =( 0.14,( p( =( 0.51,( OR( =( 1.25).( ( In(
contrast,( a( significant( effect( of( early( life( trauma( on( the( probability( of( heavy( drinking( was(
observed( in( FKBP5( rs1360780*C/C( genotype( individuals( (B( =( N0.29,( SE( =( 0.15,( p( =( 0.003,(
OR(=(0.747).((**(p(<(0.01,(NS(=((not(significant)(
(
(

(
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of( 10( (Chatterjee,( 2000).( ( More( importantly,( removal( of( these( contrasts( did( not( alter( the(
interaction(findings(of(interest.((
We( also( ran( several( supplemental( analyses.( ( First,( we( augmented( the( model( to(
examine(whether(the(FKBP5(genotype(×(ELT(interaction(varied(by(university.((To(do(this,(
we(entered(the(2Nway(interactions(among(university,(ELT(and(genotype(along(with(the(3N
way(university(×(genotype(×(ELT.((None(of(these(interactions(was(significant((all(p’s(>(0.50).((
We( then( estimated( a( similar( model( to( evaluate( the( moderating( effect( of( sex( (instead( of(
university);(again,(none(of(2Nway(or(3Nway(interactions(was(significant((all(p’s(>(0.20)()
)
Discussion)
)

(In(the(current(study(we(examined(heavy(drinking,(a(risk(factor(for(alcoholNrelated(

health( problems( and( the( development( of( alcohol( use( disorder( (Kranzler( et( al.,( 1990,(
Dawson( and( Archer,( 1993),( in( 1845( participants( from( two( universities( as( a( function( of(
FKBP5#rs1360780( genotype.( ( We( found( no( main( effect( of( FKBP5( rs1360780( genotype( on(
the(probability(of(heavy(drinking(but(a(significant(interaction(effect(of(FKBP5#genotype(and(
earlyNlife( trauma( on( the( probability( of( heavy( drinking( in( students( of( African( or( European(
ancestry.((In(contrast,(we(did(not(see(an(interaction(of(genotype(with(the(number(of(pastN
year( negative( life( events( in( predicting( heavy( drinking.( ( These( findings( are( in( agreement(
with(prior(research(reporting(no(main(effect(of(FKBP5(genotype,(but(a(genotype(x(earlyNlife(
trauma( interaction( effect( on( the( subsequent( occurrence( of( psychiatric( symptoms( (Zannas(
and( Binder,( 2014).( ( Our( results( complement( previous( findings( in( relation( to( gene( by(
environment( effects( of( FKBP5( and( earlyNlife( trauma( and( expand( them( to( include( a( link(
between(these(factors(and(heavy(drinking(in(young(adults.(((
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Previous( work( has( implicated( the( FKBP5#rs1360780( minor( TNallele( as( a( risk( allele(
for(psychiatric(symptoms(in(individuals(exposed(to(early(life(trauma.((Consistent(with(the(
direction(of(allelic(effects(previously(reported,(we(observed(that(TNallele(carriers(reported(
more( heavy( drinking( days( in( the( setting( of( early( life( trauma( than( CNallele( homozygotes,(
while(in(the(absence(of(early(life(trauma(the(frequency(of(heavy(drinking(did(not(differ(by(
rs1360780( genotype.( ( This( interaction( observed( did( not( reflect( a( greater( frequency( of(
heavy( drinking( among( TNallele( carriers( with( a( history( of( childhood( trauma,( but( a( lower(
frequency( of( heavy( drinking( days( among( CNallele( homozygotes( who( had( been( exposed( to(
childhood( trauma.( ( This( result( suggests( that( individuals( with( the( C/C( genotype( who(
experience(early(adversity(may(be(protected(from(heavy(drinking(as(young(adults.(((
(

Resilience,(defined(as(an(individual’s(ability(to(adapt(successfully(to(adversity,(is(an(

active( process( involving( changes( at( the( molecular( level( that( result( in( normalization( of(
biological(and(behavioral(functions(in(the(setting(of(stress((Russo(et(al.,(2012).((Resilience(
develops( in( approximately( 10N25%( of( maltreated( children( (Walsh( et( al.,( 2010).( ( The(
biological( mechanisms( leading( to( resilience( in( some( children( but( not( others( exposed( to(
earlyNlife(trauma(are(not(understood(but(likely(involve(interactions(between(the(type(and(
timing(of(trauma/adversity(and(genetic(variation,(epigenetic(responses,(social(supports(and(
psychological( factors.( ( Related( to( our( finding,( Buchmann( et( al.( (2014)( examined( the(
interaction(between(FKBP5(rs1360780(genotype(and(early(life(trauma(on(cortisol(increases(
following( the( Trier( Social( Stress( Test( (TSST)( in( healthy( young( adults.( ( They( found( that( a(
history( of( early( life( trauma( interacted( with( the( FKBP5( rs1360780*C/C( genotype( to(
moderate( TSSTNinduced( increases( in( cortisol( levels( (Buchmann( et( al.,( 2014).( ( This( group(
also( reported( that( higher( levels( of( selfNreported( childhood( emotional( neglect( were(
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associated( with( reduced( threatNrelated( amygdala( reactivity( in( rs1360780*C/C(
homozygotes( (Holz( et( al.,( 2014).( ( Interestingly,( polymorphisms( in( the( HPA( axisNrelated(
gene(encoding(the(corticotropin(releasing(hormone(receptor(1((CRHR1)(have(been(shown(
to( be( protective( with( respect( to( effects( of( earlyNlife( trauma( on( the( development( of(
depression(in(adulthood((Bradley(et(al.,(2008,(Polanczyk(et(al.,(2009).((Similarly,(functional(
genetic(variation(in(the(NPY(gene,(which(encodes(the(anxiolytic(neuropeptide(Y,(has(been(
implicated( in( resiliency( to( stress( (Zhou( et( al.,( 2008),( and( higher( plasma( levels( of(
neuropeptide( Y( promote( resilience( to( PTSD( in( combatNexposed( veterans( (Yehuda( et( al.,(
2006).( ( Neuropeptide( Y( has( also( been( implicated( as( protective( from( greater( alcohol(
consumption( in( stressNexposed( primates( (Lindell( et( al.,( 2010).( ( Although( the( drinking(
motives( potentially( linking( the( interactive( effects( of( earlyNlife( stress( and( FKBP5( genotype(
on(the(frequency(of(heavy(drinking(in(college(students(are(not(clear,(the(emerging(literature(
on(the(effects(of(FKBP5(genotype(suggest(that(they(may(relate(to(developmental(effects(of(
earlyNlife( stress( x( genotype( interactions( on( hormonal( stress( response( regulation(
(Buchmann( et( al.,( 2014)( and/or( developmental( effects( on( neural( systems( related( to(
threat/stress(reactivity((Holz(et(al.,(2014,(White(et(al.,(2012).((
(

Strengths(of(the(current(study(include:(i)(a(large(sample(that(was(diverse(in(gender,(

race/ethnicity,( and( socioeconomic( background,( ii)( the( selfNreporting( of( alcohol(
consumption(near(its(realNtime(occurrence,(thus(limiting(recall(error(and(bias,(and(iii)(the(
examination( of( heavy( drinking( in( college( students,( which( is( a( public( health( concern.((
Weaknesses( of( the( study( include:( i)( the( retrospective( selfNreporting( of( both( earlyNlife(
trauma( and( pastNyear( life( stress( via( questionnaire( and( ii)( the( lack( of( distinction( between(
the( proportion( of( heavy( drinking( related( to( stress( vs.( social( enhancement( or( emotionN
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related(drinking.((Because(the(frequency(of(stressNrelated(drinking(was(not(well(defined,(it(
is(unclear(whether(FKBP5(genotype(interacts(with(earlyNlife(trauma(to(produce(differences(
in( copingNrelated( drinking( or( socialNrelated( activities( in( the( college( student( sample(
examined.(
(

In( conclusion,( we( found( that( the( FKBP5# rs1360780*C/C( genotype# interacts( with(

selfNreported( history( of( earlyNlife( trauma( to( predict( fewer( days( of( heavy( alcohol(
consumption(in(young(adult(college(students.((To(our(knowledge,(this(is(the(first(study(to(
implicate( interactions( between( early( life( trauma( and( variation( in( FKBP5( with( alcohol(
consumption.( ( Importantly,( these( results( are( consistent( with( the( assignment( of( risk( and(
protective(alleles(at(this(locus(with(prior(reports(identifying(interactions(of(rs1360780(with(
childhood(trauma(on(risk(of(PTSD(and(depression.(
(

(
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Chapter)5.)
Examining)FKBP5)mRNA)Expression)in)Human)iPSCFDerived)Neural)Cells)
The(following(chapter(is(a(duplicate(version(of(a(manuscript(to(be(submitted(in(2015.(
Lieberman,(R.,(Kranzler,(H.(R.,(and(Covault,(J.(
)
Abstract:(((
(

The(transcriptional(activity(of(the(glucocorticoid(receptor((GR,(encoded(by(NR3C1)(

is( regulated( by( molecular( chaperones( including( FK506( Binding( Protein( 51( (FKBP5,(
encoded( by( FKBP5).( ( In( peripheral( blood( leukocytes,( FKBP5( mRNA( expression( is(
upregulated(following(activation(of(the(GR(via(its(binding(to(GR(response(elements((GRE)(
located(in(promoter(and(intronic(regions(of(the(FKBP5(gene,(creating(a(short(feedback(loop.((
The( single( nucleotide( polymorphism( rs1360780( in( one( FKBP5( intronic( GRE( has( been(
associated( with( psychiatric( illness( and( functional( molecular( effects( on( protein( and( mRNA(
expression,( chromatin( structure,( and( DNA( methylation.( ( However,( examination( of( the(
molecular( effects( of( rs1360780( has( largely( been( limited( to( easily( accessible( peripheral(
cells,( and( may( not( reflect( activity( in( neural( cells.( ( To( examine( FKBP5( mRNA( expression(
following( GR( activation( in( human( neural( cells,( we( utilized( induced( pluripotent( stem( cells(
(iPSCs)( derived( from( 20( subjects.( ( Following( differentiation( into( forebrainNlineage( mixed(
neural(cultures,(cells(were(exposed(to(1(μM(dexamethasone(for(6(hr(and(mRNA(expression(
of(FKBP5(and(NR3C1(was(analyzed(using(qPCR.((Results(from(the(iPSCNderived(neural(cells(
were( compared( with( those( from( a( subset( of( 15( fibroblast( lines.( ( We( found( no( significant(
change( in( mRNA( expression( of( either( FKBP5( or( NR3C1( in( iPSCNderived( neural( cultures(
following( dexamethasone( treatment.( ( However,( there( were( significant( changes( in( FKBP5(
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and( NR3C1( in( fibroblasts,( mimicking( previous( findings( in( peripheral( bloodNderived( cells.((
There(was(no(effect(of(FKBP5#rs1360780(genotype(on(FKBP5(mRNA(expression(in(neural(
cells(or(fibroblasts.((These(results(suggest(that(iPSCNderived(forebrainNlineage(neural(cells(
are(not(a(suitable(cell(model(for(researchers(wanting(to(examine#relationships(between(GR(
activation,(FKBP5(expression,(and(genetic(variation(in(human(neural(cells(in#vitro,(and(raise(
the( question( whether( results( seen( in( nonNneural( cells( are( broadly( representative( of(
glucocorticoid(effects(on(FKBP5(expression(in(neural(cells.(
(
Introduction(
The( hypothalamicNpituitaryNadrenal( (HPA)( axis( response( to( stress( requires( an(
interaction(of(many(signaling(molecules(to(function(properly.((Dysregulation(of(the(stress(
response(can(be(damaging,(potentially(increasing(vulnerability(to(disease,(particularly(if(the(
affected( individual( is( genetically( predisposed( (De( Kloet,( 2004).( ( Indeed,( differences( in(
response(to(stress(have(been(observed(in(individuals(with(a(variety(of(psychiatric(disorders(
including(schizophrenia,(bipolar(disorder,(depression,(postNtraumatic(stress(disorder,(and(
alcohol( use( disorder,( among( others.( ( However,( the( molecular( mechanisms( that( underlie(
dysregulation(of(the(stress(response,(particularly(those(in(the(human(brain,(remain(unclear.(((
The(glucocorticoid(receptor((GR)(is(a(cytosolic(transcription(factor(activated(by(the(
stress(hormone(cortisol((de(Kloet(et(al.,(2005,(Schatzberg(et(al.,(2014).((Following(cortisol(
binding,( the( GR( translocates( into( the( cell( nucleus( and( functions( as( a( regulator( of(
transcription(by(binding(to(specific(DNA(sequences(in(promoter(or(enhancer(regions(called(
GR(response(elements((GREs)((de(Kloet(et(al.,(2005,(Binder,(2009,(Grad(and(Picard,(2007).((
GR(translocation(is(a(complex(process(involving(a(variety(of(molecular(chaperones(and(coN
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chaperones( including( the( FK506( binding( protein( 51( (FKBP5),( which( is( encoded( by( the(
FKBP5( gene.( ( FKBP5( is( part( of( a( protein( heteromericNcomplex( that( represses( the(
transcriptional( activity( of( the( GR( by( reducing( cortisol( binding( affinity( and( inhibiting( GR(
translocation(to(the(nucleus((Sinclair(et(al.,(2013,(Grad(and(Picard,(2007,(Stechschulte(and(
Sanchez,( 2011).( ( Following( GR( activation,( FKBP5( mRNA( is( upregulated( via( GR( binding( to(
GREs(located(in(promoter(and(intronic(regions(of(FKBP5.((Increased(levels(of(FKBP5(protein(
inhibit( GR( activity,( creating( a( short( negative( feedback( loop( whereby( GR( activation( down(
regulates(GR(function((Binder,(2009,(Zannas(and(Binder,(2014a).(((
Polymorphisms( within( a( 100( kb( haplotype( block( in( FKBP5( that( is( tagged( by( the(
rs1360780(single(nucleotide(polymorphism((SNP)(have(been(linked(to(a(number(of(stressN
related(psychiatric(conditions(including(PTSD,(anxiety,(depression,(and(addictive(disorders(
(Binder(et(al.,(2008,(Klengel(et(al.,(2013,(Lavebratt(et(al.,(2010,(Binder(et(al.,(2004,(Kang(et(
al.,(2012,(Roy(et(al.,(2010,(Levran(et(al.,(2014,(Jensen(et(al.,(2014,(Huang(et(al.,(2014).((For(
PTSD,( childhood( trauma,( but( not( adult( trauma,( interacts( with( FKBP5( genotype( to( predict(
symptoms,(while(for(other(stressNrelated(disorders(FKBP5(genotype(interactions(have(been(
reported( with( both( childhood( and( lifetime( stressors( (Zannas( and( Binder,( 2014a).( ( These(
genetic(variants(may(lead(to(differential(expression(of(FKBP5(mRNA(and(protein(by(altering(
chromatin(structure(and(DNA(methylation((Binder(et(al.,(2004,(Klengel(et(al.,(2013,(Binder,(
2009),( which( may( have( functional( longNlasting( consequences( for( an( individual’s( response(
to(stress.(((For(example,(in(a(study(of(310(infants,(carriers(of(the(FKBP5(rs1360780(minor(TN
allele( had( increased( cortisol( reactivity( to( minor( stress( (Luijk( et( al.,( 2010).( ( However,( no(
genotype(effect(was(observed(on(salivary(cortisol(levels(in(a(sample(of(368(healthy(adults(
using(the(trier(Social(Stress(Test((Mahon(et(al.,(2013),(suggesting(that(genotype(effects(on(

(

99(

stress( response( may( vary( during( development.( In#vitro( evidence( for( developmental( stateN
specific( regulation( of( FKBP5( comes( from( examination( of( human( hippocampal( progenitor(
cells,( where( dexamethasone( exposure( during( the( proliferation/differentiation( phase,( but(
not( during( the( postNproliferation/differentiation( phase,( induced( long( lasting( DNA( deN
methylation( of( FKBP5( (Klengel( et( al.,( 2013).( ( However,( studies( examining( FKBP5( mRNA(
expression(following(GR(activation(or(as(a(function(of(genotype(have(largely(relied(on(easily(
accessible( peripheral( blood( cells,( immortalized( human( cell( lines,( or( animal( models,(
suggesting( expression( studies( using( human( neural( cells( will( be( of( importance,( since( gene(
expression(profiles(in(peripheral(cells(are(weakly(correlated(with(expression(in(the(central(
nervous(system((Sullivan(et(al.,(2006).((To(our(knowledge(no(study(has(examined(the(effect(
of(dexamethasone(exposure(on(FKBP5(induction(in(genetically(characterized(human(neural(
cells,(which(supports(the(utility(of(an(in#vitro(human(iPSCNderived(neural(cell(model(system.(
The(purpose(of(this(study(was(to(examine(gene(expression(changes(in(iPSCNderived(
human(neural(cells(in#vitro(following(acute(GR(activation(with(the(synthetic(glucocorticoid(
dexamethasone.( ( We( reprogrammed( fibroblasts( generated( from( 20( donor( subjects( into(
induced( pluripotent( stem( cells( (Takahashi( and( Yamanaka,( 2006,( Takahashi( et( al.,( 2007)(
and,( using( an( established( protocol( to( differentiate( stem( cells( into( a( forebrain( lineage,(
examined(the(effects(of(a(6(hr(dexamethasone(exposure(on(mRNA(expression(of(FKBP5(and(
the( GR( gene( NR3C1# in( human( neural( cells.( ( Gene( expression( changes( following( acute(
dexamethasone( treatment( were( compared( between( iPSCNderived( neural( cultures( and( a(
subset(of(15(donor(subjects’(fibroblasts.((
(
Materials)and)Methods(
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Human#iPSCs#
(

iPSCs( were( generated( from( fibroblasts( obtained( using( a( skin( punch( biopsy( of( the(

inner,( upper( arm( from( 20( participants( enrolled( in( either( a( laboratory( study( examining(
effects( of( alcohol( or( a( clinical( treatment( study( at( the( UCONN( Health( Center( (UCHC,(
Farmington,( CT)( (Kranzler( et( al.,( 2014a,( Milivojevic( et( al.,( 2014).( ( Biopsy( samples( were(
minced( and( cultured( in( Dulbecco’s( modified( eagles( medium( (DMEM,( Life( Technologies)(
supplemented( with( 20%( fetal( bovine( serum( (FBS,( Life( Technologies),( 1x( nonNessential(
amino( acids( (Life( Technologies)( and( 1x( penicillin/streptomycin( (Life( Technologies).((
Fibroblast(cultures(were(expanded(and(passaged(using(trypsin((Life(Technologies)(prior(to(
being(frozen(or(sent(for(reprogramming.(
(

The( UCHC( Stem( Cell( Core( (Farmington,( CT)( reprogrammed( fibroblasts( to(

pluripotency(using(either(a(retrovirus(to(express(five(factors((OCT4,(SOX2,(KLF4,(cPMYC,(and(
LIN28)( (N=13)( or( a( sendai( virus( to( express( four( factors( (OCT4,( SOX2,( KLF4,( and( cPMYC)(
(N=7).((Two(to(four(weeks(after(viral(transduction,(multiple(pluripotent(stem(cell(colonies(
for(each(subject(were(selected(and(expanded(as(individual(clones.((TwentyNseven(iPSC(lines(
generated(from(the(20(donor(subjects(were(used(for(the(current(experiments,(with(2(clones(
examined(from(seven(donor(subjects(for(whom(data(from(the(two(clones(was(averaged(and(
plotted(as(a(single(point(along(with(those(from(the(other(13(subjects.(
(

As( previously( described( (Lieberman( et( al.,( 2012),( iPSCs( were( cultured( on( a( feeder(

layer( of( irradiated( mouse( embryonic( fibroblasts( using( human( embryonic( stem( cell( media(
containing(DMEM(with(F12((DMEM/F12,(1:1(ratio,(Life(Technologies)(supplemented(with(
20%(Knockout(Serum(Replacer((Life(Technologies),(1x(nonNessential(amino(acids,(1(mM(LN
glutamine( (Life( Technologies),( 0.1( mM( βNmercaptoethanol( (MP( Biomedicals,( Solon,( OH),(
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and( 4( ng/mL( of( basic( fibroblast( growth( factor( (bFGF,( Millipore).( ( iPSCs( were( monitored(
daily(and(colonies(exhibiting(spontaneous(differentiation(were(manually(removed.((Media(
was(fully(replaced(daily(and(cells(were(cultured(for(7(days,(or(to(confluency,(before(being(
passaged(using(1(mg/mL(Dispace((Life(technologies)(in(DMEM/F12.(
(
iPSC#Neural#Differentiation#
(

iPSCs( were( differentiated( into( neural( cell( cultures( as( previously( described(

(Lieberman(et(al.,(2012)(using(an(established(protocol(developed(by(the(WiCell(Institute(for(
the( differentiation( of( human( embryonic( stem( cells( into( neural( cells( of( a( forebrain( lineage(
(#SOPNCHN207,(REV(A,(www.wicell.org,(Madison,(WI).((Briefly,(we(used(an(“Embryoid(Body”(
(EB)Nbased( protocol( wherein( iPSC( colonies( are( removed( from( the( feeder( layer( substrate(
and( cultured( in( suspension( before( going( through( a( neural( induction( phase( to( generate(
primitive( neuroepithelial( cells.( ( Following( 3( weeks( of( culture( in( neural( induction( media,(
cells(were(dissociated(and(cultured(in(24Nwell(plates(on(Matrigel((BD(Biosciences,(Bedford,(
MA)( coated( glass( coverslips( in( neural( differentiation( media( containing( the( neural( growth(
factors( B27( supplement( (Life( Technologies),( laminin( (SigmaNAldrich),( brainNderived(
neurotrophic( factor( (BDNF,( Peprotech,( Rocky( Hill,( NJ),( glialNderived( neurotrophic( factor(
(GDNF,( Peprotech),( and( insulinNlike( growth( factor( 1( (IGFN1,( Peprotech).( ( All( cells( were(
incubated(at(37O(in(5%(CO2.(
(
Fibroblast#Culture(
(

Fibroblasts( available( from( 15( of( the( 20( donor( subjects( were( thawed( from( liquid(

nitrogen( storage( and( plated( into( 12Nwell( culture( dishes( in( fibroblast( media( containing(
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DMEM((Life(Technologies)(supplemented(with(10%(fetal(bovine(serum((Life(Technologies)(
and(1x(nonNessential(amino(acids((Life(Technologies).((Cells(were(cultured(to(confluency(for(
10N14(days(with(full(media(changes(twice(per(week.(
(
Immunocytochemistry#
(

Six( to( eight( weeks( after( being( plated( onto( glass( coverslips,( neural( cultures( were(

fixed( in( 4%( paraformaldehyde( in( PBS( for( 20( min( at( room( temperature( and( permeablized(
using(0.2%(triton(XN100((SigmaNAldrich)(in(PBS(for(10(min.((Following(a(1Nhr(block(using(
5%( donkey( serum( (Jackson( ImmunoResearch,( West( Grove,( PA),( cultures( were( incubated(
overnight(at(4O(with(the(following(primary(antibodies(diluted(in(5%(donkey(serum(in(PBS:(
mouse( antiNbeta( IIINtubulin( (1:500,( Covance,( Dedham,( MA),( mouse( antiNGFAP( (1:500,(
Millipore,( Brillerica,( CA),( rabbit( antiNMAP2( (1:500,( Millipore),( and( rabbit( antiNTBR1( (a(
forebrain( glutamatergic( neuromarker;( 1:1000,( ProteinTech( Group,( Chicago,( IL)( incubated(
overnight( with( the( addition( of( 0.1%( triton( XN100.( ( Cells( were( then( incubated( at( room(
temperate(for(45(min(in(donkey(antiNmouse(alexa(flour(594((1:1000,(Life(Technologies)(and(
donkey( antiNrabbit( alexa( flour( 488( (1:1000,( Life( Technologies)( secondary( antibodies(
diluted(in(3%(donkey(serum(in(PBS(for(visualization.(
(
Acute#Dexamethasone#Exposure#
(

Six(to(seven(weekNold(neural(cells(and(≈95%(confluent(fibroblast(primary(cultures(

were( exposed( to( 1( μM( dexamethasone( (SigmaNAldrich)( for( 6( hr.( ( This( concentration( of(
dexamethasone( has( previously( been( shown( to( increase( expression( of( FKBP5( in( human(
peripheral( blood( mononuclear( cells( (Vermeer( et( al.,( 2004).( ( Dexamethasone( was(
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reconstituted( to( a( concentration( of( 100( mM( in( dimethyl( sulfoxide( (DMSO,( SigmaNAldrich)(
and( diluted( to( experimental( concentrations( in( either( neural( differentiation( media( for( use(
with( neural( cells( or( in( fibroblast( media( for( use( with( fibroblasts.( ( On( the( day( of( the(
experiment,(plates(of(cells(were(removed(from(the(incubator(and(100%(of(the(media(was(
aspirated( and( replaced( with( 500( μL( of( neural( differentiation( media( or( 1( mL( of( fibroblast(
media(containing(either(vehicle((DMSO)(or(dexamethasone.((For(neural(cells,(4N6(wells(of(a(
24Nwell(plate(were(used(per(condition.((For(fibroblasts,(3(wells(of(a(12Nwell(plate(were(used(
per(condition.((Cells(were(returned(to(the(incubator(during(the(6(hr(exposure.(
(
SevenPDay#Dexamethasone#Exposure#(
(

Neural( cell( cultures( differentiated( from( 10( cell( lines( (N=4( rs1360780*C(

homozygotes(and(N=6(TNallele(carrier)(derived(from(seven(donor(subjects(were(exposed(to(
a(priming(dose(of(100nM(dexamethasone(two(weeks(after(neural(plating.((On(the(first(day(
of( treatment,( media( was( aspirated( and( fresh( neural( differentiation( media( containing(
100nM(dexamethasone(was(added(to(the(neural(cell(cultures.((DexamethasoneNcontaining(
media(was(fully(replaced(after(three(days(for(an(additional(four(days.((Following(seven(days(
of( treatment,( media( was( fully( aspirated( and( replaced( with( normal( neural( differentiation(
media(for(an(addition(three(weeks,(after(which(neural(cells(were(acutely(exposed(to(neural(
differentiation( media( containing( 1μM( dexamethasone( or( DMSO( as( described( above.( ( For(
this(pilot(experiment,(two(separate(iPSC(clones(were(examined(from(3(donor(subjects.(
(
Quantitative#Polymerase#Chain#Reaction#(qPCR)#
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(

Following( 6( hr( dexamethasone( exposure,( RNA( was( extracted( from( the( neural( cell(

and( fibroblast( cultures( using( TRIzol( reagent( (Life( Technologies)( according( to( the(
manufacturer’s(protocol.(((RNA(was(quantified(using(a(NanoDrop(2000(spectrophotometer(
(Thermo(Fischer(Scientific,(Pittsburgh,(PA)(and(50(μL(of(cDNA(was(synthesized(from(2(μg(of(
RNA( using( a( High( Capacity( cDNA( Reverse( Transcription( Kit( (Life( Technologies)( per( the(
manufacturer’s( protocol.( ( Additionally,( the( RNA( samples( for( all( subjects( underwent( the(
same( preparation( without( the( addition( of( reverse( transcriptase( to( test( for( potential( DNA(
contamination.(
(

cDNA( was( analyzed( by( qPCR( using( an( Applied( Biosystems( 7500( instrument( (Life(

Technologies)(and(FAMNlabeled(TaqMAN(Assay(on(Demand((Life(technologies)(probe(and(
primer( sets( for( NR3C1( (Hs00353740_m1)( and( FKBP5( (Hs01561006_m1).( ( Expression( of(
these( genes( was( normalized( to( the( VICNlabeled( housekeeping( gene( GUSB# (betaN
glucuronidase,(4326320E,(Life(Technologies).((cDNA(synthesized(from(RNA(extracted(from(
each( individual( well( was( plated( in( triplicate( onto( an( Optical( 96Nwell( plate( (Life(
technologies)(and(20(μL(reactions(were(carried(out(using(Gene(Expression(Master(Mix((Life(
Technologies)( per( the( manufacturer’s( protocol,( with( the( addition( of( 0.1%( bovine( serum(
albumin((BSA,(Life(Technologies).(((
PCR(cycles(were(as(follows:(95OC(for(10(min,(followed(by(40(cycles(of(95OC(for(15(sec(
and(60OC(for(60(sec.((A(standard(curve(consisting(of(a(4Nlevel(serial(dilution(of(100%,(50%,(
25%,(and(12.5%(cDNA(from(neural(cells(differentiated(from(one(subject(was(added(to(each(
plate( to( determine( relative( mRNA( expression( between( all( subjects( and( across( different(
qPCR(plates.((Data(shown(in(graphs(are(displayed(as(mRNA(expression(normalized(to(the(
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housekeeping( gene( GUSB( where( a( unit( of( 1( is( equivalent( to( the( same( abundance( of( the(
target(gene(relative(to(GUSB(in(the(reference(RNA(sample.(((
(
Statistical#Analysis#
#

Gene(expression(was(analyzed(for(statistical(significance(via(OneNWay(ANOVA(with(a(

Bonferroni(postNtest(comparing(selected(cell(type(and(treatment(condition(using(GraphPad(
Prism( software( (V5.0f( ( for( Mac,( GraphPad( Software,( San( Diego,( CA,( www.graphpad.com).((
Statistical(significance(was(identified(as(p<0.05.((PostNhoc(testing(compared(drug(treatment(
within(cell(type,(basal(differences(in(gene(expression(between(neural(cells(and(fibroblasts,(
and( between( cell( type( and( drug( treatment( as( a( function( of( rs1360780( C/C( vs.( TNcarrier(
genotype.((
(
Results(
mRNA# Expression# of# FKBP5# and# NR3C1# is# Altered# in# Fibroblasts# but# not# in# iPSCPDerived#
Neural#Cultures#Following#Dexamethasone#Treatment(
(

iPSCs( derived( from( the( 20( subjects( were( differentiated( into( mixed( neural( cultures(

containing( MAP2,( Beta( IIINTubulin,( and( TBR1Npositive( neurons( and( GFAPNpositive(
astrocytes( (Figure( 5.1ANB).( ( Acute( dexamethasone( treatment( did( not( significantly( alter(
mRNA(expression(of(either(FKBP5#(postNhoc(test,(p>0.05,(Figure(5.2A)(or(NR3C1((potNhoc(
test,(p>0.05,(Figure(5.2B)(in(iPSCNderived(neural(cultures.(
(

Fibroblasts( used( for( iPSC( reprograming( were( available( from( 15( of( the( 20( donor(

subjects.( ( Acute( dexamethasone( treatment( significantly( increased( expression( of( FKBP5(
(postNhoc( test,( t=12.1,( p<0.0001,( Figure( 5.2A)( and( decreased( expression( of( NR3C1( (postN

(
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hoc( test,( t=2.6,( p<0.05,( Figure( 5.2B)( in( fibroblast( cultures.( ( Comparing( expression( levels(
between(neural(cells(and(fibroblasts(revealed(a(significantly(higher(level(of(NR3C1(mRNA(in(
fibroblasts( at( baseline# (postNhoc( test,( t=18.2,( p<0.0001,( Figure( 5.2B)( with( no( significant(
difference(observed(for(baseline(levels(of(FKBP5((postNhoc(test,(p>0.05,(Figure(5.2A).(
(
FKBP5# mRNA# Expression# in# Neural# Cells# and# Fibroblasts# Does# Not# Differ# by# rs1360780#
Genotype(
(

The(20(neural(cell(lines(examined(consisted(of(7(rs1360780*C(homozygotes(and(13(

rs1360780*TNallele( carriers( (12( C/T( and( 1( T/T).( ( No( significant( effect( of( dexamethasone(
was(observed(in(neural(cells(derived(from(donor(subjects(of(either(genotype((postNhoc(test,(
p>0.05,(Figure(5.3),(and(no(significant(difference(in(basal(expression(was(observed((postN
hoc(test,(p>0.05).(((
(

The( 15( fibroblast( lines( examined( included( 6( rs1360780*C( homozygotes( and( 9(

rs1360780*TNallele( carriers( (8( C/T( and( 1( T/T).( ( Exposure( to( 1( μM( dexamethasone(
significantly(upregulated(FKBP5(mRNA(expression(in(fibroblasts(from(both(C/C((postNhoc(
test,(t=7.4,(p<0.0001)(and(TNallele(carriers((postNhoc(test,(t=9.3,(p<0.0001)((Figure(5.3).((No(
significant(difference(was(observed(between(C/C(and(TNallele(carrier(genotypes(in(the(basal(
expression( of( FKBP5( (postNhoc( test,( p>0.05)( or( its( induction( by( dexamethasone( exposure(
(postNhoc(test,(p>0.05).(
(
#

(

#
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Figure)5.1.))iPSCs)Differentiate)into)Mixed)Neural)Cultures)
)

)
)
7( weeks( postNplating( iPSCNderived( neural( cultures( contain( a( mixture( of( neurons( and( glia.((
(A)( Neural( cultures( contain( MAP2Npostive( neurons( (green)( and( GFAPNpositive( astrocytes(
(red).(((B)(The(deep(layer(forebrain(nuclear(marker(TBR1((green)(is(seen(coNlocalizing(in(
the( nucleus( of( neurons( marked( by( the( neural( marker( Beta( IIINTubulin( (red).( ( Nuclei( are(
labeled(with(DAPI((blue).((Scale(bars(represent(20μm.(
#
#

(
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Figure) 5.2.) ) FKBP5) and) NR3C1) mRNA) Expression) in) Fibroblasts) and) iPSCFDerived)
Neural)Cultures)Following)6)Hr)Dexamethasone)Exposure)
)

)
(A)( A( significant( effect( of( dexamethasone( exposure( was( observed( on( FKBP5( mRNA(
expression(in(fibroblasts((postNhoc(test,(t=12.1,(p<0.001)(but(not(iPSCNderived(neural(cells(
(postNhoc(test,(p>0.05)(((B)(A(significant(effect(of(dexamethasone(exposure(was(observed(
on( NR3C1( mRNA( expression( in( fibroblasts( (postNhoc( test,( t=2.6,( p<0.05)( but( not( in( iPSCN
derived(neural(cells((postNhoc(test,(p>0.05).((Comparison(of(basal(expression(in(fibroblasts(
vs.(iPSCNderived(neural(cells(revealed(significantly(lower(NR3C1(mRNA(expression(in(iPSCN
derived(neural(cell(cultures((postNhoc(test,(t=18.2,(p<0.0001).(((****p<0.0001,(***p<0.001,(
*p<0.05)(
#
#

(
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Figure)5.3.))Genetic)Variation)in)FKBP5#Does)Not)Associate)with)Differences)in)FKBP5)
mRNA)Induction)Following)Dexamethasone)Exposure)

)
Dexamethasone( did( not( significantly( increase( FKBP5( mRNA( expression( in( iPSCNderived(
neural(cells(derived(from(either(rs1360780(genotype(((C/C;(postNhoc(test,(p>0.05,(TNcarrier;(
postNhoc( test,( p>0.05).( ( A( significant( upregulation( of( FKBP5( mRNA( was( observed( in(
fibroblasts( derived( from( donor( subjects( of( both( rs1360780( genotype( (C/C;( postNhoc( test,(
t=7.4,( p<0.0001,( TNcarrier;( postNhoc( test,( t=9.3,( p<0.0001).( ( No( significant( difference( was(
observed( between( rs1360780( genotype( in( the( induction( of( FKBP5( mRNA( following(
dexamethasone( treatment( in( fibroblasts( (postNhoc( test,( p>0.05).( ( (****p<0.0001,(
***p<0.001,(*p<0.05)(
#
#

(
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Early#Exposure#to#Dexamethasone#does#not#Induce#Responsiveness#to#Acute#Dexamethasone#in#
Neural#Cells#by#rs1360780#Genotype(
(

In( view( of( a( prior( report( identifying( an( FKBP5( rs1360780( genotype( interaction( on(

longNlasting(DNA(deNmethylation(with(early(exposure(to(dexamethasone(using(a(neural(cell(
line( (Klengel( et( al.,( 2013),( in( an( exploratory( fashion( we( examined( whether( iPSCNderived(
neural( cells( from( rs1360780( C/C( vs.( TNallele( carriers( would( become( responsive( to(
dexamethasone( following( exposure( to( a( priming( dose( of( 100nM( dexamethasone( at( an(
earlier( time( point( of( cell( maturation.( ( A( subset( of( 10( iPSCNderived( neural( cell( lines( (4(
rs1360780*C( homozygotes,( and( 6( TNallele( carriers)( were( exposed( to( 100nM(
dexamethasone(for(seven(days,(following(which(cells(were(cultured(in(normal(neural(media(
for(threeNweeks(prior(to(a(6(hr(1μM(dexamethasone(challenge((Figure(5.4A).((We(chose(to(
expose( the( neural( cultures( at( twoNweeks( due( to( the( morphological( characteristics( of( the(
culture,( in( which( cultures( are( generally( sparse( while( multiple( neurites( projecting( from(
plated( cell( clusters( can( be( observed( with( migrating( cells( along( the( processes.( ( Treatment(
with( 100nM( dexamethasone( at( week( two( postNplating( did( not( induce( changes( in( FKBP5(
mRNA(expression(following(6(hr(1μM(dexamethasone(challenge(at(sixNweeks(in(neural(cells(
derived(from(either(rs1360780(C/C((postNhoc(test,(p>0.5)(or(TNallele(carrier((postNhoc(test,(
p>0.05)(donor(subjects((Figure(5.4B).(
(
Discussion(
(

The( differentiation( of( iPSCs( enables( researchers( to( examine( difficultNtoNobtain(

human(cell(types(in#vitro.((In(the(current(study,(we(examined(the(effect(of(acute(exposure(to(
1(μM(dexamethasone(on(mRNA(expression(of(FKBP5(and(NR3C1(in(27(human(neural(cell((

(
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Figure) 5.4.) ) Developmental) PreFTreatment) with) Dexamethasone) Does) Not) Activate)
FKBP5) mRNA) Expression) in) Neural) Cells) Following) Subsequent) Acute)
Dexamethasone)Exposure)

)
(A)(A(subset(of(10(iPSCNderived(neural(cell(lines(from(4(rs1360780*C(homozygotes(and(6(
rs1360780*TNallele( carriers( were( preNtreated( with( 100nM( dexamethasone( at( twoNweeks(
postNplating(for(seven(days.(((B)(Following(a(subsequent(21Nday(washout,(acute(challenge(
with( 1μM( dexamethasone( for( 6( hrs( did( not( significantly( change( FKBP5( mRNA( expression(
levels(in(neural(cells(derived(from(either(rs1360780*C(homozygotes((postNhoc(test,(p>0.05)(
or(TNallele(carriers((postNhoc(test(p>0.05).(
(
(

(
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lines( differentiated( from( iPSCs( that( were( derived( from( 20( donor( subjects.( ( This(
concentration( of( dexamethasone( had( previously( been( shown( to( induce( FKBP5( expression(
in(human(peripheral(blood(mononuclear(cells((Vermeer(et(al.,(2004),(a(cell(type(chosen(in(
many(studies(of(the(effects(of(dexamethasone(on(gene(expression(due(to(its(sensitivity(to(
glucocorticoids.((However,(differences(in(the(sensitivity(to(glucocorticoids(can(vary(across(
cell( types( (Ebrecht( et( al.,( 2000)( and( little( research( has( examined( the( effect( of(
dexamethasone(treatment(in(neural(cells,(particularly(those(from(human(donors.(
(

We(found(that(the(expression(of(FKBP5(mRNA(did(not(significantly(change(in(human(

iPSCNderived( neural( cells( following( dexamethasone( treatment,( which( contrasts( findings(
using( peripheral( bloodNderived( cells( reporting( large( increases( following( dexamethasone(
stimulation,(including(a(10Nfold(upregulation(in(whole(blood((Menke(et(al.,(2012)(and(15N
fold(increases(in(TN(and(BNlymphocytes((Ebrecht(et(al.,(2000).((Interestingly,(we(did(observe(
a( significant( upregulation( of( FKBP5#mRNA( following( dexamethasone( treatment( in( human(
fibroblasts.( ( Comparing( results( from( previous( studies( to( our( current( data( suggests( that(
FKBP5#mRNA( expression( is( induced( less( strongly( in( neural( tissue( than( in( peripheral( cells(
following( GR( activation.( ( Support( for( this( argument( comes( from( examination( of( the( SHN
SY5Y( human( neuroblastoma( cell( line,( in( which( gene( expression( for( FKBP5( increased( by(
≈25%(following(exposure(to(cortisol((Tatro(et(al.,(2009),(a(finding(that(was(mimicked(in(the(
mouse( hippocampal( HTN22( cell( line,( which( showed( a( ≈50%( increase( in( FKBP5( mRNA(
expression(following(a(6(hr(corticosterone(exposure,(with(a(peak(increase(of(≈250%(after(
three( days( (Lee( et( al.,( 2010).( ( Additional( rodent( studies( report( that( regulation( of( FKBP5(
mRNA( expression( varies( by( brain( region,( with( the( highest( basal( expression( found( in( the(
hippocampal( CA1( and( dentate( gyrus( regions.( ( Increases( in( FKBP5# mRNA( expression(
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resulting(from(stimulation(with(dexamethasone(or(acute(stress(ranged(from(approximately(
50N200%( and( differed( by( brain( region,( with( larger( increases( in( FKBP5( mRNA( expression(
found( in( the( central( amygdala( and( paraventricular( nucleus( than( in( the( hippocampal( CA1(
and( dentate( gyrus( regions,( and( no( change( in( expression( observed( in( the( CA2( and( CA3(
regions((Scharf(et(al.,(2011).((FKBP5(expression(was(also(increased(in(the(prefrontal(cortex(
of( DBA2/J( mice( following( an( acute( alcohol( injection,( which( increased( in( a( doseNresponse(
fashion,(but(was(not(increased(in(the(ventral(tegmental(area(or(nucleus(accumbens((Kerns(
et( al.,( 2005,( Costin( et( al.,( 2013),( further( suggesting( brain( regionNspecific( regulation.( ( It( is(
possible(that(we(did(not(observe(a(significant(change(in(FKBP5(mRNA(expression(following(
dexamethasone( exposure( due( to( the( forebrainNtype( neural( differentiation( protocol( used.((
Future(research(might(aim(to(differentiate(human(iPSCs(into(other(neural(cell(types,(such(as(
hippocampal(dentate(gyrusNlike(neural(cells((Mertens(et(al.,(2015),(in(attempts(to(elucidate(
mechanisms(that(lead(to(differences(in(FKBP5#mRNA(induction(following(GR(activation(that(
vary(by(brain(region.(
(

PostNmortem( analysis( of( human( brain( gene( expression( has( implicated( FKBP5( in(

psychiatric( disorders.( ( FKBP5( mRNA( levels( are( over( 2Nfold( higher( in( the( hippocampus( of(
alcoholic( individuals( (McClintick( et( al.,( 2013),( significantly( elevated( in( the( dorsolateral(
prefrontal( cortex( of( individuals( with( bipolar( disorder( and( schizophrenia( (Sinclair( et( al.,(
2013),(and(significantly(lower(in(the(amygdala(of(suicide(victims((PerezNOrtiz(et(al.,(2013).((
At( the( genetic( level,( SNPs( spanning( promoter( and( intronic( regions( of( the( gene( have( been(
associated( with( anxiety( and( depression( (Binder( et( al.,( 2004,( Kang( et( al.,( 2012),( postN
traumatic(stress(disorder((Binder(et(al.,(2008,(Klengel(et(al.,(2013),(and(most(recently(with(
severity( of( alcohol( withdrawal( symptoms( (Huang( et( al.,( 2014)( and( negative( effects( of(
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nicotine((Jensen(et(al.,(2014).((At(the(molecular(level,(FKBP5(genetic(variation(is(associated(
with(altered(chromatin(structure(and(differences(in(methylation(in(traumatized(individuals(
(Klengel(et(al.,(2013),(leading(to(“high(induction”(and(“low(induction”(alleles(where(FKBP5(
expression( is( upregulated( more( in( traumaNexposed( carriers( of( the( rs1360780( TNallele(
(Binder,( 2009).( ( However,( conclusive( evidence( for( an( FKBP5( risk( genotype( moderating(
FKBP5( expression( is( lacking,( and( to( our( knowledge( is( limited( to( a( few( studies.( ( Using(
peripheral(blood(mononuclear(cells,(Binder(et(al.((2004)(found(no(significant(difference(in(
FKBP5( mRNA( expression,( but( significantly( higher( FKBP5( protein( levels( in( rs1360780( TN
allele(homozygotes((Binder(et(al.,(2004).((In(postNmortem(human(brain(from(controls(and(
subjects( with( bipolar( disorder( or( schizophrenia,( a( significant( effect( of( rs4713916,( a( SNP(
located( in( the( promoter( region( of( FKBP5( and( in( moderate( linkage( disequilibrium( with(
rs1360780((D’=0.85),#on(basal(FKBP5(protein(expression(was(found(in(homozygotes(of(the(
minor( TNallele( (Sinclair( et( al.,( 2013).( ( Perhaps( most( relevant( to( our( findings( due( to( the(
examination( of( expression( following( GR( activation,( Hoehne( et( al.( (2014)( found( that(
psychosocial( stress( increased( FKBP5( mRNA( expression( in( peripheral( blood( cells( of(
rs1360780(CNallele(homozygotes,(but(TNallele(carries(showed(a(blunted(induction(of(FKBP5(
mRNA( that( did( not( differ( from( unstressed( controls( (Hoehne( et( al.,( 2014).( ( It( may( be( that(
FKBP5(genotype(effects(on(gene(expression(following(dexamethasone(stimulation(can(only(
be(seen(in(the(setting(of(developmental(stress(occurring(at(particular(time(points,(as(human(
hippocampal( progenitor( cells( treated( with( dexamethasone( during( the( early(
proliferation/differentiation( phase,( but( not( later( in( the( postNproliferation/differentiating(
phase,( exhibited( longNlasting( deNmethylation( of( FKBP5( DNA( (Klengel( et( al.,( 2013).((
However,( this( study( did( not( look( at( the( effect( of( dexamethasone( treatment( at( these( two(
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time(points(on(FKBP5(mRNA(expression(and(was(limited(to(the(use(of(a(single(genetically(
uncharacterized(neural(progenitor(cell(line,(whereas(human(iPSC(technologies(allow(for(the(
examination(of(neural(cells(from(multiple(genetically(characterized(donor(subjects.((In(the(
current( study,( we( found( no( effect( of( FKBP5( rs1360780( genotype( on( induction( of( FKBP5(
following( acute( dexamethasone( exposure( in( either( human( iPSCNderived( neural( cells( or(
fibroblasts,( or( in( neural( cells( preNtreated( with( dexamethasone( at( an( earlier( stage( of(
development.((A(limitation(of(our(study(is(that(our(TNallele(carrier(group(contained(only(a(
single(rs1360780(TNallele(homozygote,(which(could(have(obscured(an(association(between(
genotype(and(FKBP5(gene(expression(if(dexamethasone(response(differences(are(limited(to(
T/T(individuals.(
(

In(summary,(we(found(that(acute(dexamethasone(treatment(significantly(increased(

levels( of( FKBP5( mRNA( in( fibroblasts,( but( not( iPSCNderived( forebrainNlineage( neural( cells.((
No(significant(effect(of(FKBP5(rs1360780(genotype(on(FKBP5#mRNA(expression(following(
dexamethasone(treatment(was(observed(in(either(fibroblasts(or(iPSCNderived(neural(cells,(
or( in( neural( cells( preNtreated( with( a( priming( dose( of( dexamethasone( earlier( in( cell(
maturation.( ( This( work( supports( the( potential( of( using( iPSC( neural( differentiation( to(
examine( effects( of( genetic( variation( and( drug( exposure( on( mRNA( expression( in( human(
neural( cells,( but( suggests( that( future( research( aimed( at( exploring( stressNresponse( genes(
using(iPSC(technologies(may(wish(to(identify(differentiation(methods(that(generate(neural(
cell(types(that(express(GR(at(higher(levels(and(are(more(sensitive(to(GR(activation(than(the(
default( forebrain( lineage.( ( This( work( further( suggests( that( changes( in( FKBP5( gene(
expression(following(dexamethasone(exposure(observed(in(human(peripheral(cells(may(not(
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adequately(reflect(the(gene(expression(effects(in(human(neural(cells(derived(from(the(same(
subjects(in#vitro((
)

(
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Chapter)6.)
Discussion)and)Future)Directions(
(

The(overall(goal(of(this(dissertation(was(to(examine(the(utility(of(iPSCs(in(the(study(

of(alcohol(use(disorder.((We(started(by(examining(the(effects(of(acute(and(chronic(alcohol(
exposure( on( neural( cell( cultures( derived( from( alcoholics( and( nonNalcoholics( (Chapter( 2).((
Next( we( used( iPSCs( to( examine( the( molecular( phenotype( of( a( single( nucleotide(
polymorphism( in( the( GABAA( α2( subunit( gene( (GABRA2)( associated( with( development( of(
alcohol(use(disorder(in(neural(cells(derived(from(genetically(characterized(donor(subjects(
(Chapter(3).((Finally,(we(identify(a(novel(gene(x(environment(interaction(in(the(FKBP5(gene(
that( moderates( heavy( drinking( in( large,( diverse( human( sample( (chapter( 4)( and( further(
examine( the( molecular( characteristics( of( FKBP5( expression( by( genotype( and( following(
stimulation( with( the( synthetic( glucocorticoid( dexamethasone( in( iPSCNderived( human(
neural( cells( (chapter( 5),( as( previous( work( examining( regulation( of( FKBP5( expression( has(
been(conducted(only(in(rodent(and(human(peripherallyNderived(cells.(((
(

Psychiatric( disorders( have( complex( genetic( influences( and( are( difficult( to( model(

both(in#vivo(and(in#vitro.((The(advent(of(human(iPSC(technologies(promises(to(revolutionize(
psychiatric(research(by(making(previously(unobtainable(human(neural(cells(accessible(for(
the(study(of(molecular(phenotypes(associated(with(psychotic(illness(and(the(exploration(of(
novel(pharmacological(agents(for(treatment.((In(order(to(characterize(the(validity(of(using(
neural(cells(derived(from(iPSCs(to(study(the(biology(of(alcohol(use(disorder,(we(examined(
whether(they(recapitulate(some(of(the(previous(findings(associated(with(the(disorder(that(
were( originally( observed( in( animal( or( human( postNmortem( samples.( ( Our( initial( study( in(
chapter( 2( examined( the( acute( and( chronic( effects( of( alcohol( on( NMDA( receptor(
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electrophysiological( responses( and( gene( expression( and( found( that( changes( observed( in(
response( to( alcohol( treatment( did( in( fact( replicate( findings( reported( previously( in( other(
model(systems.((We(found(that(NMDA(receptorNmediated(depolarization(was(attenuated(by(
acute( alcohol( and( that( following( chronic( exposure,( mRNA( expression( of( NMDA( receptor(
subunits(were(significantly(upregulated(in(neural(cells(derived(from(alcohol(donor(subjects.((
We(chose(to(examine(alcohol(effect(on(the(NMDA(receptor(gene(expression(because(prior(
work(in(animal(and(human(postNmortem(models(had(established(it(as(a(target(for(alcohol’s(
actions((Nagy,(2008b),(and(the(primary(goal(of(the(first(study(was(to(validate(iPSCs(as(a(tool(
to( study( AUD.( ( Additional( studies( examining( alcohol’s( effect( on( the( NMDA( receptor( in(
human(iPSCNderived(neural(cells(could(include(exploring(postNtranslational(and(epigenetic(
modifications(that(occur(in(response(to(acute(and(chronic(alcohol,(as(acute(alcohol(has(been(
shown(to(induce(phosphorylation(of(the(NR2B(subunit((Yaka(et(al.,(2003a),(and(long(lasting(
changes( in( methylation( have( been( found( in( the( GRIN2B( gene( following( chronic( exposure(
(Marutha( Ravindran( and( Ticku,( 2005)( in( rodent( models.( ( As( GABAA( receptors( are( also( a(
primary(target(of(alcohol,(we(examined(the(effect(of(acute(and(chronic(alcohol(exposure(on(
GABANmediated( currents( and( subunit( gene( expression.( ( No( effect( of( acute( or( chronic(
alcohol( was( observed( on( the( GABAA( receptor;( results( that( are( discussed( in( detail( later.((
Interestingly,( while( examining( GABAA( subunit( gene( expression( following( chronic( alcohol(
exposure,(we(noticed(large(variability(in(the(basal(mRNA(levels(of(genes(encoding(certain(
subunits.((This(eventually(led(to(the(findings(presented(in(chapter(3.(
(

iPSCs(offer(a(powerful(tool(to(study(the(neurogenetics(of(psychiatric(disorders(with(

the( ability( to( differentiate( neural( cells( from( genetically( characterized( donor( subjects.( ( In(
chapter( 3( we( examined( in# vitro( molecular( correlates( of( a( common( polymorphism( in( the(

(

119(

GABRA2(gene((rs279858,(TN(to(CNSNP)(where(the(CNallele(has(been(replicated(in(numerous(
studies(to(be(associated(with(the(development(of(AUD.((In(chapter(3(we(found(that(mRNA(
expression( of( GABRA2( was( lower( in( carriers( of( the( AUDNrisk( CNallele( using( qPCR( on( RNA(
extracted(from(36(iPSCNderived(neural(cell(lines.((Furthermore,(as(GABRA2(resides(within(a(
cluster( of( four( GABAA( genes( on( chromosome( 4p12,( examination( of( the( adjacent( genes(
reveled(that(mRNA(expression(of(all(four(genes(was(significantly(correlated,(such(the(low(
expression(of(one(gene(predicted(low(expression(of(all(four(genes,(which(was(significantly(
associated(with(the(AUDNrisk(CNallele(in(GABRA2.((Low(expression(of(the(chromosome(4p12(
GABAA(cluster(was(replicated(using(RNA(sequencing,(which(also(revealed(that(expression(of(
GABAA(gene(residing(on(other(chromosomes,(neural(genes(encoding(ion(transporters,(and(
the( neuronNspecific( transcription( factor( NEUN( did( not( differ( between( the( lowNexpression(
and( highNexpressing( cell( lines,( which( importantly( suggests( that( the( differences( in(
chromosome( 4p12( GABAA( gene( expression( were( not( due( to( the( cells( being( of( a( different(
developmental(state.((This(finding(is(challenging(to(relate(to(the(human(condition(because(
no( genotype( association( with( expression( level( was( found( in( adult( human( postNmortem(
brain( samples.( ( However,( our( finding( can( be( related( to( reports( indicating( that( GABRA2(
genotype(is(associated(with(differences(in(brain(oscillations(measured(by(EEG((Edenberg(et(
al.,(2004),(and(in(activation(of(brain(regions(to(reward(anticipation(and(drug(cues(measured(
using(fMRI((Villafuerte(et(al.,(2012,(Heitzeg(et(al.,(2014,(Kareken(et(al.,(2010),(such(that(the(
molecular( effect( of( the( polymorphism( that( influences( risk( of( AUD( might( be( via(
developmental( mechanisms( affecting( brain( connectivity( related( to( genotype( effects( on(
GABAA(expression(during(development(rather(than(due(to(alterations(in(ligand(binding(or(
channel( function( between( genotypes( in( adulthood.( ( Although( in( its( current( state( these(
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findings(present(challenges(in(being(relatable(to(development(of(AUD(in(humans,(they(could(
lead(to(advances(in(our(understanding(of(the(disorder(through(additional(related(studies.((
For( example,( future( work( could( use( this( molecular( phenotype( as( a( marker( to( identify( a(
functional( polymorphism( linked( to( rs279858( responsible( for( the( low( expression( of( the(
chromosome( 4p12( GABAA( genes( in( iPSCNderived( neural( cells.( ( Furthermore,( researchers(
could( use( the( molecular( phenotype( to( identify( genetic( variation( that( associates( with( AUD(
across( a( wider( population,( considering( that( the( marker( we( used( to( stratify( cell( lines(
(rs279858( in( exon( 5( of( GABRA2,( which( is( synonymous( polymorphism)( is( associated( with(
AUD( in( Caucasians( but( not( African( Americans( (Covault( et( al.,( 2008).( ( Finally,( one( can(
imagine(that(the(yetNtoNbe(identified(variant(that(leads(to(the(low(expression(phenotype(in(
our( neural( cultures( could( be( used( as( a( pharmacogenetic( marker( for( the( effects( of(
medications( designed( to( treat( AUD,( in( hopes( to( identify( patients( that( are( more( likely( to(
respond(to(pharmacological(intervention.(
(

Identification(of(novel(genetic(markers(that(associate(with(hazardous(drinking(is(an(

important( component( in( the( prevention( of( AUD,( while( understanding( the( molecular(
correlates( of( these( genetic( markers( could( aid( in( clinical( treatment.( ( In( chapter( 4( we(
examined( the( association( of( a( polymorphism( within( the( FKBP5( gene( (rs1360780)( which(
encodes(the(glucocorticoid(chaperone(FK506(binding(protein(51(on(hazardous(alcohol(use(
in( a( large,( diverse( college( student( sample.( ( This( gene( has( been( extensively( examined( in(
other( stressNrelated( psychiatric( conditions( inducing( PTSD,( depression,( and( anxiety.( ( We(
found( that( FKBP5( rs1360780( genotype( interacted( with( self( reported( early( life( trauma( to(
moderate(the(frequency(of(heavy(drinking,(a(risk(factor(for(the(development(of(AUD.((This(is(
the( first( time( that( a( polymorphism( in( this( gene( has( been( associated( with( alcohol(
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consumption.((Importantly,(in(chapter(5,(we(utilized(iPSC(neural(differentiation(to(further(
explore( the( molecular( characteristics( of( FKBP5( and( the( effect( of( rs1360780( genotype( on(
FKBP5( expression( in( neural( tissue.( ( Previous( in# vitro( studies( on( FKBP5# gene( expression,(
both( as( a( function( of( stimulation( with( dexamethasone( and( rs1360780( genotype,( have(
largely(relied(on(peripheral(blood(cells(due(to(their(ease(of(generation(and(responsiveness(
to( glucocorticoids.( ( One( limitation( of( using( peripheral( blood( cells( is( that( gene( expression(
changes,( either( following( drug( exposure( or( by( genotype,( may( not( accurately( reflect(
occurrences( in( neural( cells.( Despite( this( limitation,( many( have( proposed,( perhaps(
erroneously,( that( FKBP5( expression( is( upregulated( in( the( brain( following( glucocorticoid(
receptor( activation,( and( that( rs1360780( genotype( causes( differential( regulation( by(
glucocorticoids(of(the(FKBP5(gene.((Binder((2009)(has(acknowledged(this(limitation,(stating(
“so(far(all(published(data(supporting(the(induction(of(FKBP5(by(glucocorticoids(have(been(
in(nonNbrain(tissues”((Binder,(2009).((This(highlights(a(promising(use(for(iPSC(technology,(
in(that(genotypeNspecific(neural(cultures(can(be(generated(and(examined(in#vitro(to(answer(
questions( such( as( are( the( effects( of( dexamethasone( consistent( in( peripheral( cells( and(
neural( cells?( ( We( set( out( to( answer( this( question( by( doing( a( simple( experiment( utilizing(
neural(cells(from(20(donor(subjects(characterized(by(their(FKBP5(rs1360780(genotype.((We(
found(no(significant(induction(of(FKBP5(following(acute(stimulation(with(dexamethasone(at(
concentrations( reported( to( induce( expression( in( peripheral( blood( cells( (Vermeer( et( al.,(
2004).( ( Furthermore,( no( effect( of( FKBP5( genotype( was( observed( on( basal( or( stimulated(
expression( levels.( ( Perhaps( most( interesting,( FKBP5( expression( in( subjectNmatched(
fibroblasts( were( responsive( to( dexamethasone( treatment,( suggesting( that( tissueNspecific(
regulation(of(FKBP5(may(exist.((It(could(be(argued(that(this(is(the(most(significant(aspect(of(
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this( study,( in( that( we( examined( two( tissue( types( derived( from( the( same( donor( subject.((
Future(work(may(wish(to(explore(additional(cell(types,(considering(that(expression(levels(of(
FKBP5(differ(by(brain(region(in(rodent(models((Scharf(et(al.,(2011),(it(may(be(that(FKBP5(
mRNA( expression( is( more( sensitive( to( the( effects( of( dexamethasone( in( some( neural(
subtypes( compared( to( others.( ( Additionally,( it( would( be( interesting( to( compare( and(
contrast(epigenetic(changes(following(acute(and(chronic(treatment(with(dexamethasone,(as(
long(lasting(deNmethylation(has(been(reported(in(dexamethasone(treated(human(cell(lines(
(Klengel(et(al.,(2013),(which(could(be(explored(in(various(iPSCNderived(neural(subtypes.(
(

One(of(the(areas(that(our(iPSC(system(did(not(model(prior(rodent(students(was(the(

potentiation( of( GABAA( receptor( function( by( acute( alcohol( and( a( regulation( of( GABAA(
subunit(expression(following(chronic(alcohol,(which(have(been(some(of(the(more(replicated(
findings( in( rodent( models( (Kumar( et( al.,( 2009).( ( In( our( experiments,( iPSCNderived( neural(
cells(failed(to(replicate(findings(that(GABAA(receptorNmediated(currents(are(potentiated(by(
acute( alcohol,( in( both( the( original( report( (chapter( 2),( which( examined( the( effect( of( acute(
50mM( alcohol( on( GABANevoked( currents( in( a( pilot( experiment( consisting( of( only( 4( cells(
derived(from(one(subject,(and(more(recently(in(a(larger(sample(of(47(neurons(derived(from(
7(donor(subjects((Figure(6.1).((Although(we(failed(to(see(an(effect(of(acute(alcohol(on(GABAA(
receptor(currents,(it(is(important(to(note(that(results(from(prior(reports(suggest(that(not(all(
neurons( show( GABAA( modulation( by( alcohol,( with( GABAA( receptor( currents( being(
potentiated( by( alcohol( in( only( a( subset( of( neurons( (20N70%)( (Signore( and( Yeh,( 2000,(
Aguayo,(1990).((This(result(that(may(be(in(part(be(due(to(brainNregion(specific(sensitivity(of(
GABAA( receptors( to( alcohol( (Weiner( and( Valenzuela,( 2006),( which( may( be( influenced( by(
differences(in(the(diversity(of(subunits(expressed(between(brain(regions,(since(subunit((
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Figure)6.1.))Acute)Alcohol)Does)Not)Potentiate)GABAA)Receptor)Currents)
)

(
(
No( effect( of( acute( alcohol( exposure( (50mM)( was( observed( on( GABANevoked( currents( in(
mature(iPSCNderived(neural(cells(diiferentiated(from(7(donor(subjects.((Each(dot(represents(
when( GABA( was( applied( via( puff( application,( which( was( repeated( every( 30( seconds,( and(
alcohol(was(perfused(into(the(recording(chamber(following(a(5Nminute(baseline.(((
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stoichiometry(is(a(major(determinant(of(the(GABAA(receptor’s(physiological(properties(and(
pharmacological( targets( (Rudolph( et( al.,( 2001,( Sieghart( and( Sperk,( 2002).( ( That( alcohol(
differentially(modulates(GABAA(receptors(by(brain(region(due(to(subunit(composition(of(the(
receptor(leads(to(an(interesting(idea(for(future(work.((Since(iPSCs(were(first(introduced(in(
2006( and( 2007,( numerous( protocol( have( been( utilized( to( differentiate( various( cell( types,(
including( cultures( enriched( for( dopamine,( serotonin,( and( GABAergic( neurons,( among(
others.((Considering(the(results(presented(in(Chapter(2,(it(might(be(useful(to(compare(and(
contrast( the( effect( of( acute( alcohol( on( GABAA( and( NMDA( receptor( currents( in( multiple(
neural( cell( types( differentiated( from( a( single( donor( subject.( ( One( might( expect( that( the(
proportion( of( responsive( cells( to( acute( alcohol( will( differ( between( regional( neural( cell(
types.((Results(from(a(study(such(as(this(could(then(be(used(to(compare(responsive(neural(
cell( types( between( donor( subject( phenotype( (i.e.( nonNalcoholic( vs.( alcoholic)( or( between(
carriers( of( AUDNrisk( genotypes( to( explore( potential( differences( in( response( to( acute(
alcohol.(
(

Modulation( of( GABAA( receptor( gene( expression( following( chronic( alcohol( is( one( of(

the(most(robust,(replicated(findings(in(studies(examining(rodent(and(human(postNmortem(
brain( samples( (Kumar( et( al.,( 2009).( ( Therefore,( we( examined( the( effect( of( 7Nday( alcohol(
exposure(on(expression(of(three(GABAA(subunit(genes,(GABRA1,#GABRG2,#and(GABRD,(in(our(
iPSCNderived(neural(cells(in(an(attempt(to(further(validate(the(utility(of(iPSCNbased(models(
to(study(AUD.((We(originally(included(examination(of(the(GABRA2(and(GABRA4(genes,(but(
the( large( effect( of( rs279858( genotypeNassociated( differences( in( expression( of( these( genes(
(Chapter( 3( and( discussed( above)( obscured( alcohol( effects.( ( Using( neural( cultures( derived(
from(12(subjects((7(nonNalcoholics,(5(alcoholics)(we(found(no(significant(change(in(mRNA((
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Figure)6.2.))No)Effect)of)Chronic)Alcohol)on)GABAA)Subunit)mRNA)Expression(
(

(
(
7Nday(exposure(to(50mM(alcohol(does(not(induce(changes(in(expression(of(genes(encoding(
GABAA(receptor(the((A)(α1((GABRA1),((B)(γ2((GABRG2),(or((C)(δ((GABRD)(subunits(in(neural(
cells(derived(from(either(nonNalcohol((white(bars)(or(alcoholic((black(bars)(donor(subjects.(((
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expression(of(these(three(genes(following(7Nday(alcohol(exposure((Figure(6.2).((There(are(
numerous( possibilities( as( to( why( GABAA( receptor( gene( expression( was( not( modulated( in(
our( neural( cultures.( ( One( can( speculate( that( the( GABAA( receptors( in( the( forebrainNtype(
neural( cells( that( we( differentiate( are( not( susceptible( to( the( effects( of( alcohol,( as( subunit(
composition(moderates(alcohol’s(effects((Wallner(et(al.,(2006),(and(that(differentiation(into(
neural( cultures( enriched( for( other( neural( subtypes( might( evoke( significant( expression(
differences( following( chronic( alcohol.( ( Furthermore,( it( may( be( that( the( concentration( and(
duration( of( alcohol( exposure( that( we( used( (50mM( for( 7( days)( was( inadequate( to( induce(
adaptive( changes( in( these( genes.( ( Finally,( it( may( be( that( our( iPSCNderived( neural( cultures(
are(lacking(the(necessary(transmitters(that(are(targets(of(alcohol(inducing(adaptive(changes(
in(GABAA(gene(expression.(((
(

In( neural( cells,( alcohol( exposure( induces( the( synthesis( of( GABAANmodulating(

neurosteroids( (Barbaccia( et( al.,( 1999,( Tokuda( et( al.,( 2011),( which( can( acutely( modulate(
GABAA(receptor(activity((Uchida(et(al.,(2002,(Sanna(et(al.,(2004)(while(chronic(neurosteroid(
exposure( can( induce( changes( in( GABAA( receptor( gene( expression( (Gulinello( et( al.,( 2001,(
Follesa( et( al.,( 2004)( that( are( similar( the( modulatory( effects( of( acute( and( chronic( alcohol(
exposure(on(GABAA(receptors,(suggesting(that(alcohol’s(effects(on(the(GABAA(receptor(are(
mediated( through( neurosteroids( rather( than( via( a( direct( interaction( with( the( receptor(
(Morrow( et( al.,( 1999).( ( Preliminary( work( supports( the( idea( that( our( iPSCNderived( neural(
cells( are( deficient( in( basal( GABAANmodulating( neurosteroids.( ( Gas( chromatography/( mass(
spectrometry((GC/MS)(was(performed(on(iPSCNderived(neural(cell(conditioned(media(and(
reveled( no( detectable( levels( of( GABAANmodulating( neurosteroids( (androsterone,(
androstanediol,( and( allopregnanolone).( ( Interestingly,( the( cultures( do( possess( functional(
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enzymes( that( synthesize( these( neurosteroids.( ( When( we( spiked( in( the( labeled( precursors(
D5Nandrostenedione(and(C13Ntestosterone,(after(a(brief(4Nhour(incubation(period(we(were(
able( to( detect( the( downstream( metabolites( androsterone( and( androstanediol,( indicating(
that(our(cultures(contain(active(5αNreductase,(3αNhydroxysteroid(dehydrogenase(and(17βN
hydroxysteroid( dehydrogenase( (Figure( 6.3).( ( An( intriguing( possibility( is( that( we( were(
unable(to(detect(changes(in(both(the(acute(actions(of(alcohol(on(GABANevoked(currents(and(
the( chronic( effects( on( GABAA( compensatory( gene( expression( due( to( a( lack( of( precursor(
neurosteroids(in(the(culture,(and(that(by(adding(precursors(to(the(media(we(may(be(able(to(
observe( effects( of( alcohol( at( GABAA( receptors.( ( To( explore( this( possibility,( we( incubated(
mature( neural( cells( from( one( subject( for( 3N4( hours( with( the( neurosteroid( precursor(
pregnenolone,( which( is( a( precursor( of( GABAANmodulating( neurosteroids( androsterone,(
androstanediol,( and( allopregnanolone,( prior( to( electrophysiological( recordings( examining(
the( acute( effect( of( alcohol( on( GABANevoked( currents.( ( As( described( previously,( no(
potentiating(effect(of(acute(alcohol(was(observed(on(GABAA(receptorNmediated(currents(in(
untreated(cells.((However,(a(≈30%(potentiation(of(GABANevoked(responses(to(acute(alcohol(
was( observed( when( the( cells( were( pretreated( with( the( neurosteroid( precursor,( an( effect(
that( was( not( observed( with( alcohol( was( coNperfused( with( dutasteride,( which( inhibits(
neurosteroid(synthesis(by(blocking(the(key(enzyme(5αNreductase((Figure(6.4).((To(explore(
neurosteroid/alcohol( interactions( on( GABAA( receptor( gene( expression( after( chronic(
exposure,( mature( neural( cells( from( two( subjects( were( treated( with( 3.16nM( of( the(
neuroactive(precursor(steroid(pregnenolone,(50mM(alcohol,(and(a(combination(of(the(two(
for( 7Ndays.( ( Similar( to( our( previous( findings,( no( effect( of( alcohol( was( observed( on( GABAA(
subunit(mRNA.((Furthermore,(no(effect(was(observed(when(the(cells(were(treated(with((
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Figure) 6.3.) ) Synthesis) of) Neuroactive) Steroids) Following) Administration) of) Labeled)
Precursor) Steroids) D5FAndrostenedione) and) C13FTestosterone) in) IPSCFDerived)
Neural)Cells)
)

(

(
(
Following( a( 4Nhour( incubation( with( labeled( precursor( steroids( in( mature( iPSCNdeirved(
neural(cultures,(we(were(able(to(detect(downstream(neuroactive(metabolites(Androsterone(
and( Androstanediol( using( GC/MS.( ( Neither( Androsterone( nor( Androstanediol( could( be(
detected( in( neural( cell( media( that( was( not( incubated( with( precursor( steroids( (data( not(
shown).((Neurosteroid(synthesis(pathway(adapted(from(Milivojevic(et(al.((2011).(
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Figure)6.4.))Acute)Effect)of)Alcohol)on)GABAFevoked)Currents)in)Neurons)Incubated)
with)the)Neurosteroid)Precursor)Pregnenolone)
(

(
(
As(an(exploratory(experiment,(neural(cells(derived(from(one(control(subject(were(used(to(
examine( the( effect( of( acute( alcohol( on( GABANevoked( currents( following( 3N4( hour(
neurosteroid( precursor( treatment.( ( The( same( experimental( design( was( used( as( seen( in(
Figure( 6.1.( ( As( discussed( previously,( no( effect( of( acute( alcohol( was( observed( on( GABAN
evoked( currents.( ( Bath( application( of( 50mM( alcohol( induced( a( modest( potentiation( of(
GABANevoked( current( when( neural( cultures( were( incubated( for( 3N4( hours( prior( to(
recording( with( pregnenolone.( ( This( potentiation( was( not( observed( when( alcohol( was( coN
applied(with(the(drug(dutasteride,(which(inhibits(neurosteroid(synthesis.(
(
(
(
(

(
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Figure)6.5.))Chronic)Exposure)to)Alcohol)+)Pregnenolone)Does)Not)Induce)Changes)in)
GABAA)Subunit)mRNA)Expression)
)

(
(
Mature(neural(cultures(from(two(donor(subjects(were(used(to(examine(whether(chronic(7N
day( treatment( with( a( 3.16nM( pregnenolone( or( a( combination( of( 3.16nM( pregnenolone(
+50mM( alcohol( regulated( expression( of( genes( encoding( GABAA( receptor( subunits.( ( As(
discussed(previosuly,(no(effect(of(alcohol(was(observed(on((A)(GABRA1,((B)(GABRG2,(and(
(C)( GABRD( mRNA( expression( following( 7Ndays( of( alcohol( exposure( (solid( gray( bars).( ( No(
effect( of( pregnenolone( (hashed( bars)( or( a( combination( of( pregnenolone( +alcohol( (gray(
hashed(bars)(regulated(expression(of(these(subunits.(((
(
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pregnenolone,(or(a(combination(of(alcohol(+(pregnenolone((Figure(6.5).((A(limitation(of(this(
study( includes( lack( of( information( about( the( metabolic( halfNlife( of( pregnenolone( in( cell(
culture.( ( While( limited( conclusions( can( be( drawn( from( examining( alcohol/neurosteroid(
interactions( in( neural( cells( from( only( a( few( subjects,( it( is( important( to( highlight( the(
possibility(that(the(neural(media(that(is(used(for(the(prolonged(culture(of(these(cells(may(be(
deficient( in( certain( compounds( necessary( for( observing( full( neural( development,(
replication(of(in#vivo(physiology,(or(the(effects(of(drugs/alcohol.((In(support(of(this,(a(recent(
report( examined( popular( neural( differentiation( media( and( found( that( it( did( not( contain(
physiologicallyNrelevant( concentrations( of( chemical( compounds,( and( actually( inhibited(
neuronal(activity(and(network(development((Bardy(et(al.,(2015).((The(group(tested(a(neural(
medium( with( concentrations( of( salts,( amino( acids,( and( vitamins( that( more( closely(
resembles(human(physiologic(composition(and(reported(increased(number(of(synaptically(
active( neurons.( ( Future( work( examining( the( effect( of( alcohol( exposure( will( benefit( from(
these( advances( in( defining( optimal( neural( cell( media( to( explore( whether( differences( in(
GABAA( receptor( function( and( gene( expression( can( be( observed( in( this( in# vitro( model(
system.(
(

One( benefit( of( human( iPSCs( as( a( model( system( to( study( AUD( is( the( potential( to(

identify( novel( targets( of( alcohol( that( may( lead( to( novel( and( potentially( more( efficacious(
treatments.( ( One( method( to( identify( novel( genes( that( are( regulated( by( alcohol( is( by(
examining(expression(of(the(entire(transcriptome(using(tools(such(as(microarray(and(RNA(
sequencing.((To(date,(many(studies(have(used(largeNscale(gene(expression(profiling(to(study(
AUD,(including(examination(of(basal(transcript(level(in(human(postNmortem(brain(derived(
from( alcoholics( vs.( controls( (McClintick( et( al.,( 2013,( Liu( et( al.,( 2006)( and( from( alcohol(
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preferring( vs.( nonNpreferring( rats( (Liang( et( al.,( 2010,( Edenberg( et( al.,( 2005),( which( have(
also( been( used( to( examine( the( effects( of( chronic( alcohol( selfNadministration( (Rodd( et( al.,(
2008).( ( A( limitation( of( postNmortem( studies( includes( not( being( able( to( decipher( whether(
significant( gene( expression( differences( were( present( at( baseline( or( after( years( of(
alcoholism,( while( the( rodent( studies( are( limited( in( their( relatedness( to( the( human(
condition.((Therefore,(RNA(sequencing(of(alcoholNexposed(human(iPSCNderived(neural(cells(
may( provide( useful( insights( into( gene( expression( changes( following( alcohol( exposure( in(
human( neural( cells.( ( Since( gene( expression( changes( following( alcohol( exposure( could( be(
identified( by( examining( shamNtreated( vs.( alcoholNtreated( cells( derived( from( the( same(
subject,( contrasts( could( also( be( made( between( cells( derived( from( alcoholics( vs.( nonN
alcoholics.((We(have(currently(sequenced(neural(cells(exposed(to(50mM(alcohol(for(7(days,(
as(well(as(the(paired(sham(condition,(from(a(total(of(10(donor(subjects(consisting(of(5(nonN
alcoholic(and(5Nalcoholic(donor(cell(lines,(and(are(in(the(process(of(analyzing(the(results.((To(
our(knowledge,(this(will(be(the(first(time(transcriptome(profiles(will(be(generated(following(
alcohol( exposure( of( human( iPSCNderived( neural( cells( from( phenotypically( characterized(
donors.( ( Preliminary( findings( indicate( that( basal( expression( levels( between( neural( cells(
derived(from(nonNalcoholics(and(alcoholics(are(highly(correlated,(and(exposure(to(alcohol(
for( 7( days( causes( a( greater( number( of( significantly( regulated( genes( in( the( neural( cells(
derived(from(nonNalcoholic(donor(subjects((Figure(6.6).((The(only(similar(study(reported(to(
date( used( peripherally( derived( lymphoblastioid( cells( from( 21( controls( and( 21( alcoholics(
that( were( exposed( to( alcohol( for( 24( hours( before( microarray( analysis.( ( This( study( found(
that( alcohol( exposure( caused( many( small( changes( in( gene( expression,( and( the( genes( that(
differed(between(controls(and(alcoholics(clustered(into(functional(groups(including(integrin((
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(
Figure)6.6.)Effects)of)Chronic)Alcohol)Exposure)on)the)Transcriptome)
)

(
(
RNA( Sequencing( was( used( to( examine( the( effects( of( 7Nday( alcohol( exposure( on( gene(
expression( in( mature( neural( cells( derived( from( 5( nonNalcoholic( and( 5( alcoholic.( Donor(
subjects.( ( (A)( Basal( gene( expression( was( highly( correlated( between( donor( subject(
phenotype( across( the( entire( transcriptome.( ( (B( and( C)( More( genes( were( significantly(
regulated( in( neural( cells( derived( from( control( subjects( following( chronic( 7Nday( alcohol(
treatment( using( paired( tNtest.( ( Genes( that( were( significantly( regulated( were( grouped( into(
bins(based(on(foldNchange(in(expression.(
(

(
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signaling,(ERK/MAPK(signaling,(and(Rho(family(GTPase(signaling((McClintick(et(al.,(2014).((
However,(because(gene(expression(profiles(in(peripheral(cells(are(weakly(correlated(with(
the(expression(in(the(central(nervous(system((Sullivan(et(al.,(2006),(we(anticipate(that(our(
sequencing(results(using(human(neural(cells(may(be(more(relevant(to(the(in#vivo#condition.(((
(

The(results(reported(in(this(dissertation(highlight(some(of(the(potential(benefits(of(

using( iPSCs( in( the( study( of( AUD.( ( An( additional( benefit( of( using( iPSCs( is( the( ability( to(
genetically( modify( mutations( through( the( use( of( TALEN( or( CRISPR( technologies,( which(
could( be( of( interest( in( our( studies( if( a( functional( mutation( is( discovered( that( leads( to(
reduced(chromosome(4p12(GABAA(gene(cluster(expression.((Furthermore,(iPSCs(have(the(
potential( to( be( used( in( the( study( of( pharmacogenetics( of( candidate( AUD( treatments.( ( For(
example,(topiramate’s(efficacy(in(reducing(heavy(drinking(was(found(to(be(moderated(by(a(
polymorphism( in( a( gene( encoding( the( GluK1( subunit( of( the( kainate( receptor( subunit(
(GRIK1,( rs2832407),( which( itself( is( a( target( of( topiramate( (Kranzler( et( al.,( 2014a).( ( iPSCs(
could( be( generated( from( donor( subjects( characterized( at( this( marker( (rs2382407)( and(
differentiated(into(neural(cell(types(to(examine(the(molecular(effects(of(topiramate(between(
genotypes.( ( Challenges( of( utilizing( iPSC( technology( include( the( generally( limited(
understanding(we(currently(have(of(induced(stem(cells(and(neural(differentiation.((The(field(
is( continuing( to( explore( and( discover( the( optimal( conditions( needed( for( iPSCNderived(
neural( cells( to( best( recapitulate( in#vivo#characteristics,( for( example( the( derivation( of( new(
culture( mediums( that( facilitate( neural( connectivity( (Bardy( et( al.,( 2015).( ( Additionally,(
research(is(continuing(to(gain(insights(into(the(transcriptome(and(epigenetic(landscapes(of(
human( iPSCs( compared( to( embryonic( stem( cells( and( parent( tissues( (BarNNur( et( al.,( 2011,(
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Choi( et( al.,( 2015),( which( may( lead( to( iPSC( derivation( and( differentiation( protocols( that(
better(mimic(the(human(in#vivo(condition.(((
(

(
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Chapter)7.)
Conclusion(
(

AUD(is(a(complex,(heterogeneous,(devastating(disorder(that(is(prevalent(in(modern(

society.((Through(decades(of(research(examining(the(actions(of(alcohol,(we(have(gained(a(
significant( understanding( into( its( mechanisms( of( action.( ( Despite( this,( prevention( and(
treatment(of(AUD(is(lacking.((Better(model(systems(to(explore(in#vitro(actions(of(alcohol(and(
molecular( effects( of( AUDNassociated( genetic( polymorphisms( may( lead( to( novel(
understandings(of(the(disorder(and(in(turn(more(efficacious(treatment(options.((The(studies(
presented( here( have( examined( the( use( of( human( induced( pluripotent( stem( cell(
differentiation(as(a(model(for(AUD(research.((Although(many(challenges(are(presented(with(
the(use(of(iPS(cells(in(the(study(of(complex(psychiatric(disorders,(we(conclude(that(human(
iPSCs(provide(an(adequate(substrate(for(future(researchers(to(utilize(in(the(examination(of(
drug(and(genotype(effects(that(may(influence(risk.((Through(the(use(of(subjectNspecific(cells,(
we(have(the(potential(to(gain(novel(insights(into(the(development(of(AUD,(leading(to(better(
preventative( measures( and( therapeutics( for( affected( individuals.( ( In( summary,( iPS( cell(
technologies(hold(great(promise(for(the(future(considering(that(their(application(in(the(field(
of(psychiatry(is(in(its(infancy.#
(
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